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ABSTRACT OF DISSERTATION 
Molecular Mechanisms Regulating Optic Fissure Fusion During Zebrafish Eye 
Development 
Vertebrate retinal development requires timely and precise fusion of the optic 
fissure. Failure of this event leads to congenital vision impairment in the form of 
coloboma. Recent studies have suggested hyaloid vasculature to be involved in OF 
fusion. In order to examine this link, we analyzed optic fissure fusion and hyaloid 
vasculogenesis in the zebrafish pax2a noi mutant line. We first determined that pax2a-/- 
embryos fail to accumulate F-actin in the optic fissure prior to basement membrane (BM) 
degradation. Furthermore, using 3D and live imaging we observed reduced OF hyaloid 
vascularization in pax2a-/- embryos. When examining the connection between pax2a loss 
of function and hyaloid vasculature, we observed significant reduction of talin1 
expression, a regulator of hyaloid vasculature. In addition, cranial VEGF expression was 
found to be reduced in pax2a-/- embryos. Pharmacological inhibition of VEGF signaling 
phenocopied the pax2a-/- vasculature, F-actin and BM degradation phenotypes. Lastly, we 
determined that optic fissure associated hyaloid vasculature is a source of mmp2, 
mmp14a and mmp14b expression and showed that mmp2 is functionally necessary for 
degradation of optic fissure BM. We compared transcriptomic profiles between pax2a-/-
and wildtype (WT) embryos. We sought to validate and investigate those targets which 
were thought to be of importance to the molecular machinery involved in fusion, 
particularly those involving the actin cytoskeleton and angiogenesis. This analysis 
uncovered a novel connection between regulation of angiogenesis and fusion. Loss of 
pax2a resulted in increased expression of an anti-angiogenic protease, ADAMTS1. 3D 
confocal and live imaging of retinal hyaloid vascularization in Tg[kdrl:mCherry] 
embryos indicated a significant deficit in ADAMTS1 mRNA injected embryos and 
phenocopied the pax2a mutant phenotype. We have also uncovered preliminary evidence 
that certain actin associated proteins are also differentially regulated, particularly rho-
associated protein kinase (ROCK). Taken together we propose a pax2a driven mechanism 
that ensures proper and timely hyaloid vasculature invasion of the OF by negatively 
regulating ADAMTS1 expression. This enables the timely hyaloid vascularization of the 
retina which in turn directly signals to initiate fissure fusion via cytoskeletal 
rearrangements and providing the BM remodeler mmp2.   
KEYWORDS: Optic fissure fusion, coloboma, basement membrane, F-actin, hyaloid 
vasculature, pax2 
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 The most challenging thing that will ever occur to you happened long before you 
had a conscious thought. You became you by completely building yourself from a single, 
solitary cell. Development of an organism is no easy feat, it begins with a single cell 
which divides into many. These cells then undergo specialization to become unique cell 
types. During this time, cells will interact with one another in their environment to 
coordinate this complex process. And finally, cells will move and arrange themselves into 
the proper spatial order to form all the structured organs and tissues in the body. Cell 
movements that shape tissues and organs, known as morphogenesis, is a beautifully 
complex process. Each tissue and organ in the body has a specialized way in which it 
creates its unique form. This process must be tightly regulated to ensure that the end 
result is a completely functional organ, failure could result in catastrophic consequences. 
Morphogenetic movements are able to create three-dimensional tissues from a two-
dimensional sheet of cells through an intricate process of cellular coordination. Whereby 
cell-cell communication, signaling pathways, and morphogen gradients work in concert 
to perform a very precise task resulting in cell differentiation, proliferation, and death. A 
common by-product of morphogenetic movements resulting in three-dimensional tissues 
are gaps, fissures, or holes in those developing tissues. Filling these gaps is therefore an 
essential step of morphogenesis, failure to do so will affect tissue integrity, and often has 
disastrous consequences on the function of that tissue. The mechanism that development 
uses to fill these holes is epithelial fusion, a joining of epithelial cells. Epithelial fusion is 
a mystifying mechanism, it has been studied for over a century and yet there is still little 
insight into the direct cellular mechanics of this process. The overarching goal of my 
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dissertation has been to examine the molecular mechanisms behind epithelial fusion 
during early development. 
1.1 Cellular Movement During Morphogenesis 
1.1.1 Morphogenesis 
 Morphogenesis, an elusive process in which genetics lead to geometry, is 
involved in the six fundamental stages of vertebrate development. The six stages of 
vertebrate development begin with fertilization, where fusion of two gametes begins the 
intricate process resulting in an organism. The second stage is cleavage, where rapid cell 
division occurs resulting in a multi-cellular embryo. Once cleavage has created over 100 
cells the embryo is then termed a blastula which contains two layers, the blastoderm and 
the fluid- or yolk-filled blastocoel. After formation, the blastula undergoes gastrulation 
where the 2 or 3 germ layers are created, ectoderm, endoderm, and mesoderm in 
organisms containing three germ layers. Next in development is somitogenesis, the 
formation of somites which differentiate into skeletal muscle, vertebrae, and dermis. The 
final stage of embryonic vertebrate development is organogenesis, where the organs of 
the embryo develop. Morphogenesis is the process by which tissues undergo organization 
and shape change to create the three-dimensional organs in the body. Each structure in 
the body has its own set of “code” which regulates the shape and therefore function of 
each individual organ. The genetic code that directs morphogenesis results in the 
coordinated movement of cells, these cells move in unison as a sheet which can undergo 
many types of morphogenetic movements. There are five main classes that can be used to 
describe the various morphogenetic movements during development; convergent 




1.1.2 Convergent Extension 
 Convergent extension is the process by which cells will converge along one axis, 
narrowing the tissue, and extend outwards across a perpendicular axis (Figure 1.1 A). 
This process is a way to achieve elongation of tissue without further growth. This process 
is utilized amongst vertebrate and invertebrate species, and has been particularly well 
studied during the body axis elongation of the notochord [1]. Cell movement during 
convergent extension is unique from cellular migration. However, during convergent 
extension the cellular movements are a polarized movement between neighboring cells 
resulting in tissue remodeling [2]. During convergent extension there are two axes of 
polarization that guide the mediolateral intercalating movements, and the force generated 
from these movements are exerted onto the neighboring cells, not the extracellular matrix 
(ECM) [2]. There are two modes with which the intercalation of cells during convergent 
extension can occur. The first is the cell crawling mode, most notably associated with 
convergent extension of mesenchymal cells like the notochord [1]. Here membrane 
protrusions at both ends of the elongated cell, which closely resemble actin based 
lamellipodia, are used to crawl in between neighboring cells resulting in intercalation [1]. 
The second is the cell contraction mode, and it is associated with convergent extension of 
epithelial tissue [1]. In this mode actomyosin accumulates at the cell-cell junctions which 
then generates a contractile force between the cells resulting in shrinkage of the cell 
membranes which provides enough force to move neighboring cells [3]. One of the most 
vital molecular pathways governing both modes of convergent extension is that of the 
planar cell polarity (PCP) pathway, which is composed of cytoplasmic proteins 
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Dishevelled and Prickle, as well as transmembrane proteins Frizzled, Vangl, and Celsr 
[4]. Interestingly, studies have shown that Rho and its downstream effector Rho-
associated protein kinase (ROCK) transduce the signals from the PCP components 
resulting in the cytoskeletal dynamics of actin polymerization and actomyosin contraction 
required for both modes of convergent extension [5, 6].  
 
1.1.3 Epiboly 
 Epibolic movements involve the spreading and thinning of tissue through 
coordinated movement of an entire sheet of epithelial cells to enclose the deeper layers of 
the embryo (Figure 1.1 B). There are many different ways in which epiboly can be 
accomplished; cell division, cell shape change, cell intercalation, or a combination 
thereof [7]. Epiboly has been extensively studied during zebrafish gastrulation [8]. 
During epiboly, cells will dome outward at the area of the blastula and will undergo cell 
shape and location changes in order to extend vegetally towards the opposite pole, 
eventually encapsulating the entire embryo. There are two characteristics of epibolic 
movement, radial intercalation and the coordinated flattening of cells to allow for the 
spreading of the epithelial sheet.  Radial intercalation is unique from that of mediolateral 
intercalation in that cells will exchange places throughout an entire multi-layered tissue 
instead of within the same plane. Radial intercalation does not require the polarization of 
cells and therefore does not use the PCP pathway as does mediolateral intercalation. The 
radial intercalations during epiboly require the use of cell adhesion molecules for proper 
formation, specifically E-cadherin [9]. Zebrafish half-baked/E-cadherin mutants show 
that cells will still intercalate but will not remain and these cells will travel back to their 
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starting position [9]. The proposed driving mechanism behind the cell shape changes 
which provide the tension needed for epiboly to complete has been shown to be through 
the recruitment of actin and myosin II to the margins of the enveloping layer [10]. It is 
proposed that myosin II is required after 50% epiboly has been reached in order to 
constrict the encapsulating layer and complete the envelopment of the embryo through a 
“purse-string mechanism” [11].  
 
1.1.4 Involution 
 Involution involves the concerted inward movement of a sheet of cells from a 
growing external layer. These cells spread themselves along the internal surface of the 
remaining outer layer (Figure 1.1 C). Involution is involved in the formation of many 
processes including amphibian gastrulation, where migrating marginal cells involute at 
the dorsal lip of the blastopore. These involuting cells will create many structures 
including the archenteron, the prechordal plate, and the notochord. Involution also occurs 
during Drosophila head involution, where through dramatic cell shape changes the 
anterior tissues of the embryo are internalized [12]. The particular genes and pathways 
involved during involution are poorly understood and those that are known appear to be 
tissue/cell type specific [13]. An example of this is during the involution of cells through 
the dorsal lip in amphibians. A forkhead gene, MocuFH1, seems to control the involution 
of the presumptive notochord and mesenchymal cells [14]. When treated with antisense 
oligodeoxynucleotides, these two populations of cells fail to undergo involution at the 
dorsal lip [14]. However, the presumptive muscle cells are unaffected by the treatment, 




 Ingression is conceivably one of the most studied morphological process. During 
ingression epithelial cells transform into migrating mesenchymal cells (Figure 1.1 D). To 
do so they change many properties about themselves, they change their cellular 
architecture, their motility, as well as their adhesive properties. One example is during 
primitive streak development during gastrulation. During primitive streak development 
epithelial cells lose their apico-basal polarity, as well as their adherent junctions [15]. 
Once again, cytoskeletal changes are crucial for ingression to occur, these cells must 
ingress out of the epithelium and become migratory within each individual cell which 
heavily depends on cytoskeleton function [16]. The beginning of cytoskeletal changes 
occurs by apical constriction as well as a disorganized basal cytoskeleton [16]. Finally, 
through the activity of matrix metalloproteases, the basement membrane of these cells are 
broken down [17]. Perhaps one of the most well-known examples of ingression is that of 
neural crest cells, which emigrate from the epithelium and migrate to other locations in 
the developing embryo. During neural tube development the neural plate epithelium rolls 
upward to form a cylindrical structure. Once the apposing sheets contact one another and 
begin to fuse, the cells located directly next to the fusing tissue near the dorsal midline 
undergo ingression, commonly referred to as epithelial to mesenchymal transition (EMT) 
[18]. These neural crest cells go on to contribute to the formation of a number of tissues 
in the developing embryo. Many signaling pathways have been associated with EMT 





 Invagination, much like involution, involves the inward movement of cells. 
Unlike involution, invagination is the bending of a sheet of cells inward to create a 
pocket, as if being poked from the exterior surface (Figure 1.1 E). Invagination occurs 
during the development of many tissues and can be accomplished through two different 
types of mechanisms, axial and orthogonal [20]. Axial invagination occurs at a singular 
point and invaginates along the axis that the tissue will form, such as the initiating phase 
of gastrulation where the blastula cells invaginate to form the ectoderm and endoderm 
[20]. Orthogonal invagination occurs along a line instead of a singular point which 
creates a furrow, the axis of which is perpendicular to the area of invagination, as seen 
during the formation of the neural tube [20]. Broadly, there are two molecular 
mechanisms that can direct invagination, the cytoskeleton and the extracellular matrix. 
These two mechanisms have been shown to work both independently as well as in 
concert during development [21, 22]. The cytoskeleton is often used to drive apical 
constriction through the activation of Shroom, RhoA, ROCK, and actin-myosin 
contractility which result in a cytoskeleton driven invagination event [23]. The 
extracellular matrix, on the other hand, is used to stiffen the basal lamina which results in 
a resistance of the basal surface to deform [24]. To accomplish this, cells often swell their 
extracellular matrices by secreting a large chondroitin sulphate proteoglycan [24]. These 
proteoglycans can absorb water causing the matrix to swell. Due to this differential 
swelling the matrix buckles inward resulting in invagination of the sheet of cells [24]. 
One example of these two molecular mechanisms of invagination occurring 
simultaneously is during neural tube development. During neural tube folding there are 
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two distinct curvatures in the tissue, one being convex at the dorsolateral hinges, while 
the median hinge point is concave. The median hinge point shows apical constriction 
through use of the cytoskeleton, while the dorsolateral hinges are basal in origin through 
use of the ECM [25, 26]. 
1.2 Epithelial Fusion During Retinal Morphogenesis 
 
1.2.1 Epithelial Fusion  
 All the various types of morphogenetic movements are crucial for proper 
development of an organism. However, these morphogenetic movements are just the 
initial steps in forming a functional three-dimensional organ. Often times, as a result of 
these cellular movements, gaps, fissures, or holes are created in the tissue. Filling these 
gaps is an essential process of morphogenesis. Failure to do so will affect tissue integrity, 
and often has disastrous consequences on the function of the organ. The mechanism 
which development uses to fill these gaps is called epithelial fusion. Epithelial fusion can 
be observed during the formation of many organs including, neural tube, heart, palatal 
shelf, urethra, uterine ligament, diaphragm, eyelid, optic fissure, and even dorsal closure 
in Drosophila. Epithelial fusion is susceptible to disturbance which results in congenital 
malformations. For example, failure of the neural tube to close results in several different 
disorders, including spina bifida, and anencephaly [27]. Failure of the epithelium to fuse 
in the heart results in many congenital heart defects [28]. Failure of the palatal shelf to 
fuse results in cleft palate [29]. And failure of the optic fissure to fuse results in coloboma 
[30]. Many of these congenital defects present themselves as part of syndromes, such as 
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CHARGE syndrome, where those affected experience colobomas, heart defects, and 
more [31]. This suggests that there are shared common mechanisms amongst fusion 
events, thus understanding mechanisms regulating one fusion event might be applicable 
to other fusion events as well.  
 
1.2.2 Retinal Morphogenesis 
1.2.2.1 Eye Field Specification 
 Vertebrate eye development is a highly conserved process which shares many of 
the same mechanisms amongst all vertebrate species [32]. Eye development begins with 
the specification of the eye field in the diencephalon. The specification of the eye field 
relies on the expression of a network of key transcription factors Six3, Rx, and Pax6 [33].  
 Six3 is one of the earliest transcription factors in eye specification, and is required 
for the repression of Wnt activity in the diencephalon [34]. Overexpression of Six3 results 
in the formation of ectopic eyes in fish [35]. Loss of function of Six3 in mouse knock-out 
models result in the loss of markers anterior to the midbrain coupled with the expansion 
of markers posterior to the midbrain [36]. Congruently, overexpression of Wnt signaling 
represses Six3 expression resulting in the same loss of eye field specification as Six3 
mutants [37].  
 Pax6 has been considered the master eye regulating gene, though in more recent 
studies it is suggested that this title belongs to Six3 [38]. Pax6 mutant mice initially 
develop primitive eye structures but are unable to properly develop and disappear as 
development progresses [39]. Pax6 has the ability to activate transcription of Six3 and is 
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suggested to be the reason why ectopic expression of Pax6 has the ability to induce eye 
formation [40].  
  A class of retinal homeobox transcription factors known as Rx are also required 
during eye field specification. Rx genes are involved in the control of proliferation 
through regulation by Six3 and Optx2 [33]. Loss of function of Rx3 in zebrafish results in 
failure of optic vesicle evagination and thus complete absence of the retina [41].  
 Together Six3, Pax6, and Rx are required to restrict the expression of Otx2 [42]. 
Otx2 appears to be required to set up the eye field transcription network of Six3, Pax6, 
and Rx, but once this network has been established Otx2 expression is down-regulated in 
the eye field region [43]. It is suggested that Otx2 acts permissively during eye 
development to confer competence of the eye field region since it has been shown that 
Six3 can only induce ectopic eye formation within the Otx2 expression domain [35].  
 
1.2.2.2 Eye Field Division 
 Once the eye field has been specified, it must then undergo division into two 
symmetrical primordium to eventually create the optic vesicles. To achieve this division 
members of the Shh-, Tgf-𝛽-, and Fgf- families are secreted within this region [44]. 
Without proper regulation of these factors the eye field fails to undergo division and 
results in cyclopia, the formation of a single eye [44]. It is suggested that due to these 
secreted factors prospective hypothalamic cells migrate anteriorly through the eye field 
physically separating the eye field into the two symmetrical primordium [45].  
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 Shh is a crucial morphogen for patterning of the eye primordium [46]. Through 
Fgf signaling the eye primordium is capable of responding to Shh signaling which must 
be tightly regulated [46]. As stated previously, absence of Shh results in cyclopia, 
alternatively, over expression of Shh result in the over development of proximal 
structures at the consequence of distal structures [47].  
 
1.2.2.3 Evagination 
 Morphogenesis and proliferation usually go hand in hand, however, this appears 
to not be the case with optic vesicle evagination. Evagination of the optic vesicles is 
achieved through different mechanisms dependent upon species. In mouse, it is proposed 
that extensive cell shape changes are the driving force of evagination [48]. In zebrafish, 
migration of the retinal progenitor cells (RPCs) seem to be the driving force [49]. Cells 
immigrate to this region where they intercalate and epithelialize resulting in growth of the 
optic vesicle [50]. The optic vesicles then continue extending out from the diencephalon 
due to the continuous intercalation of newly arriving RPCs [51]. These migrating RPCs 
display a specific migratory pattern determined by signaling and cell adhesion molecules, 
and in zebrafish the migratory behavior seems to rely heavily on Rx3 [52]. At the onset 
of neurulation Rx3 positive RPCs show a delayed migration pattern in comparison to 
non-RPCs [49]. In the absence of Rx3, RPCs still form but they remain at the midline and 





1.2.2.4  Optic Cup 
 The formation of the optic cup from the optic vesicle requires morphogenetic 
movements to create the bi-layered spherical structure. This is achieved through 
invagination of the optic vesicle once it reaches the overlying surface ectoderm. At this 
point the optic vesicle invaginates to create the optic cup which is attached to the optic 
stalk leading back to the forebrain. The overlying surface ectoderm invaginates to create 
the lens placode. It was previously thought that formation of the optic cup required the 
lens placode in order to form, but recent findings have shown that contact with the 
surface ectoderm is only required to initiate the invagination process through temporal 
regulation [52]. Once the optic vesicle reaches the surface ectoderm the optic cup will 
continue to form in the absence of the lens placode as observed through ablation 
experiments [53].  
 The invagination of the optic cup relies heavily on cell shape changes to direct the 
cellular movements [54]. This is achieved through basal constriction of the cells creating 
a triangular shape [54]. In the absence of Opo, a transmembrane protein responsible for 
controlling the location of focal adhesions, basal constriction fails to occur resulting in 
failure of the optic cup to form [54]. The basal constriction of these cells results in rim 
involution, whereby cells traverse the outer layer moving inward around the rim of the 
optic cup into the inner layer of the optic cup resulting in the bi-layered spherical optic 
cup [55]. Once the optic cup has formed it is comprised of an outer layer of retinal 
pigmented epithelium (RPE), an inner layer of neural retinal cells, retinal ganglion cells 
and their axons which traverse the length of the optic stalk to the forebrain, and a fissure 
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along the ventral length of the optic stalk. After fusion of this fissure the optic stalk 
becomes the optic nerve, and retinal morphogenesis has completed. 
1.3 Fusion of The Optic Fissure 
1.3.1 Optic Fissure Fusion 
 As a consequence of the formation of the three-dimensional retinal sphere from a 
flat sheet of cells is the formation of a fissure along the ventral length of the optic stalk. 
This fissure allows for migratory mesenchymal cells to enter the retina to establish 
vasculature networks onto the back of the lens. This vasculature is known as the hyaloid 
vasculature, and is a temporary circulatory system required for ocular development. In 
most species this circulatory system will degenerate once mature blood vessels begin to 
grow [56]. The optic fissure will undergo epithelial fusion to attach the adjacent lobes to 
sheath the retinal ganglion cell axons. The timing of fusion of the optic fissure varies by 
species, in humans this occurs between the 5th and 7th week of gestation, in zebrafish 
fusion occurs between 32 and 72 hours post fertilization (hpf) [57]. Like many other 
epithelial fusion events, when fusion fails to occur it results in congenital disorders. In the 
case of the optic fissure the result is coloboma.  
 
1.3.2 Coloboma  
 Coloboma is a leading cause of pediatric blindness accounting for approximately 
10% of all cases worldwide [58]. Approximately 1 child in every 10,000 births are 
diagnosed with coloboma, though incidence seems to be at a higher rate on the Indian 
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subcontinent. Coloboma is a spectrum disorder and can present itself to varying degrees. 
Depending on the location and degree to which the fissure was able to fuse will 
determine the amount of visual acuity the affected individual will have [58]. A large gap 
in the more proximal regions of the fissure will expose a significantly larger portion of 
the retinal ganglion cell axons to the external environment resulting in neuronal death and 
complete blindness in the affected eye [59]. While a small gap at the most distal regions 
of the fissure will mildly affect visual acuity [59]. There are many different coloboma 
classifications depending on the structure that has been affected. One of the most 
common classes of coloboma is iris coloboma, these are most commonly in the ventral 
region of the iris resulting in a keyhole like shape in the pupil. Lens coloboma are when a 
section of the lens is missing, and large lens colobomas can result in the displacement of 
the lens. Macular coloboma is when a portion of the macula, region of the retina 
responsible for central vision, is missing resulting in partial loss of vision. Optic nerve 
coloboma can appear with retinal or choroidal colobomata and can result in retinal 
detachments. While surgery can be performed to correct the appearance of colobomas 
and to repair retinal detachment, unfortunately, any visual loss experienced is permanent 
and is unable to be corrected. Fusion of the optic fissure doesn’t occur simultaneously, it 
is a step wise process that begins in the medial regions of the fissure and “zippers” 
proximally and distally from this location. Due to this, failure of fusion could occur at 
any localized point resulting in a broad spectrum of effects on those who have this 
disorder [59]. Coloboma can also be unilateral affecting only one eye, or bilateral 
affecting both eyes. It is even suggested that cases of colobomata are underreported as 
small lesions in the proximal regions could go unnoticed with adequate vision function 
15 
 
[58]. Most of the work done on understanding coloboma investigates the spatial and 
temporal control of gene patterning preceding, during, and after optic fissure fusion. 
From this previous work several genetic pathways have been elucidated including 
BMP/TGF-𝛽, retinoic acid (RA), SHH, FGF, Wnt/𝛽-catenin, and a whole host of 
transcription factors.  
 
1.3.3 Transcription Factors and Sonic Hedgehog 
 Most causes for coloboma are due to genetic abnormalities. However, for non-
syndromic instances of coloboma in humans over 70% percent of individuals do not have 
an identified genetic cause [58]. Identification of the genetic cause in syndromic 
coloboma, however, is much higher [58]. Mutations in the transcription factors pax2 and 
pax6 (paired box) can result in coloboma, mutations in pax2 accounts for approximately 
50% of individuals with renal coloboma syndrome [60]. It has been reported that 92 
mutations have been found in the pax2 gene, and one particular mutation has been 
reported 57 times in individuals with coloboma [61]. Even though pax2 has been closely 
associated with coloboma little is known about how this transcription factor functions or 
what its targets are. Sox2, Sox4, and Sox11 (SRY-related HMG-box genes) have also 
been associated with coloboma [62]. It has been shown that Sox4 and Sox11 limit sonic 
hedgehog (shh) signaling in the ventral region of the optic cup and when mutated in 
zebrafish results in expression of shh in the ventral region leading to coloboma [62]. 
Transcription factors associated with the periocular mesenchyme (POM) have also been 
linked to coloboma, in particular pitx2 [63]. POM cells are a sub-population of cranial 
neural crest cells which migrate to the eye and develop many structures in the anterior 
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segment of the eye. POM cells are also partly responsible for the establishment of the 
hyaloid vasculature in the retina [64]. Many of these POM associated transcription 
factors have been observed to cause coloboma in the zebrafish model, however, these 
mutations are rare within human patients [64]. Many other transcription factors have also 
been linked to coloboma, for a comprehensive list of genes associated with coloboma see 
Table 1.1. 
 
1.3.4 Bone Morphogenetic Protein/Transforming Growth Factor Signaling in Optic 
Fissure 
 Bone morphogenetic proteins (BMP)/Transforming Growth Factor-𝛽 (TFG-𝛽) are 
a class of growth factors known for coordinating tissue architecture during 
morphogenesis. To date two particular BMP’s have been shown to be required for optic 
fissure morphogenesis, BMP4 and BMP7. Sonic Hedgehog (SHH) restricts the 
expression of BMP4 to the dorsal regions of the retinal tissue [65]. BMP4 thus dorsally 
induces the expression of certain T-box transcription factors known for their repressive 
capabilities [65]. BMP4 also restricts a well-known eye patterning gene, Vax2, from the 
dorsal regions of the retina [66]. Tgfβ signaling can trigger changes to the extracellular 
matrix (ECM) and is also inhibited by BMP signaling [67]. In both mouse and zebrafish 
loss of Tgfβ2 results in coloboma [68]. It was specified that Tgfβ signaling in the optic 
fissure induces the expression of BMP4 antagonists to allow Tgfβ signaling to induce 
changes to the ECM permitting the fusion of the optic fissure [68]. BMP7 controls the 
formation of the optic fissure, and controls the early expression of Pax2 [69]. In mouse, 
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loss of BMP7 results in an absent hyaloid artery as well as microphthalmia/anophthalmia 
and failure of optic fissure formation [69].  
 
1.3.5 Fibroblast Growth Factor Signaling in Optic Fissure  
 Fibroblast Growth Factor (FGF) signaling is required during eye development as 
it regulates the formation of the eye field as well as specifies the neural retina [70]. 
Research into FGF signaling usually focuses on its receptors as the genetic redundancy of 
FGFs is large, in mice alone there are 22 different FGF genes [70]. In mice, Fgfr1/Fgfr2 
mutants display a coloboma phenotype and is considered to be caused by a loss of Pax2 
expression [71]. Also in mice, it has been shown that mutations in the FGF genes which 
result in the activation of Ras-ERK signaling result in coloboma due to a loss of Pax2 in 
the optic fissure [72]. In humans, most instances of coloboma due to FGF mutations are a 
part of syndromes. Coloboma is observed in those with Noonan syndrome which is a 
result of a gain of function mutation in Ras/MAPK signaling [73]. Coloboma has also 
been observed in two families that have COMMAD syndrome which is the result of a 
mutation within the MITF gene [74].  
 
1.3.6 Retinoic Acid Pathway in the Optic Fissure 
 Retinoic acid (RA) is responsible for establishing the dorsoventral axis in the 
retina. It upregulates Vax2 while simultaneously inhibiting Shh [75]. Retinoic acid also 
plays a role in the upregulation of both Foxc1 and Pitx2 in the POM [76]. Retinoic acid 
also acts in collaboration with the Hippo-YAP pathway in the regulation of migratory 
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neural crest cells, and both have been shown to be involved in optic fissure 
morphogenesis [77]. Mutations in several genes regulated by Hippo-YAP and Retinoic 
acid affect optic fissure closure, RBP4, PTCH1, ALDH1A3, and the RA synthesis gene 
STRA6 all result in colobomatous defects in human patients [78-80]. In both zebrafish 
and humans, mutations in Yap1 result in optic fissure closure defects [81]. Studies in yap 
mutant medaka fish show a loss of actinomyosin contractibility [77]. It is suggested that 
this loss of contractibility is the reason why zebrafish yap mutants have a loss of the 
ventral retinal pigmented epithelium (RPE) which affects the movement of cells around 
the optic fissure during closure [77]. The RA pathway has also been linked to coloboma 
through environmental causes by a maternal dietary deficiency in vitamin A (retinol) 
[82]. Amongst many different species such as pigs, rats, and even humans a maternal 
deficiency in vitamin A has resulted in offspring with congenital eye defects including 
coloboma [82]. Research has shown that eye defects can be rescued by adding an 
exogenous active metabolite of retinol, retinoic acid, in vitamin A deficient subjects, 
indicating that vitamin A operates through the RA pathway [83]. 
 
1.3.7 Wingless-related Integration Site/𝛽-catenin in the Optic Fissure 
 Wingless-related Integration Site (Wnt)/𝛽-catenin is a well known signal 
transduction pathway which has been shown to be tightly regulated in optic fissure 
closure. The Wnt/ 𝛽-catenin pathway requires tight regulation in the optic fissure as it has 
been shown that an up- and down-regulation of the pathway results in optic fissure 
defects [84, 85]. In mice the up-regulation of Wnt signaling by a mutation in Wnt 
19 
 
repressor Foxg1 results in a reduction of expression in Pax2 within the optic fissure 
resulting in coloboma [84]. Alternatively, in mice the down-regulation of Wnt signaling 
through a mutation in Wnt receptor Fzd5 resulted in an over expression of Pax2 in the 
optic fissure leading to coloboma [85]. Altering Wnt signaling has also been shown to 
affect other key genes and pathways in the optic fissure including Vax2, BMP, and RA, 
and all result in optic fissure defects [86]. However, mutations in the Wnt pathway are 
very rare amongst the human population. To date, the only mutation in humans found is 
in the Wnt receptor Fzd5 gene [87]. It was found in a large family with isolated coloboma 
where an autosomal dominant frameshift mutation in Fzd5 was thought to cause effects 
on the actin cytoskeleton within the optic fissure [87].  
1.4 Molecular Mechanisms in Optic Fissure Fusion 
 With 70% of isolated coloboma cases being idiopathic [58], it suggests that the 
most advantageous method of understanding coloboma would lie in understanding the 
molecular mechanisms governing optic fissure fusion. Little is understood about the 
molecular mechanisms involved in optic fissure fusion. However, though little is known 
about each mechanism involved it has been shown that there are three crucial molecular 
machineries required for optic fissure fusion, the basement membrane, actin cytoskeleton, 
and endothelial cell migration [88] (Figure 1.2).  
 
1.4.1 Basement Membrane 
 The basement membrane is a specialized type of extracellular matrix. The 
basement membrane is one of the few common features shared amongst all multicellular 
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animals, appearing very early on in their evolution [89]. This thin, tough, and flexible 
sheet of molecules is a crucial component of all epithelium. This sheet of molecules 
provides a multitude of functions to the epithelium. It is a barrier that distinguishes the 
boundaries of developing tissues [90]. The basement membrane provides the architecture 
of the epithelium, while also being a crucial component of cell-to-cell signaling [90]. 
Many other functions of the basement membrane involve determining cell polarity, 
promoting proliferation, cell survival, and differentiation, and also acts as a highway for 
migrating cells [90]. The basement membrane is made cell-autonomously and excreted 
from the cell to form its basement membrane [90].  The major components of the 
basement membrane are part of a class of ancient extracellular matrix macromolecules, 
laminin, collagen IV, perlecan, and nidogen [90].  
 
1.4.1.1 Laminin 
 Laminin is the primary organizer of the basement membrane, in early 
development laminin is mostly the sole constituent of the basement membrane [91]. 
Laminins are a large family of proteins, there are at least 16 different isoforms expressed 
in mammals [91]. Each of these laminins contain three inter-coiled polypeptide chains, an 
𝛼, 𝛽, and 𝛾, which form a cross shaped structure (Figure 1.3). Each laminin isoform has 
its own polypeptide chain composition allowing them to associate in many different 
combinations, and as such the compositions of the laminins have a high level of cell type 
specificity [91]. Laminin will spontaneously organize itself into a network in vitro 
through interactions between its three short arms [91]. It is believed this is the mechanism 
through which it uses to organize itself in vivo while simultaneously using the long arm 
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to tether itself to receptors on the cell surface. It is thought that laminin is the scaffold 
which allows for the recruitment of all other basement membrane components [91]. The 
most studied laminin family member is laminin-111 (also known as laminin 1) named to 
correspond with its three polypeptide chains 𝛼1, 𝛽1, and 𝛾1. The globular domain at the 
head of the 𝛼 chain of laminin-111 binds to integrins on the cell surface. The globular 
domain at the head of 𝛽 and 𝛾 chains promote self-assembly, while nidogen also has a 
binding site on the second globular domain on the 𝛾 chain. The long arm of the laminin 
molecule can bind to integrins, dystroglycan, and perlecan. The 𝛾1 chain is a component 
of most laminin heterotrimers, as such, mice lacking a functional 𝛾1 chain do not survive 
past embryogenesis due to a lack of a basement membrane [92].  
 
1.4.1.2  Collagen IV 
 Like laminin, collagen IV has many different isoforms, 𝛼1(IV)- 𝛼6(IV). It 
consists of three independently synthesized protein chains, these long chains then twist 
together creating a superhelix (Figure 1.3). This superhelix has interruptions in more than 
20 different regions to allow multiple bends in the protein. Collagen IV molecules 
interact through their terminal domains to assemble into the basement membrane. The 
NH2 terminus binds to three other collagen IV molecules creating a quaternary 
assemblage of the molecules. This structure creates a flexible and felt-like network which 
gives the basement membrane its tensile strength. Unlike laminin, collagen IV does not 
seem to be required for the deposition and formation of the extracellular matrix as mice 
with null mutations in the Col4a1/2 which lack functioning 𝛼 chains develop normally up 
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to E9.5 [93]. However, collagen IV has been shown to be required for the maintenance, 
integrity, and functionality of the basement membrane as the Col4a1/2 null mutation 
caused lethality in the mice at E10.5-11.5 due to severe structural deficiencies in the 
basement membrane [93]. 
 
1.4.1.3 Nidogen 
 Previously known as entactin, nidogen is a small sulfated monomeric 
glycoprotein consisting of three globular domains. Nidogens’ second globular domain 
has the ability to bind both collagen IV and perlecan, while its third globular domain has 
the ability to bind to the 𝛾 chain of laminins (Figure 1.3). Due to these domains it has 
been proposed that nidogen acts as the cross-link between the laminin and collagen IV 
networks [94]. There are two known nidogen homologs in humans, nidogens 1 and 2. 
The two homologs appear to be redundant, loss of one functioning nidogen only presents 
subtle abnormalities [94]. However, loss of both copies of nidogen have been shown to 
result in severe abnormalities in mice [95]. Through deletion of the nidogen binding site 
on the laminin 𝛾 chain it was shown that nidogen is not detected in the basement 
membrane of most tissues showing that it fails to connect to the basement membrane 
without a laminin binding site, further validating that nidogen acts a cross link in the 







 Perlecan, a heparin sulfate proteoglycan, is a major component of basement 
membranes (Figure 1.3). Perlecan is also thought to be involved in the cross link between 
the laminin and collagen IV networks [96]. Perlecan also binds multiple growth factors 
that promote cell survival and differentiation [96]. It has also been observed that perlecan 
interacts with integrins, laminins, and dystroglycans to anchor the basement membrane to 
epithelial cells [97]. Like collagen IV, perlecan does not appear to be crucial to the 
formation of the basement membrane but is required for the maintenance of the basement 
membrane, especially in areas which undergo high levels of mechanical stress. 
Homozygous perlecan mutants form a normal basement membrane, however, in areas of 
high mechanical stress such as in the contracting myocardium, the basement membrane 
deteriorates in that region [98].  
 
1.4.2 Basement Membrane During Optic Fissure Fusion 
 The basement membrane is crucial component of optic cup morphogenesis, 
without laminin the evagination of the eye field fails to occur [99]. Laminin a1, b1, and 
c1 mutants all display to some extent defects in the development of the optic cup [99]. 
Equally as important, however, is the precise timing and control of the degradation of the 
basement membrane in key regions during development. One such region that basement 
membrane degradation is crucial is in the optic fissure. One of the critical functions of the 
basement membrane is to act as a barrier to the external environment, however, this 
barrier is detrimental for fusion of epithelial tissues [90]. Many studies have shown that 
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failure to remove the basement membrane in the region of the optic fissure results in 
colobomas. In rats, a deficiency of RA signaling at later retinal development stages 
results in the retention of the basement membrane in the optic fissure and leads to 
coloboma [83]. Pax2 and Vax2 mutants also show a retention in their basement 
membranes in the optic fissure which also leads to coloboma [88, 100]. Previous work in 
our lab has shown the main constituents of the zebrafish optic fissure basement 
membrane. These include collagen 4a1 and 4a2, perlecan, nidogen 1a, 1b and 2a, and 
laminins a1, a4, b1, c1 and c3 [101]. It was determined that nidogen removal appears to 
be a key component to the degradation of the basement membrane [101]. It is 
hypothesized that removal of nidogen exposes the proteolytic sites on the other basement 
membrane components allowing for their degradation [101]. It is also possible that by 
affecting basement membrane integrity by the removal of nidogen this allows for 
protrusions involved in fusion to form [101]. While it has been known that removal of the 
basement membrane in the region of the optic fissure must occur to allow for fusion, it 
still remains poorly understood whether removal of the basement membrane is an active 
or passive process in the mechanisms underlying optic fissure fusion.  
 
1.4.3 Basement Membrane Breakdown 
 There are a broad class of proteins known as metalloproteinases that have the 
ability to breakdown the basement membrane. These metalloproteinases are a major 
component of basement membrane breakdown and remodeling, not just during 
embryogenesis but throughout the life of an organism. There are three large families of 
metalloproteinases including matrix metalloproteinases (MMPs), a disintegrin and 
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metalloproteinases (ADAMs), and a disintegrin and metalloproteinases with 
thrombospondin motif (ADAMTS). MMPs are the largest family of metalloproteinases, 
so far over 20 human MMPs have been discovered. MMPs are crucial during 
organogenesis and branching morphogenesis and are the main enzymes involved in 
basement membrane degradation. Combined, MMPs have the ability to degrade all 
components of the basement membrane. Most MMPs are soluble proteins, though a few 
of the most recently discovered MMPs are membrane anchored and they have wide 
substrate specificities. All MMPs have a pro-domain and a catalytic domain, and some 
have a variable number of structural domains added. ADAMs, like MMPs, can be 
secreted or are single pass transmembrane proteins. ADAMs have a pro-domain, a 
metalloproteinase, disintegrin, cysteine-rich and a characteristic transmembrane domain. 
Not all ADAMs possess a functional protease domain, those that do are classified as 
sheddases because they cleave the extracellular portions off of transmembrane proteins. 
ADAMTS family of proteins is very closely related to ADAMs, they contain all the same 
domains as ADAMs except instead of a transmembrane domain they contain a 
characteristic thrombospondin motif. Unlike ADAMs and MMPs, ADAMTS are secreted 
enzymes. MMPs, ADAMs, and ADAMTS have a broad spectrum of substrate specificity, 
this contributes to the development and maintenance of many tissues and they participate 
in many physiological processes. These remodeling enzymes contribute to an 
extraordinary amount of processes including bone remodeling, angiogenesis, immunity, 
and wound healing to just name a few [102-104]. The enzymatic activity of these 
metalloproteinases is tightly controlled at the transcriptional level, by pro-peptide 
activation and by inhibition through tissue specific inhibitors of metalloproteinases. 
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Dysregulation of metalloproteinase activity leads to many pathological conditions such as 
inflammation, cancer, arthritis, dwarfism, and more [105-107].  
 
1.4.4 Actin Cytoskeleton 
 Actin, which makes up the cellular cytoskeleton, is the most abundant protein in 
most eukaryotes and in some cell types, comprising approximately 15% of the cellular 
protein content [108]. The actin cytoskeleton is a dynamic network of proteins made up 
of actin and actin binding proteins. Actin is highly conserved amongst eukaryotes where 
the amino acid sequences of actin are upwards of 90% identical. The actin cytoskeleton 
has a diverse range of functions depending on the cell. Actin filaments organize 
underneath the plasma membrane and provide strength and shape to the cell. In 
vertebrates, there are three isoforms of actin an 𝛼, 𝛽, and 𝛾, 𝛽- and 𝛾- actin are most often 
found together in most non-muscle cells while 𝛼-actin is expressed only in muscle cells. 
The actin cytoskeleton is made up of asymmetrical globular or G-actin subunits which 
are tightly associated with an ATP or ADP molecule. The G-actin subunits then assemble 
in a head-to-tail manner which forms a right handed helix. This tight structure is about 8 
nm wide and is called filamentous or F-actin. Due to the asymmetrical nature of G-actin 
the formation of F-actin has structurally different ends which are polarized and has an 
arrowhead like appearance. F-actin has a slow growing end termed minus end, and a fast 
growing end termed plus end. The subunits are positioned so that their nucleotide binding 
site points toward the minus end. The kinetic rate of association and dissociation is much 
higher, approximately 10 times higher, at the plus end. While individual actin filaments 
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are relatively flexible, in living cells these actin filaments interact with accessory proteins 
which cross-link the filaments together to form bundles. These actin filament bundles 
create extensive structures that are quite rigid. How these bundles are formed depends on 
the actions of actin binding proteins, which create specific cytoskeletal structures 
depending on the cell and the function needed by that cell. There are over 100 different 
actin binding proteins which can regulate assembly, disassembly, and/or spatial 
organization of actin filaments. The actin cytoskeleton creates many different structures 
which include microvilli, adhesion belts, the cell cortex, stress fibers, contractile rings, 
lamellipodia, and filopodia. These structures can then go on to perform its specialized 
function which can be classified into three broad categories, spatial organization of the 
cell, physical and biochemical connections to the external environment, and cell 
movement. During epithelial fusion the actin cytoskeleton has shown to be crucial in 
order for proper fusion to occur by creating specialized actin structures and through cell 
signaling.  
 
1.4.5 Actin Cytoskeleton During Epithelial Fusion 
1.4.5.1 Lamellipodia and Filopodia in Epithelial Fusion 
 The actin cytoskeleton has a diverse range of functions during epithelial fusion. 
Two specialized actin structures are thought to be of particular importance to achieve 
fusion, lamellipodium and filopodium. Lamellipodia were previously termed “ruffles” 
due to the ruffled like appearance of the protrusions formed [16]. Lamellipodia are made 
up of an actin dendritic network at the leading edge of the cell shown to be important in 
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mechano-sensing and thought to be the physical motor behind the pulling force in cell 
migration (Figure 1.4) [109]. Lamellipodia form from the nucleation of actin filaments, 
and most often the nucleating protein is the Arp2/3 complex [110]. Arp2/3 complex is 
made up of seven subunits, and the Actin-Related Proteins 2 and 3 closely resemble 
monomeric actin and aids the nucleation of new actin filaments [110]. The Arp2/3 
complex binds to the sides of existing actin filaments and creates a new actin filament at 
a 70 degree angle from the original actin filament [110]. The activity of small GTPases 
from the Rho superfamily are required for the formation of both lamellipodia and 
filopodia. Lamellipodia formation requires the activation of Rac1, this then activates 
WAVE/Scar proteins which then in turn activate the Arp2/3 complex [111].  
 In stark contrast to lamellipodia, filopodia are finger-like structures made up of 
tightly bound parallel bundles of F-actin (Figure 1.4). However, as with lamellipodia, the 
growing end of the filopodium is pointed towards the plasma membrane. The formation 
of filopodia has been shown to depend upon the activation of the cdc42 pathway [112]. 
This results in the activation of proteins from the ENA/WASP family, which prevent the 
growing actin filaments from getting capped at their growing ends [112]. Formins can 
also become activated through these small GTPases. Formins create unbranched actin 
filaments by continuous barbed end nucleation and elongation [113].  
 One of the best studied examples of lamellipodia and filopodia involvement in 
epithelial fusion is during dorsal closure in Drosophila [114]. During Drosophila dorsal 
closure actin based protrusions emanate from the leading edge of the closing epithelial 
sheets and moves the sheet of cells towards the midline [114]. Once the epithelial sheets 
appose one another the sheets fuse together in zippering-type fashion [114]. Filopodia 
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extend across the gap between epithelial sheets and appears to sense the environment to 
find the location where it should make contact, as filopodia have been observed to ignore 
cells closest to it in favor of other more distant cells [114]. It has been observed that once 
cells directly appose one another lamellipodia and filopodia interweave at the cell-cell 
interface [114]. It also appears that filopodia penetrate through the plasma membrane of 
the apposing cell creating the initial cell-cell contacts and adhesions [114]. In line with 
these observations, inhibition of cdc42 and Rac1 results in blocking the formation of the 
actin filaments observed at the leading edges and results in a failure to close the dorsal 
epithelial sheets during Drosophila development [115]. There has also been evidence of 
lamellipodia and filopodia involvement in cranial and neural tube closure. In mice a 
conditionally ablated Rac1 results in failure of epithelial fusion in the cranial and neural 
tube regions. Rho associated kinase (ROCK) is a down-stream effector from the 
activation of Rho GTPases. ROCKI and ROCKII both play roles in actin filament 
assembly by inhibiting actin depolymerization. Mice deficient in ROCKI exhibit a 
disorganization of the actin cytoskeleton in the eyelid epithelium and the umbilical ring 
[116]. Due to this deficiency of ROCKI these mice fail to close the eyelid resulting in an 
open eye phenotype, as well as failure to close the ventral body wall resulting in 
omphalocele [116].  
 
1.4.5.2 Integrins and Cell Signaling in Epithelial Fusion 
 Integrins are a superfamily of transmembrane cell adhesion receptors that form a 
heterodimer made up of an alpha and beta subunit. In zebrafish there are at least 17 
different integrin or integrin-like genes encoding 9 different alpha subunits and 8 
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different beta subunits. Integrins are the main receptors which bind and respond to the 
extracellular matrix, making them crucial during development [117]. Integrins act in two 
very critical methods, they act as cell adhesion molecules as well as signal transducers 
[117]. Integrins usually have low affinity for their binding targets and have a high 
concentration on the cell surface [117]. This creates a large number of weak adhesions 
which allow for easily reversible attachments [117]. Integrins also transmit signals to the 
cell about the extracellular matrix with which it is bound and communication from the 
cell can transmit to the integrins inhibiting or enhancing their ability to bind to their 
target [117]. The interactions between the cell and the extracellular matrix is 
accomplished through the interactions between integrins and the actin cytoskeleton [117]. 
Integrins bind to scaffolding proteins which then bind to actin creating a crosslink 
between integrins and the actin cytoskeleton [117]. Several scaffolding proteins are 
known to interact between actin and integrin, some of which include talin, α-actinin, and 
filamin [117].  
 It has been observed that both integrins and their scaffolding binding partners are 
crucial during epithelial fusion. During mouse neural tube closure integrin 𝛽1 is required 
during the “zippering” process of fusion [118]. Integrin 𝛽1 is activated at the site of the 
zippering creating a focal anchorage at a shared point in the basement membrane creating 
novel cell-cell junctions [118]. When this integrin is lost these focal adhesions fail to 
develop and as such the neural tube fails to fuse resulting in spina bifida [118]. 
Interestingly it has been found that the scaffolding protein talin is directly linked to optic 
fissure fusion. It was shown that talin mutants fail to break down the surrounding 
basement membrane in the lobes of the optic fissure up to at least 72 hours post 
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fertilization [119]. As a result these zebrafish failed to close the fissure and consequently 
developed coloboma [119]. Talin has been purported to be the most crucial aspect of 
integrin adhesion complexes [120]. In Drosophila it was observed talin was required for 
all integrin adhesive functions, and similar results were found in mice lacking both talin 
genes [121]. This suggests that inside-out and outside-in communication between the 
actin cytoskeleton and the basement membrane surrounding the lobes of the optic fissure 
is crucial.  
 
1.4.6 Hyaloid Vasculature 
 The eye is a highly metabolic organ, consuming more oxygen than even that of 
the brain. To provide the eye with the oxygen and nutrients it needs during early eye 
development, two vasculature networks are initially formed, the choroidal and hyaloid 
vasculature (Figure 1.5). Both vasculature networks originate from the same source, the 
ophthalmic artery which is derived from the carotid. These two vasculature networks thus 
form through angiogenesis, meaning they bud off from the primordial vessel. The 
choroidal vasculature network is formed posterior to the eye where it surrounds the optic 
cup. This network is closely associated with the retinal pigmented epithelium (RPE). The 
RPE constitutively expresses Vascular Endothelial Growth Factor (VEGF) which is 
crucial for maintaining the endothelial to epithelial association required for the 
maintenance of this vasculature network. Alternatively, the hyaloid vasculature forms in 
the anterior portion of the eye between the retina and the lens. The hyaloid vasculature 
takes advantage of the optic fissure to establish this network. After entering through the 
optic fissure the hyaloid artery will move through the vitreous and will eventually contact 
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the posterior end of the lens. After contact the hyaloid artery will begin to branch across 
the posterior side of the lens forming the tunica vasculosa lentis. The hyaloid vasculature 
is avenious and in order for drainage to occur the hyaloid network must form connections 
to the choroidal vasculature. The initial hyaloid artery is formed from a mesoderm 
derived endothelial cell lining and periocular mesenchyme (POM) derived pericytes 
[122]. However, after the initial formation of the hyaloid network it becomes solely 
mesoderm derived [122]. Several genetic markers of POM have shown expression in the 
migrating endothelial cells entering through the optic fissure to form the hyaloid 
vasculature, including Sox10, Pitx2, and FoxC1 to date [64, 123, 124]. In most animals 
the hyaloid vasculature regresses and is simultaneously replaced by retinal vasculature. 
However, zebrafish maintain the hyaloid vasculature which undergoes remodeling, 
moving away from the lens and towards the retina as the vitreous forms [125]. It is 
suggested that due to the closer proximity of the lens and retina in zebrafish it is more 
favorable to remodel rather than remake as is done in mammals [125]. It was widely 
believed for many years that these migrating endothelial cells were a passive process 
during optic fissure fusion, but more recent studies have found that these cells directly 
contribute to the fusion process [119]. 
 
1.4.6.1 Factors in Hyaloid Vasculature Establishment 
 One of the most well-known and studied factors that control the migration, 
establishment, and maintenance of the hyaloid vasculature is VEGF. VEGF is a highly 
potent angiogenic factor comprising five members of this gene family, VEGF-A through 
D and PGF, and has three receptors VEGFR1 through 3. Through many different studies 
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across many different species it has been shown that lack of VEGF expression, 
particularly that of VEGF-A, results in a loss of hyaloid vasculature [126-128]. 
Conversely, it has also been shown that overexpression of VEGF-A results in 
hypertrophy of the hyaloid vasculature and has consequences on the hyaloid vasculature 
regression required during mammalian development [129]. In mammals failure of the 
hyaloid vasculature to regress results in persistent hyperplastic primary vitreous [130]. 
This failure to regress is often from the inability to attenuate VEGF functioning [130]. 
VEGF can bind and essentially store itself to the extracellular matrix, interestingly VEGF 
can be cleaved by metalloproteinases which separates the matrix binding domain from 
the receptor binding domain [131]. Many therapies, including the treatment of cancer, 
have been deployed which use anti-angiogenic molecules to sequester VEGF ligands or 
inhibit VEGF function [132]. This therapy has also been deployed to treat persistent 
hyperplastic primary vitreous due to failure of hyaloid regression [133]. Many other 
genes also play a role in hyaloid vasculature development including ECM - cell 
membrane and lens gene expression, including MAGP1, Syn2, Mab21l2, and Laminin 
alpha 1 [134]. When these genes are knocked down all result in hyaloid vasculature 
defects [134].  
 
1.4.6.2 Angiocrine Signaling by Endothelial Cells 
 Endothelial cells are not just a passive conduit for the circulation of blood, but can 
also provide instructive signals during organogenesis. During embryogenesis migrating 
endothelial progenitor cells invade into developing organs and create organ-specific 
vascular niches which will release tissue specific growth factors (angiocrine factors) 
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derived from the endothelium [135]. Angiocrine factors have been shown to be crucial 
during wound repair, a similar epithelial fusion event [136]. During wound repair it has 
been shown that capillary networks are in close physical proximity to hematopoietic, 
mesenchymal, neuronal, epithelial, stem and progenitor cells which allow for the 
instructive paracrine and juxtacrine factors provided by these tissue-specific endothelial 
cells [137]. Of particular interest is the angiocrine signaling that occurs in the 
development of the blood-retina barrier. The blood-retina barrier is established by the 
maturation of the retinal pigment epithelium (RPE), choroidal endothelial cells, and the 
basement membrane that lies between both cell types, Bruch’s membrane [138]. Through 
co-culture experiments it was observed that choroidal endothelial cells secrete factors that 
remodel the basement membrane of the RPE, the integrin receptors sense this change in 
the basement membrane and start a signaling cascade through RhoGTPases which result 
in the modulation of RPE tight junctions as well as the fortification of the RPE barrier 
[138].  While angiocrine signaling has not been associated with optic fissure fusion to 
date, there is some evidence that hyaloid endothelial cells somehow contribute to 
basement membrane breakdown in the region of the optic fissure. Zebrafish cloche 
mutants, which reportedly lack all early vasculature, fail to break down the basement 
membrane in the beginning stages of optic fissure fusion, though it was ultimately stated 
to not result in coloboma as the basement membrane was eventually degraded [119]. 
Requirement of the hyaloid vasculature in optic fissure fusion is also corroborated by 
optic cup transplantation experiments, without the presence of the hyaloid vasculature 
ectopic eyes failed to undergo optic fissure fusion [139]. These experiments suggest an 
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angiocrine dependent mechanism during optic fissure fusion, where endothelial cells 
provide direct contribution to the fusion process.  
1.5 Rationale, Hypothesis, and Specific Aims 
 Although optic fissure fusion has been studied for well over a century the direct 
molecular mechanisms governing this event are still poorly characterized. We know that 
the basic machinery involves the basement membrane, the actin cytoskeleton, and 
migrating endothelial cells, but how these components interact, what they do, and how 
they function are not understood. It has only been within the last decade that it was 
discovered that hyaloid vasculature is not just a passive process taking advantage of the 
optic fissure but is part of the molecular machinery driving this fusion event. The purpose 
of this dissertation was to form a comprehensive analysis on the behaviors of the 
molecular mechanisms of optic fissure fusion, in particular that of the hyaloid vasculature 
involvement in fusion. The overarching hypothesis of this dissertation was that the 
basement membrane, actin cytoskeleton, and the hyaloid vasculature are intimately linked 
to one another to drive optic fissure fusion, and the migrating endothelial cells are a key 
player during this process and is hypothesized to be due to the angiocrine signaling that 
these cells provide. This dissertation will show the first evidence, to date, of angiocrine 
signaling during optic fissure fusion provided by the migrating endothelial cells 
establishing the hyaloid vasculature. Additionally, we show how the other two molecular 
mechanisms, basement membrane breakdown and the actin cytoskeleton, behave and 
what they could possibly contribute to this process.  This discovery was accomplished 




1.5.1 Specific Aims 
I. Characterize the basement membrane, actin cytoskeleton, and hyaloid vasculature 
in wild-type eye development. 
• Use whole mount immunohistochemistry and fluorescently tagged 
proteins to image the behaviors of these molecular mechanisms over the 
course of eye morphogenesis in the wild-type line of zebrafish. 
II. Characterize the basement membrane, actin cytoskeleton, and hyaloid vasculature 
in Pax2 mutant eye development. 
• Use whole mount immunohistochemistry and fluorescently tagged 
proteins to image the behaviors of these molecular mechanisms over the 
course of eye morphogenesis in the coloboma model, Pax2 mutants, line 
of zebrafish. 
III. Determine the consequences to optic fissure fusion in the absence of the hyaloid 
vasculature. 
• Use a vasculature specific drug inhibitor, DMH-4, to eliminate the hyaloid 
vasculature during eye development and assess the consequences to the 
basement membrane, the actin cytoskeleton, and ultimately optic fissure 
fusion. 
• Using DMH-4, assess the temporal requirement of the hyaloid vasculature 
cells during optic fissure fusion. 
IV. Investigate endothelial cell contribution of metalloproteinases through angiocrine 
signaling resulting in the breakdown of the basement membrane. 
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• Use fluorescent whole mount in situ hybridization and qPCR in wild-type, 
pax2 mutant, and DMH-4 treated embryos to investigate any vasculature 
provided metalloproteinases during optic fissure fusion.  
V. Determine the consequences to optic fissure fusion from the inhibition of mmp2. 
• Use a mmp2 drug inhibitor, ARP101, to diminish mmp2 during eye 
development and assess the consequences to the basement membrane thus 
optic fissure fusion. 
• Using ARP101, assess the temporal requirement of mmp2 during optic 
fissure fusion. 
VI. Determine transcriptional differences between wild-type and pax2 mutant eyes. 
• Perform eye dissections, RNA extraction, and illumina sequencing on 
wild-type and pax2 mutant eyes at 48 hours post fertilization.  
VII. Investigate the transcriptional differences between wild-type and Pax2 mutant 
embryos regarding actin cytoskeleton and hyaloid vasculature transcripts 
• Use whole mount in situ hybridization and qPCR to validate transcripts of 
interest from the RNA sequencing data. 
VIII. Investigate ADAMTS1 anti-angiogenic properties during the establishment of the 
hyaloid vasculature 
• Perform mRNA injections into wild-type embryos to cause the over-
expression of ADAMTS1 and assess the consequences to the hyaloid 
vasculature and the basement membrane. 
Aims I, II, III, IV, and V are in Chapter 2 
Aims VI, VII, and VIII are in Chapter 3 
38 
 
















Figure 1-1Morphogenetic Movements. 
Models depicting the five main methods of morphogenetic movements. Red arrows indicate the direction of 
force generated on the tissue. A. Convergent extension, three layers of cells (blue, purple, and yellow) 
intercalate into one sheet. B. Epiboly, a sheet of cells (purple and blue) spreads to envelop the embryo.  C. 
Involution, cells (blue) turn inward creating an underlying layer. D. Ingression, cells (blue) lose contact 
with neighboring cells undergoing epithelial to mesenchymal transition and exiting the tissue. E. 










Figure 1-2Basic Model of Optic Fissure Fusion.  

















Figure 1-3 Basement Membrane 
Diagram showing the four major components of the basement membrane. Laminin, perlecan, and collagen 
IV are capable of self-assembly (red arrows). Nidogen can bind to all other three components of the 
basement membrane, and perlecan can bind to both laminin and collagen IV. Laminins anchor the 










Figure 1-4 Lamellipodia and Filopodia 
Diagram depicting lamellipodia formed through dendritic actin polymerization, and filopodia formed 







Figure 1-5 Completed Superficial Embryonic Vasculature 
Schematic depicting the completed embryonic superficial vasculature network. Red indicates artery, blue 






 MATERIALS AND METHODS  
 
Zebrafish and embryo maintenance 
 Zebrafish were maintained using husbandry procedures approved by University of 
Kentucky IACUC committee. Embryos were kept at 28.5oC in E3 embryo media. AB and 
TL strains were used as wild-type, Tg[kdrl:mCherry] transgenic line was used to 
visualize retinal vascularization [141], Tg[rx3:GFP] was used to visualize retinal cells 
[142].  
 Pax2noi embryos were a gift from Dr. Gregory-Evans. Genotyping analysis was 
conducted by amplifying the region of gDNA with the noi mutation using the forward 
primer: 5’- CTCGCTCTGCCTCCATGATTG3-’and the reverse: 5’- 
GGCACTGAAAGAGCACAGG -3’. The resultant 460bp amplicon was digested with 
TaqI (NEB) which would recognize and digest the WT allele sequence but not the mutant 
allele. 
 Cloche (clom39) mutant line was a gift from Dr. Mason Posner. Embryos were 
phenotyped for heart edema and genotyped as described by Reischauer et al., 2016 [143]. 
 
Immunohistochemistry (IHC) 
 Dechorionated embryos were fixed with 4% PFA in PBS at room temperature for 
3h and washed with PBST 4 times for 5 minutes. Embryos were then permeabilized with 
Proteinase K, 30𝜇g/mL 10 minutes for 24-28 hpf, 50𝜇g/mL 15-20 minutes for 32-48 hpf 
and 75𝜇g/mL 20 minutes for 56-72 hpf, washed 2 times in PBST for 5 minutes and 
blocked overnight at 4oC with 10% sheep serum, 0.8% Triton X-100 and 1% BSA in 
PBS. Primary mouse anti-laminin antibody (ThermoFisher – 1:100) in blocking buffer 
(1% sheep serum, 1% BSA and 0.8% Triton X-100 in PBS) were incubated overnight at 
4oC and washed 5 times in PBST for 15 minutes. Secondary antibody, goat anti-rabbit 
(Alexa Fluor® 488 – Abcam – 1:1000), DAPI 1:1000, and phalloidin (Alexa Fluor® 555 




treated with proteinase K as described above and stained with DAPI 1:1000 overnight. 
The embryos were washed 2 times in PBST for 15 minutes and visualized using a Nikon 
C2+ confocal microscope equipped with a 40X (1.15NA) water immersion objective. 
Embryos were embedded in 1.2% low melting point agarose on glass bottom 35mm 
dishes (Fluorodish, World Precision Instruments). Images were captured in steps of 3.5 
microns for a total of 31.5 microns using Nikon Elements software. Image adjustment, 
such as cropping and brightness/contrast was performed using Adobe Photoshop. 
 
Analysis of Fluorescence signal 
 Fiji software (https://fiji.sc) was used to measure the fluorescence intensity of 
laminin and phalloidin signal from raw image data. In order to account for variability in 
staining, normalization values were measured for laminin and actin pixel intensity where 
an area directly outside of the choroid fissure was measured and a ratio was generated 
between the two values (Appendix 2.1B). In cases where the fissure edges were farther 
apart then the size of the box used for analysis, the box was divided into two and used to 
measure fluorescence intensity on each side of the fissure. Measured values from both 
boxes was added and then normalized.  For Tg[krdl:mCherry], 3D reconstructions of the 
optic fissure were generated and individual cells were counted (from the opening of the 
OF through the back of the lens). 
 
Statistics 
 Student’s t-test was used to compare individual time points. One-way ANOVA 
was used to analyze across treatments. Graphs are displayed as mean +/- standard 
deviation. Analysis was performed using Prism8 graphing software (GraphPad). 
 
Total RNA Sequencing 
 WT and Pax2-/- embryos were dissected and collected at 48 hpf and RNA was 




heart defects only observed in pax2a-/- embryos, as verified by previous genotyping 
experiments. Dissected eyes were suspended in 1 mL of trizol and sheared with a 22-
gauge needle. Samples were incubated at room temperature for 5 minutes, then 200 𝜇L of 
chloroform was added and vortexed for 1 minute. Samples were then centrifuged at 
12,000 g for 15 minutes at 4℃. Aqueous phase was removed and put into fresh RNAse 
free tube. 3 𝜇L of Glycoblue was added to samples and vortexed for 5 seconds. 500 𝜇L of 
100% Isopropanol was then added and vortexed for an additional 10 seconds. Samples 
then were incubated at room temperature for 10 minutes. Samples were then centrifuged 
at 12,000 g for 10 minutes at 4℃. Supernatant was removed and 1 mL of 75% EtOH was 
added and vortexed for 10 seconds. Samples were then centrifuged at 7,500 g for 5 
minutes at 4℃. Supernatant was removed and samples then underwent a pulse 
centrifugation and any remaining supernatant was removed. Samples were then air-dried 
for 7 minutes at room temperature under a fume hood. 20 𝜇L of RNAse free ddH2O was 
added to the samples and mixed until pellet dissolved. Samples were finally incubated at 
60℃ for 12 minutes and then stored at -80℃. 
 The RNA then underwent a DNase treatment using the DNA-free Kit. 2 𝜇L of 
10X DNaseI Buffer, and 1 𝜇L of rDNaseI was added to the entire 20 𝜇L sample. Samples 
were incubated at 37℃ for 20 minutes, and then 2 𝜇L of DNase Inactivation Reagent was 
added. Samples were then incubated at room temperature for 2 minutes, mixing samples 
3 times. Samples were centrifuged at 10,000 g for 1.5 minutes. Supernatant was then 
removed and placed into fresh RNase free tube and stored at -80℃. 
 Purified total RNA was sent to Applied Biological Materials Inc. for Illumina 
sequencing (PE150bp, 30-40 million reads/sample). Bioinformatic analyses were 
completed using RSEM. Those transcripts which had a greater than 0.95 posterior 
probability of being differentially expressed were considered significant. Panther 







Whole-mount in situ hybridization (WISH) 
 Whole-mount in situ hybridization was performed as previously described [144]. 
RNA probes were generated using PCR with T7 promoter sequence linkers and 
subsequently transcribed [DIG or FITC labeled] using T7 polymerase (Roche). Primer 
sequences are all found in Table 2.1. Images were captured using a Nikon Digital sight 
DS-Fi2 camera mounted on a Nikon SZM800 stereo scope using Elements software. 
Dissected eyes from 24, to 72hpf embryos were mounted in 70% glycerol and imaged 
under DIC using a Nikon TiE compound microscope equipped with a 20X (0.7NA) 
objective and Elements software. Image adjustment, such as cropping and 
brightness/contrast was performed using Adobe Photoshop. 
 
qPCR analysis 
 32hpf embryos were anesthetized with tricane, tail tips were collected for 
genotyping and the heads, dissected just posterior of the eyes, were fixed in RNAlater. 
After genotyping, embryos corresponding to WT and pax2a-/- were pooled, 5-10 
embryos, and total RNA isolated using a RNAaqueous kit (Ambion). DMSO and DMH4 
treated embryos were harvested in the same fashion absent any genotyping. qPCR was 
performed as previously described [145]. Primer sequences are all found in Table 2.1. 
 
2 color fluorescent in situ hybridization 
 FWISH was performed as previously described [146]. Images were collected 
using a Nikon C2+ confocal microscope with a 20X (0.95NA) objective and images were 
adjusted for brightness and contrast using Adobe Photoshop. 
 
Live imaging analysis  
 Live imaging of Tg[kdrl:mCherry] embryos was conducted using a Nikon C2+ 




embryos were imbedded in 1.1% low gelling agarose in 1-inch glass bottomed Flourodish 
cell culture dishes (World Precision Instruments) and covered in embryo media, 3-amino 
benzoic acidethylester (tricaine) to anaesthetize the embryos and 1-phenyl 2-thiourea 
(PTU) to inhibit pigmentation. Z-stacks 75𝜇m thick with a step size of 2.5𝜇m were 
captured over the course of 6 hours at 10 minute intervals. The time lapse data were 
reconstructed in 3D using Elements software. Image adjustment, such as cropping and 
brightness/contrast was performed using Adobe Photoshop. After imaging, embryos were 
removed and genotyped. 
 
Inhibitor treatments 
 Embryos were incubated in embryo media with 5, 25, 50, or 100 𝜇M of DMH-4 
(Sigma Life Science) in DMSO starting at 12hpf. Fresh DHM4 containing media was 
added every 12hpf for timepoints past 24hpf. For ARP101 (Tocris) treatments embryos 
were dechorionated and treated with 10, 15, 20, 25 or 30𝜇M ARP101 in fish water from 
24 to 48hpf, unless stated otherwise. 
 
Cloning and mRNA synthesis. 
 Full coding domain sequences for adamts1 (NCBI reference sequence 
XM_021475923.1), were amplified from 24hpf zebrafish cDNA using primers 5’- 
CTCGAGTCAACAGGGAGTCAGATTGC-3’ for adamts1, cloned into pGEMT 
(Promega), digested with AsiSI/XhoI, BamHI/XhoI respectively and subsequently cloned 
into pCS2+. All constructs were verified by sanger sequencing (Eurofinsgenomics). 
mRNA was synthesized from linearized pCS2 constructs using SP6 mMessage 








Alt-R-crRNA CRISPR injections 
 Alt-R mmp2 crRNA, tracrRNA was pre-designed and synthesized by IDT. 
Duplex formation and dilution with Alt-R Cas9 v.3 enzyme was carried out as described 
by Hoshijima et al. 2019 [147]. 
Ethics Statement 
 The use of zebrafish in this study was approved by the University of Kentucky 






Table 2-1 Primer Sequences 
WISH 


















































































Gene Primer Sequences Primer Sequences2 
tln1 TTGGGGCAATTCCAGCAAAC TGCTTCGCACAGGTTGTTAG 
cldn5b TACATCGTCGCAGGCTTGTT GATGCTGCCCATCCGATGTA 
tjp1a CACAGAAGCAAGAGCCTGGA AAAACCCGGTGCCCTGTG 
flt4 CAGTCCAAAACAGCCAGCAC CAACTCCACAGGCGAGTCTT 
vegfaa CAACGCGTATCGCAGCATAAT AAGGCTCACAGTGGTTTTCTT 
vegfab TGTTGTATGTGACGGTGGGG GCAAAACCGTGGTTCCAGAC 
vegfc TGGAGAAAGACGCTGTGCAT TGCACTGAAGCTCCTCACTG 
mmp2 TCAGGGTCGAGATGATGGGT GAAAAGGAGCTCATGGGGACA 
mmp14a ACGCAGCTTATGAACGCAAT TCCTGTGCCAAGCTCCTTAA 
mmp14b TCTTCAAAGGGGACAGGCAT CACCAGTTCCCAGTTCTCCT 
ROCK1 CAGGAAAGCCCAGCTAACCA CGTGTGAGGTTATTGCAGAGG 
ROCK2a GGGAAGTCCAGCTGGTTAGG TCCTCCCAGAAGAAGGCAGA 
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3.1 ABSTRACT 
 Vertebrate retinal development requires timely and precise fusion of the optic 
fissure (OF). Failure of this event leads to congenital vision impairment in the form of 
coloboma. Recent studies have suggested hyaloid vasculature to be involved in OF 
fusion. In order to examine this link, we analyzed OF fusion and hyaloid vasculogenesis 
in the zebrafish pax2a noi mutant line. We first determined that pax2a-/- embryos fail to 
accumulate F-actin in the OF prior to basement membrane (BM) degradation. 
Furthermore, using 3D and live imaging we observed reduced OF hyaloid vascularization 
in pax2a-/- embryos. When examining the connection between pax2a loss of function and 
hyaloid vasculature, we observed significant reduction of talin1 expression, a regulator of 
hyaloid vasculature. In addition, cranial VEGF expression was found to be reduced in 
pax2a-/- embryos. Pharmacological inhibition of VEGF signaling phenocopied the pax2a-
/- vasculature, F-actin and BM degradation phenotypes. Lastly, we determined that OF 
associated hyaloid vasculature is a source of mmp2, mmp14a and mmp14b expression 
and showed that mmp2 is functionally necessary for degradation of OF BM. Taken 




vasculature invasion of the OF in order to facilitate availability of the BM remodeler 
mmp2.  
3.2 INTRODUCTION 
 Ocular development is a highly conserved process amongst vertebrate species. 
Assembly of the hemispherical, retinal structure from an initially flat sheet of cells 
requires many complex morphogenetic movements. One such morphogenetic movement 
involves the invagination of the optic vesicle which results in a fissure forming at the 
ventral region of the developing retina. This fissure, known as the choroid or optic fissure 
(OF), enables hyaloid vasculature cell migration into the developing retina and 
subsequent establishment of the hyaloid vasculature. Hyaloid vasculature is a temporary 
circulatory system required for ocular development, and in most cases will degenerate 
once mature blood vessels begin to grow [125, 148-150]. As soon as the hyaloid 
vasculature has been established, the two opposing retinal epithelial sheets of the OF will 
undergo fusion. Thereby, they encase the ganglion cell axons localized in the optic stalk 
and complete retinal morphogenesis. Failure of OF fusion leads to a congenital blinding 
disorder known as coloboma [151-153]. Coloboma is a prevalent cause of pediatric 
blindness, accounting for approximately 10% of cases worldwide [152, 154]. This makes 
it one of the leading causes of pediatric blindness. Coloboma is a spectrum disorder 
presenting unilaterally or bilaterally and ranging in severity from minor visual 
impairment, to complete blindness in the affected eye [155]. This spectrum of severity is 
associated with the location and degree to which the OF was able to fuse and the severity 




 Coloboma has been studied for many decades in many different species. Work 
over this time has led to a general outline of the signaling and morphogenetic pathways 
required for proper OF formation and fusion (recently reviewed in [156]). In particular, 
opposing action of bone morphogenetic protein (BMP) and sonic hedgehog (Shh) 
signaling establishing the dorsal-ventral pattern of the optic vesicle and ensuring proper 
expression of optic stalk and OF regulators pax2, vax1 and vax2 [157, 158]. However, 
the actual molecular mechanisms driving OF fusion remains largely unknown. The 
process of epithelial tissue fusion is not unique to the eye and occurs throughout 
development, encompassing neural tube closure, palatal shelf formation and eyelid 
development [159]. Epithelial fusion has been studied for over a century, and is known to 
involve transcriptional regulation, cell signaling pathways and morphogen gradients [160, 
161]. The actin cytoskeleton is thought to be a crucial component of the machinery 
driving epithelial fusion in many tissues [162]. The importance of the actin cytoskeleton 
during epithelial fusion involves lamellipodial and filopodial projections between the two 
opposing epithelia. These help to “zipper” the cells together to form a single continuous 
sheet. When lamellipodial and filopodial projections are precluded, epithelial fusion often 
fails [163]. Lamellipodia and filopodia have been observed during OF fusion almost 3 
decades ago [164-166]. However, the functional and regulatory mechanisms behind these 
projections remain unknown. Another cellular mechanism known to be directly involved 
in epithelial fusion is the degradation of the basement membrane (BM). During epithelial 
fusion, the BM acts as a physical barrier restricting the establishment of cell-cell contacts, 
which must be removed in order to complete fusion. Recent work from several labs, 




fusion [88, 119, 167, 168]. However, the molecular mechanisms facilitating this process, 
in particular BM degradation, also remain largely unknown. It was recently suggested 
that hyaloid vasculature cells migrating through the OF could potentially signal or 
facilitate BM degradation [119]. Hyaloid vasculature nourishes the developing retina and 
lens while connecting to the choroid vasculature for proper blood flow [125]. Hyaloid 
vasculogenesis takes advantage of an open OF so that vasculature cells can migrate into 
the developing optic cup. Once OF fusion is completed, hyaloid vasculature is fully 
established. James et al. 2016, showed that mutations in zebrafish talin1 (tln1), an actin 
cytoskeleton scaffolding protein known to be required for endothelial cell migration 
[169], result in OF fusion defects. Theirs, and previous studies also indicated that cloche 
mutants, which lack all early hyaloid vasculature, have delayed BM breakdown in the 
region of the OF [119, 170]. Since the hyaloid vasculature requires an open fissure to 
complete establishment of its network, it has been proposed that migrating hyaloid 
vasculature cells may regulate the timing of fissure fusion. This mechanism could 
potentially involve vasculature-mediated activation of the fusion machinery within the 
retinal rim cells, or direct supply of molecular factors, such as matrix proteases [171]. In 
support of this hypothesis, recent optic cup transplantation experiments in zebrafish 
embryos confirm that in the absence of hyaloid vasculature, ectopic retinal OFs fail to 
initiate fusion [139]. Hence, there is a clear link between OF fusion and hyaloid 
vasculature.  
 In our current study, we have undertaken a detailed analysis of zebrafish OF 
fusion in the pax2a-/- coloboma model [172]. This included characterizing the timing of 




vascularization. When comparing pax2a+/+ and pax2a-/- eyes we discovered decreased OF 
hyaloid vascularization and OF fusion failure. In particular we found that pax2a-/- 
embryos exhibit a decrease in tln1, hyaloid vasculature makers as well as VEGFaa, 
VEGFab and VEGFc expression. Modulation of vascularization via pharmacological 
inhibition of VEGF signaling phenocopied the pax2a-/- hyaloid vasculature and coloboma 
phenotypes. Mechanistically, we also show that hyaloid vasculature is a source of mmp2, 
mmp14a and mmp14b and that mmp2 activity is necessary for OF BM degradation. 
Taken together, we propose a novel pathway for the regulation of OF fusion where pax2a 
mediates proper timing and abundance of hyaloid vasculature cell recruitment to the OF 
and subsequent vasculature supplied mmp2-dependent BM degradation. 
 
3.3 RESULTS 
3.3.1 Optic fissure basement membrane degradation is preceded by F-actin 
accumulation. 
 Several recent studies have undertaken a detailed time course to map out the exact 
timing of OF fusion in numerous species, including zebrafish [88, 119, 167, 168]. 
Overall, in zebrafish, the data point to ~32-36hpf as the time of OF fusion initiation, as 
observed by BM degradation. To decipher the molecular mechanisms regulating OF 
fusion we also performed a detailed time course analysis of OF BM degradation using 
laminin immunohistochemistry (IHC) while additionally analyzing F-actin. Our goal was 
to determine whether changes in F-actin levels in the OF were correlative with fusion. 
James et al, 2016 had recently suggested that infiltrating vasculature endothelial cells 




had shown that interactions between vasculature and the fissure resulted in an increase of 
F-actin [119]. As such, we first performed whole mount IHC for laminin deposition in 
embryos starting at 24hpf. We sampled every 4 hours up to 48hpf and then at 56 and 
72hpf (Figure 3.1A). To analyze the progression of the fusion process, we quantified the 
laminin signal within the OF from 3D confocal scans. We quantified distal, medial and 
proximal regions of the fissure (Appendix 2.1A). Regions of the BM outside the OF and 
juxtaposed to the developing lens were used to normalize the laminin signal (Appendix 
2.1B). When comparing results from the three regions we did not observe significant 
differences in the distribution of laminin or F-actin (Appendix 2.1C). Going forward we 
focused on quantifying laminin signal in the central proximal region (medial) of the 
fissure (Figure 3.1C). This region has been previously shown to represent the site of 
fusion initiation, is known to interact with hyaloid vasculature and is easily identified in 
24-72hpf embryos [119]. In agreement with recent studies in zebrafish, we found that OF 
fusion initiates at ~32-36hpf and does so in a central region of the fissure, subsequently 
proceeding proximally and distally. From observing distance between the fusing lobes of 
the retina in our time course for OF laminin status, Figure 3.1A, we observed apposition 
to complete between 36-44hpf (Figure 3.1A). By 48hpf, we observed most of the laminin 
signal was removed from the OF, and by 72hpf, little to no laminin persists in the region 
(Figure 3.1A, C).  
   To track F-actin levels during fusion we stained the laminin labeled embryos with 
phalloidin and quantified the signal within the fissure. To normalize phalloidin staining 
intensity we used an interior region of the retina (Appendix 2.1B). Our analysis revealed 




BM degradation is initiated (Figure 3.1D). The observed increase of F-actin signal 
correlates with the timing of hyaloid vasculature migration (24-32hpf) into the fissure. 
The nature of our assay did not precisely identify the cellular source of F-actin but it 
likely predominantly consisted of retinal rim and hyaloid vasculature cells. Taken 
together, we conclude that BM degradation is preceded by an increase of F-actin within 
the OF.  
 
3.3.2 Optic fissure fusion mechanics are disrupted upon loss of pax2a function. 
 In order to test our hypothesis that an increase in F-actin is involved in the 
initiation of OF fusion we compared our findings to an established model of coloboma, 
the pax2a noi line [172]. Pax2 is required for OF fusion in several model systems and has 
been documented in human coloboma cases [173-175]. The noi mutation is predicted to 
result in a loss of pax2a function due to a premature stop codon at position 198 [176]. 
Originally characterized for their no-isthmus phenotype, pax2anoi/noi embryos (referred to 
as pax2a-/- from this point on) elicit a fully penetrant unfused OF [177, 178]. 
Unfortunately, homozygous mutants are not viable and do not enable the study of 
coloboma at juvenile or adult stages. We hypothesized that examining the molecular 
events leading to OF fusion in the pax2a noi system would inform us whether these 
events are functionally important. Similar to our WT study, we examined apposition, 
laminin and F-actin levels throughout the time of OF fusion (Figure 3.1B, D, Appendix 
2.2). In stark contrast to WT, pax2a-/- embryos did not exhibit a significant decrease in 
laminin signal between 32-48hpf. In fact, as expected, laminin appeared to be largely 




pax2a null mice had also indicated failure of BM degradation and retention of laminin 
[175]. While there is a moderate decrease in laminin signal in pax2a-/- embryos from 32-
36hpf (p=>0.0001), there was no significant loss of laminin signal between 36-48hpf. 
This result is significantly different in WT embryos (p=>0.0001) which display a major 
decrease in laminin signal during this time. IHC images clearly show that laminin persists 
in the pax2a-/- fissure up to and including 72hpf (Figure 3.1B). When examining OF F-
actin levels in pax2a-/- embryos we did not detect the expected increase between 24 and 
32hpf (Figure 3.1D). In fact, up to 48hpf F-actin levels measure significantly lower than 
in WT embryos. Similar results were also observed when quantifying distal and proximal 
regions of the fissure (Appendix 2.1D). Our data therefore suggest that the absence of OF 
F-actin accumulation between 24 and 32hpf, correlates with failure to initiate fusion. 
Lastly, when examining retinal lobe distance in pax2a-/- embryos we did not observe any 
significant defects in the degree of apposition up to 48hpf (Appendix 2.2). Taken 
together, we conclude that in the absence of pax2a, F-actin fails to accumulate in the OF 
and this correlates with the failure to degrade the BM. Based on our findings, we 
therefore conclude that retinal lobes still become apposed by 48hpf in pax2a mutants. In 
summary, we propose that accumulation of F-actin is necessary for the initiation of OF 






3.3.3 Loss of pax2a function leads to reduced hyaloid vasculature within the optic 
fissure. 
 Work by James et al. 2016, suggested that F-actin accumulation in the OF may 
result from interaction between retinal rim cells and invading hyaloid vasculature. To test 
this possibility, we examined hyaloid vasculature in pax2a-/- Tg[kdrl:mCherry] embryos. 
Using 3D in vivo time-lapse confocal microscopy we recorded migration of mCherry 
expressing cells through the OF from 24 to 30hpf (Figure 3.2A). At 24hpf, both WT and 
pax2a-/- embryos contain mCherry expressing cells within the fissure. However, over the 
next six hours of imaging it is apparent that pax2a-/- embryos have significantly fewer 
mCherry expressing cells pass through the OF (Figure 3.2A). To visualize this effect, we 
fixed WT and pax2a-/- Tg[kdrl:mCherry] embryos at 24, 32, 36 and 48hpf to collect and 
render 3D confocal stacks (Figure 3.2B). Starting as early as 32hpf, we noticed a clear 
reduction in the number of vasculature cells within the OF and retina. Furthermore, we 
counted the number of mCherry positive cells found within the OF at 32 and 36hpf 
(Figure 3.2C). The data indicated that in pax2a-/- embryos there is a significant reduction 
in the number of mCherry expressing cells at both 32 and 36hpf (Figure 3.2C). 
Additionally, using 3D rendering, we noted that in 48hpf pax2a-/- embryos the hyaloid 
vasculature established in the back of the lens is reduced in size and lacks proper 
connections to the newly forming choroidal and superficial vasculature systems. In the 
previously aforementioned study, James et al. 2016 also showed that tln1 is necessary for 
hyaloid vasculature recruitment to the OF and subsequent fusion. Since pax2a-/- embryos 
lack BM degradation, fail to initiate F-actin accumulation and have reduced hyaloid 
vascularization (Figure 3.1,2), we sought to examine tln1 expression in this model. To 




for tln1 comparing WT siblings to pax2a-/- mutant embryos. WT expression of tln1 was 
observed in the OF between 28 and 48hpf coinciding with pax2a expression (Figure 
3.2D, Appendix 2.3). In pax2a-/- embryos, OF tln1 expression appears significantly 
reduced compared to WT while retaining similar expression in periocular regions (Figure 
3.2D). Tln1 expression is also reduced in the mid brain-hind brain boundary, another 
region of strong pax2a expression (Figure 3.2D, Appendix 2.3A). Our WISH data was 
further supported by qPCR results showing a significant decrease in tln1 expression at 
32hpf (Figure 3.2E). Finally, to verify our observations were indicative of reduced 
hyaloid vasculature we also analyzed expression of additional vasculature markers flt4, 
tjp1a and cldn5b [64, 179]. qPCR comparison of 32hpf WT and pax2a-/- embryo heads 
indicated a significant decrease of flt4, tjp1a and cldn5b expression, validating our 
observation of overall reduced vasculature in mutant embryos (Figure 3.2E). Overall, our 
data indicate that   pax2a-/- embryos exhibit decreased expression of tln1 and impaired 
hyaloid vascularization of the OF.  
 
3.3.4 Inhibition of VEGF signaling impairs optic fissure fusion mechanics.  
 Based on our discovery of impaired OF hyaloid vasculature in pax2a-/- embryos, 
we next examined whether this phenomenon is associated with failure of OF fusion. 
Hence, we turned our attention to vascular endothelial growth factor (VEGF) signaling. 
VEGF, the ligand for vascular endothelial growth factor receptor (VEGFR), is a prime 
candidate for regulating the migration and proliferation of hyaloid vasculature cells. In 
support of this notion, when examining expression patterns for VEGF ligands, vegfaa, ab, 




(Figure 3.3A). In order to test for a link between the loss of pax2a function and VEGF 
signaling we analyzed vegfaa, ab and c expression in pax2a-/- embryos. Fluorescent 
wholemount in situ hybridization (FWISH) at 32hpf indicated a decrease of vegfaa, ab 
and c expression in the cranial regions of mutant embryos (Fig 3A). These results were 
also supported by qPCR (Figure 3.3B). Our data therefore suggest that a decrease in 
VEGF signaling may be a factor responsible for reduced hyaloid vascularization of the 
OF in pax2-/- embryos. This finding may also explain the severe vascular phenotypes 
pax2a-/- embryos develop, in particular heart edema and other cardiac misfunction. 
 In order to test whether VEGF signaling plays a direct role in hyaloid 
vascularization of the OF and subsequently fissure fusion we sought to inhibit VEGF 
activity. We therefore took advantage of a dorsomorphin derivative, DMH4, which has 
been shown in zebrafish to selectively inhibit VEGF signaling independent from BMP 
[180]. Based on published working concentrations, we conducted a dose response to 
examine DMH4 effects on hyaloid vasculature using Tg[kdrl:mCherry] as a readout 
[180]. Treatment of embryos from 12-24hpf, ranging from 1-100𝜇M, resulted in a dose 
dependent reduction of mCherry signal in the developing retina (Appendix 2.4A). We 
decided to use the 100𝜇M concentration for subsequent experiments as this concentration 
was able to completely inhibit vascularization of the retina up to 56hpf without any 
significant impact on overall embryo health (Appendix 2.4B,C). Embryos were treated 
starting at 12hpf and examined for fissure fusion status via whole mount laminin IHC at 
24, 32, 36, 48, 56 and 72hpf (Figure 3.3C). 3D confocal imaging revealed a persistence 
of laminin signal within the fissure up and including 72hpf in all embryos examined 




in OF fusion (Appendix 2.4D). Long term treatment with 100𝜇M DMH4, 56hpf+, did 
result in a degree of retinal toxicity (Appendix 2.4B). To circumvent this effect, we also 
treated embryos from 12-72hpf with 25 and 50𝜇M DMH4 (Appendix 2.4B). Toxicity 
appeared reduced at the lowest concentration, 25𝜇M, while still eliciting a failure of OF 
fusion phenotype in 87.5% of treated embryos (Figure 3.3D, Appendix 2.4E). Observed 
retention of OF laminin signal at 48hpf in DMH4 vs DMSO treated embryos generated 
an overall pattern of results very similar to what we observed in pax2a-/- (Figure 3.3E). 
While DMH4 treatment did result in a significant reduction of OF laminin signal from 
36-48hpf (p=<0.0002), OF laminin levels of DMH4 treated embryos were significantly 
higher than DMSO controls at 48hpf (Figure 3.3E). When measuring the degree of retinal 
lobe apposition at 48hpf, we saw no negative effects of DMH4 treatment. This suggests 
that the observed failure of OF BM degradation is unlikely to result from optic cup 
morphogenesis delay (Appendix 2.2). However, it remains possible that apposition is 
initially delayed by DMH4 treatment yet completes by 48hpf. In addition to laminin, we 
also imaged and quantified OF F-actin levels during DMH4 treatment (Figure 3.3F). 
Similar to pax2a-/- embryos, DMH4 treatment prevented the accumulation of OF F-actin 
between 24-32hpf (Figure 3.3F). This was in contrast to DMSO treated embryos which 
exhibited the expected accumulation of F-actin in the fissure between 24-32hpf.  
 To show timing specificity of our DMH4 treatments we also performed a time 
course analysis. When treating embryos with DMH4 starting at 12hpf we observed total 
inhibition of fissure fusion, indicated by retention of OF laminin signal at 48hpf. 
However, when DMH4 was added at later time points, 24, 28 or 32hpf we observed a 




DMH4 treatment at 32hpf had little effect on OF fusion. To correlate our DMH4 time 
course treatment to hyaloid vasculature, we imaged vasculature using the 
Tg[kdrl:mCherry] line (Figure 3.4C). Starting DMH4 treatment at 24 or 28hpf 
significantly reduced the number of hyaloid vasculature cells in the OF at both 32 and 
36hpf and by 48hpf, little to no vasculature was observed (Figure 3.4C). Quantification of 
hyaloid cells within the fissure at 32 and 36hpf supported these observations (Figure 
3.4D). Importantly, the degree of OF hyaloid vascularization correlated with the rates of 
OF fusion failure observed (Figure 3.4B). Significant reduction directly correlated to an 
increase in fusion failure (Figure 3.4B). On the other hand, delay of DMH4 treatment 
until 32hpf did not eliminate all hyaloid vasculature in the OF at 48hpf and correlated 
with increased rates of OF fusion (Figure 3.4B). Sufficient hyaloid vasculature 
recruitment to the OF is therefore critical at early stages of OF fusion, 24-28hpf.  
 Lastly, in order to confirm the source of tln1 in the OF as hyaloid vasculature, we 
assessed tln1 expression after DMH4 treatment. Fluorescent whole mount in situ 
hybridization (FWISH) indicated a significant decrease of tln1 but not pax2a expression 
in DMH4 treated embryos (Figure 3.4E). qPCR analysis supported our observation 
(Figure 3.4F). This suggests that tln1 is most likely expressed by the vasculature cells 
within the OF. Based on these findings, we conclude that inhibition of VEGF signaling 
results in failure of F-actin accumulation and basement membrane breakdown due to the 






3.3.5 Hyaloid vasculature is a source of mmp2 necessary for OF BM degradation. 
 The above data confirm and support a model where hyaloid vasculature drives or 
initiates the OF fusion process. However, a missing key to this model is the mechanism 
by which vasculature cells induce fissure fusion. James et al 2016, along with others, 
have suggested vasculature cells may be a source of BM degradation enzymes, such as 
matrix metalloproteases (mmp). To investigate this further, we used WISH to examine 
mmp expression within the OF between 24-48hpf. Our examination of mmp expression 
indicated that mmp2, 14a and 14b were expressed within the fissure between 28-36hpf 
(Appendix 2.5A and Famulski lab unpublished data). Mmp2 had recently been associated 
with OF fusion in the mouse while evidence from an mmp2 metalloproteinase activity 
probe in zebrafish indicated mmp2 activity is present in the developing eye and likely OF 
[181, 182]. mmp14 is an activator of mmp2 and its co-expression with mmp2 within the 
fissure suggests mmp2 is in fact active [183, 184]. To test whether mmp2 fits within our 
model we assayed mmp2, mmp14a and mmp14b expression in pax2a-/- and DMH4 treated 
embryos. In both cases, OF expression of mmp2, mmp14a and mmp14b was reduced as 
observed by FWISH and confirmed by qPCR (Figure 3.5A, B, Appendix 2.5B). This 
suggested that all three may be expressed by the hyaloid vasculature cells. To assess this, 
we performed two color FWISH for mmp2 and kdrl. Confocal imaging verified that 
mmp2 expression is co-localized with that of kdrl within the OF (Figure 3.5C). 
Conversely, when performing two color FWISH for mmp2 and rorB, a retina specific 
probe, we did not detect co-localization of the signals. We therefore conclude that the 




 Finally, to determine whether mmp2 activity is necessary for OF fusion we 
treated embryos with ARP101, a specific mmp2 inhibitor previously shown to be 
effective in zebrafish [185]. Treating embryos with ARP101 from 24-48hpf inhibited OF 
BM breakdown in a dose dependent manner (Figure 3.6A, Appendix 2.6A,B). When 
compared to DMSO, embryos treated with 15 or 20𝜇M ARP101 either completely or 
partially retain their OF BM up to 48hpf (Figure 3.6B). To ensure that inhibition of 
mmp2 activity is not affecting hyaloid vasculature migration into the OF we imaged 
Tg[kdrl:mCherry] DMSO or ARP101 treated embryos from 24-48hpf. OF associated 
vasculature appeared unchanged at 32, 36 and 48hpf (Figure 3.6C). Furthermore, 
quantification of hyaloid cells within the fissure at 32 and 36hpf indicated that inhibition 
of mmp2 activity does not have any effects on OF vascularization (Figure 3.6D). Lastly, 
we also examined pax2a expression in ARP101 treated embryos and did not observe any 
negative effects (Appendix 2.6C). We therefore concluded that mmp2 activity is 
necessary for BM breakdown in the OF. To determine when mmp2 activity is required 
we performed a time course of the ARP101 treatment starting between 24-32hpf and 
assayed BM status at 48hpf (Figure 3.6E). Treatments started later than 30hpf had little to 
no effect on OF BM degradation, indicating that mmp2 activity is optimally required 
between 24-30hpf (Figure 3.6E). This finding also correlates with the observed timing of 
mmp2 expression in the OF (Appendix 2.5A). However, because we cannot determine 
exactly how quickly ARP101 inhibits enzymatic activity in our assay, active mmp2 may 
persist in the OF longer than 30hpf. Lastly, in addition to pharmacological inhibition of 
mmp2 function, we also sought to examine the consequences of mmp2 gene inactivation. 




been shown to provide highly effective CRISPR mediated F0 gene knockouts in zebrafish 
[186]. Injection of a pre-designed mmp2 crRNA duplex with Cas9 enzyme resulted in 
~53% of embryos displaying a coloboma like phenotype at 72 hpf (Appendix 2.7). 
Confocal imaging of laminin staining indicated a partial failure in OF BM degradation 
and persistence of a minor fissure. The observed phenotype was similar to but not as 
pronounced as observed in pax2-/- embryos at 72hpf. This may result from incomplete F0 
phenotypes. As such, future examination of germline transmitted loss of function alleles 
of mmp2 will be necessary to fully examine the functional consequence on OF fusion. 
Taken together, we propose that mmp2 activity is part of the mechanism involved in OF 
BM degradation and subsequent fusion of the fissure. 
3.4 DISCUSSION 
 Studies of OF fusion dating back several decades have been suggesting a direct 
connection between the fusion process and hyaloid vasculature found within the fissure. 
In fact, this hypothesis has been recently strengthened by data showing that a reduction of 
hyaloid vasculature in the fissure, or removal of optic vesicles from sources of 
vasculature inhibits or significantly delays fusion [119, 139]. In our study, we have 
characterized a pax2a driven mechanism that ensures proper vascularization of the OF 
and expression of BM remodelers mmp2, 14a and 14b. In conclusion, our findings further 
validate the notion that hyaloid vasculature is an active and necessary component of the 
machinery driving OF fusion in zebrafish. 
 Several recent reports, including this one, have comprehensively characterized OF 




orderly progression involving: 1) retinal growth and cellular rearrangement leading to 
nasal and temporal retinal lobe apposition,  2) invasion of the fissure by endothelial and 
neural crest cells forming the hyaloid vasculature system,  3) cellular signaling, either 
between retinal rim cells or between rim cells and the migrating vasculature cells, 4) 
degradation or removal of the basement membrane to enable physical connection of the 
rim cells and subsequent formation of a continuous retinal epithelial sheet via re-
polarization and cell-cell adhesion. Step 1 has been nicely characterized in a few recent 
publications outlining the flow of retinal cells and morphological formation of the fissure 
[68, 187, 188]. For step 2, several reports have carefully characterized the formation of 
the hyaloid vasculature system, including migration of hyaloid vasculature precursor cells 
into the fissure as soon as it forms [125, 148, 149]. Importantly, perturbation of this 
process, or removal of the developing eye from its source, has been shown to lead to 
fissure fusion failure [119, 139]. To date, steps 3 and 4 are the least understood. Recent 
work from our lab has characterized the composition of core BM components within the 
fissure [167]. Additionally, work from other labs has identified several molecular 
components associated with cell-cell adhesion and epithelial sheet fusion to function 
within the fissure, including 𝛽-catenin, n-cadherin, and netrin [84, 119, 168, 189-191]. 
However, the timing and the molecular mechanism organizing and regulating these 
components remains uncharacterized. Finally, the elephant in the room has always been 
the identity of the BM degradation mechanism. To date, only adamts16 has been 
functionally examined in context of fissure fusion while mmp2 activity was detected 
during mouse OF fusion and mmp23bb was implicated in the fusion process from 




 While attempting to address the mechanistic aspects of steps 3 and 4 using the 
pax2a noi model we first uncovered a relationship between F-actin and BM degradation. 
Work by James et al. 2016 suggested that F-actin accumulation may be indicative of 
hyaloid cell interaction with retinal rim cells. During our detailed time course analysis, 
we discovered that BM degradation is in fact preceded by an increase in F-actin signal 
within the OF (Figure 3.1). When assayed in pax2a-/- embryos the F-actin accumulation is 
absent while the hyaloid vasculature in the OF is also diminished. The timing of F-actin 
accumulation coincides with the active migration of hyaloid vasculature cells through the 
fissure (Figure 3.2).  Furthermore, we showed pharmacologically, via VEGF inhibition, 
that hyaloid vasculature is necessary for the accumulation of F-actin and OF BM 
degradation. Transcriptionally, we showed that the decrease in hyaloid vasculature in 
pax2a-/- embryos coincides with a significant decrease in tln1 expression. Tln1 is a key 
regulator of endothelial cell migration, recently shown to be directly involved in OF 
fusion [119]. In fact, loss of tln1 function has been previously shown to decrease OF 
associated vasculature and inhibit BM degradation [119]. In our study, we detected a 
significant decrease in tln1 expression upon VEGF inhibition (DMH4 treatment), 
suggesting that tln1 expression within the OF is associated with hyaloid vasculature.  
Tln1 is known to be a direct link between the actin cytoskeleton and the BM via integrin 
[193, 194], and has been associated with the formation of adhesion junctions [195, 196]. 
One could therefore hypothesize several different models for its role in OF fusion. We 
predict that tln1 is regulating the ability of hyaloid vasculature cells to migrate properly 
through the OF, however we cannot rule out the possibility that tln1 directly participates 




the decrease of hyaloid vasculature cells within the fissure of pax2a-/- embryos. In support 
of this we observed a significant decrease in tln1 expression upon DMH4 inhibition and 
therefore absence of hyaloid vasculature in the OF. As such, the decrease in tln1 
expression is likely indicative of decreased numbers of hyaloid vasculature cells which 
require tln1 expression for proper migration into the fissure and or proliferation. 
 Our study strongly supports the notion that vasculature plays an integral part in 
OF fusion. Proper execution of angiogenesis is therefore a potential mechanism to ensure 
timely vascularization of the OF. The deficiency of hyaloid vasculature in pax2a mutant 
embryos may therefore result from a decrease in VEGF signaling. Using WISH and 
qPCR we detected a significant decrease in cranial vegfaa, ab and c expression. VEGF 
signaling is critical for angiogenesis and proper vasculogenesis throughout the embryo, a 
decrease in its activity is therefore likely to result in a series of deficiencies, including 
hyaloid vascularization of the OF. These findings supported the observation that pax2a 
mutants suffer from severe heart malfunction and subsequent edema and hemorrhage. 
The mechanisms of how pax2a regulates VEGF signaling remains unknown at this time 
and will need to be investigated in future studies. The observed decrease in VEGF 
expression does not directly correlate to regions of pax2a expression, which therefore 
suggests indirect regulation or negative VEGF feedback signaling during early 
development in the absence of pax2a function. In addition, phenotypes resulting from 
reduced VEGF signaling and therefore vasculogenesis may stem from subsequent 
circulation and cardiac function defects as well.  
 The last aspect of our proposed model pertains to the OF BM degradation 




activity during OF fusion [119]. To that end, we have discovered that mmp2 is expressed 
within the hyaloid vasculature during OF fusion (Figure 3.5). In fact, timing of mmp2 
expression correlates with the expected timing for initiation of BM degradation 
(Appendix 2.5). When we examine pax2a mutants or inhibit hyaloid vasculature 
completely (DMH4 treatment) we no longer detect expression of mmp2 or mmp14a and 
14b. Delayed treatment with DMH4 also resulted in absence of mmp2 expression (90% of 
embryos after 24-32hpf treatment (n=10) and 63% in 28-32hpf treated embryos (n=11). 
Furthermore, using ARP101, a specific mmp2 inhibitor, we showed that mmp2 activity is 
necessary for OF BM degradation, specifically between 26-32hpf (Figure 3.6). Mmp2 has 
been implicated in OF fusion previously. Mouse studies have shown mmp2 expression 
within macrophages residing in the OF. Furthermore, recent examination of mmp2 
activity, using a reporter construct, indicates that mmp2 is active in the eye and likely the 
OF [181]. Mmp14 is a known to activate mmp2 activity by cleaving the inhibitory pro-
peptide of mmp2 [183, 184]. As such, co-expression of mmp2 and 14 is further indicative 
of mmp2 playing a functional role in OF BM degradation. In the current study we did not 
directly assay the functional role of mmp14, but based on previous work linking mmp2 
activation to mmp14, it is likely that mmp14 is also going to be necessary for zebrafish 
OF fusion.  
 To date, the only BM degradation enzyme to be associated with OF fusion is 
adamts16. Loss of adamts16 function in zebrafish, via morpholino, led to a coloboma like 
phenotype which the authors credited to the inability to degrade laminin in the fissure 
[192]. We have not been able to reproduce adamts16 expression within the fissure. 




during and post fusion [168, 191, 197, 198]. Surprisingly, none of these studies identified 
any obvious candidates for carrying out BM degradation, including mmp2 and mmp14. 
However, it remains possible that the OF tissue examined lacked the hyaloid vasculature 
and therefore prevented the identification of mmp2 and mmp14 as candidates. In addition, 
expression of mmp2, 14a and 14b is transient in the fissure which may have contributed 
to their OF expression being missed by other groups. Our data indicate mmp2 activity is 
necessary for BM degradation of the OF, but it does not rule out a role for additional 
proteases. There may be several proteases involved in OF BM degradation, such as 
adamts16, mmp2 and others, yet inhibition of just one could trigger failure of the 
degradation process and lead to fissure fusion failure. Continuing studies into matrix 
protease activity will be needed to fully characterize the degradation mechanism(s) 
during OF fusion.  
 Recent studies of hyaloid vasculature during OF fissure fusion have also included 
examination of the cloche mutant line, which is considered to be avascular. Importantly, 
cloche mutants (clom39) display a delay but not a complete lack of OF fusion [119]. This 
fact confounds our and other’s results that suggest hyaloid vasculature plays a role in OF 
fusion [139]. With our new finding that mmp2 plays a significant role in OF fusion we 
therefore examined mmp2 expression in clom39 mutants (Appendix 2.8). Interestingly, 
clom39 embryos did display mmp2 expression within the OF, albeit at visibly reduced 
levels. This finding suggests that clom39 embryos either still retain a population of cells 
(possibly POM or NCC) that are found within the fissure and express mmp2, or that not 
all vasculature is eliminated in these mutants. On that note, previous examination of 




region suggesting some degree of vasculature may remain [199]. The persistence of even 
low levels of mmp2 may explain why OF fusion is delayed, but not eliminated in clom39 
mutant embryos. Furthermore, we also note that in our DMH4 treatments, which generate 
an avascular phenotype, we appear to block OF fusion completely, which is also in 
contrast to clom39 mutants. This discrepancy may result from the absence of VEGF 
signaling which may be playing a secondary role to that of angiogenesis. An angiogenesis 
independent role of VEGF may involve signaling in other cell types such as the POM or 
NCC which are known to migrate through the OF. Future studies into mmp2 activity and 
VEGF signaling as well as interaction of POM and NCC with the OF will be of high 
priority.  
 In conclusion, we present a new model for the mechanism of OF BM degradation 
where pax2a functions to enable hyaloid vasculature invasion of the OF.  Once in the 
fissure, vasculature cells express mmp2, 14a and 14b to initiate BM degradation. As soon 
as fusion begins, vasculature becomes restricted from the fissure and ultimately the two 
retinal lobes fuse. Our model aligns with the molecular events observed in the fissure, 
including accumulation of F-actin at the time of vasculature migration through the fissure 
(24-28hpf), expression of mmps (26-36hpf) and subsequent BM degradation (32-48hpf). 
In the current study we relied on pharmacological inhibition of VEGF signaling and 
mmp2 activity. Pharmacological inhibition can have potential off target effects, in 
particular developmental delays or toxicity. While we have partially controlled for these 
potential off target effects our future plans are to extend the analysis of these pathways 







Figure 3-1 An increase in F-actin dynamics preceding laminin degradation during optic 
fissure fusion is disrupted in pax2a-/- embryos. 
A) Whole mount immunohistochemistry was used to simultaneously visualize F-actin (red) and laminin 
(green) during OF fusion, 24-72hpf. Central-proximal sections obtained using confocal imaging were 
collected and quantified. Scale bar = 50𝜇m. B) Whole mount Immunohistochemistry was used to 
simultaneously visualize F-actin (red) and laminin (green) during OF fusion, 24-72hpf, in pax2-/- embryos. 
Central-proximal regions of the OF are displayed. Scale bar = 50𝜇m. C) Quantification of laminin signal 
intensity within the OF, normalized to regions of laminin staining juxtaposed to the lens. Relative pixel 
intensities are displayed. ANOVA p<0.0001. D) Quantification of F-actin intensity (phalloidin staining) 
within the OF, normalized to regions of F-actin signal within the lobe of the retina. Relative pixel 





Figure 3-2 Pax2a is necessary for recruitment of hyaloid vasculature into the optic 
fissure. 
A) In vivo 4D confocal imaging of Tg[kdrl:mCherry] pax2a+/+,+/- or pax2a-/- embryos. Time lapse series 
depicting the region of the OF (dotted white lines) and mCherry positive vasculature endothelial cells 
migrating through the fissure from 24-29hpf. Scale bar = 10m. B) Comparison of pax2a+/+,+/- and pax2a-/- 
vascularization during OF fusion, 24-48hpf. 3D reconstructions of whole mount Tg[kdrl:mCherry] (red) 
pax2a+/+,+/- or pax2a-/- embryos with DAPI (blue) stained DNA. Scale bar = 50𝜇m. C) Quantification of the 
number of mCherry positive cells from 3D confocal stacks within the region of the OF. Individual embryo 
results are depicted. ANOVA p<0.0001. D) Whole mount in situ hybridization comparing tln1 expression 
between pax2a+/+,+/- and pax2a-/- embryos at 28 and 32hpf. tln1 signal within the OF (yellow arrowhead) 
appears reduced in Pax2a-/- embryos (red *). E) qPCR analysis of tln1 expression from heads of pax2a+/+ 





Figure 3-3 Inhibiting angiogenesis disrupts optic fissure fusion mechanics. 
A) Fluorescent whole mount in situ hybridization of vegfaa, vegfab and vegfc at 32hpf in WT and pax2a-/- 
embryos. Loss of pax2a results in decreased vegfaa, ab and c expression. DAPI is depicted in blue. Scale 
bar = 100𝜇m. B) qPCR results for vegfaa, vegfab and vegfc expression from heads of pax2a+/+ and pax2a-/- 
embryos at 32hpf. C) 3D confocal images of Tg[kdrl:mCherry] (red) embryos treated with 100𝜇M DMH4 
between 24-72hpf. DNA was stained with DAPI (blue). Scale bar = 50𝜇m. D) Quantification of 48hpf 
DMH4 treated embryos for fissure fusion (absence of laminin signal), partial fusion (partial retention of 
laminin) or failure to fuse (retention of laminin throughout the fissure). n= 22 (DMSO), 52 (100𝜇M), 22 
(50𝜇M), 24 (25𝜇M) ANOVA p<0.0001. E) Quantification of laminin signal intensity within the central-
proximal region of the OF, normalized to regions of laminin staining juxtaposed to the lens. Relative pixel 
intensities are displayed. ANOVA p<0.0001. F) Quantification of F-actin signal intensity (phalloidin 
staining) within the central-proximal region of the OF, normalized to regions of F-actin signal within the 





Figure 3-4 VEGF signaling is plays a role in optic fissure fusion. 
A) Whole mount Immunohistochemistry was used to visualize laminin (green) at 48hpf after DMSO or 
DMH4 treatment. Central-proximal regions of the OF are displayed depicting fused, partially fused or 
unfused optic fissures. Scale bar = 50m. B) Quantification of 48hpf DMH4 treated embryos for fissure 
fusion (absence of laminin signal), partial fusion (partial retention of laminin) or failure to fuse (retention of 
laminin throughout the fissure). n= 41 (12-48hpf), 38 (24-48hpf), 38 (28-48hpf), 44 (32-48hpf), 40 
(DMSO). ANOVA p<0.0001. C) 3D reconstructions of whole mount Tg[kdrl:mCherry] embryos treated 
with 100 M DMH4 at various time points. Broken white line outlines the retina. Scale bar = 50m.  D) 
Quantification of the number of mCherry positive cells from 3D confocal stacks within the region of the 
OF after DMSO or DMH4 treatment. Individual embryo results are depicted. ANOVA p<0.0001. E) 
Fluorescent whole mount in situ hybridization of pax2a or tln1 probe at 32hpf in DMSO or DMH4 treated 
embryos. OF expression is indicated with a yellow arrowhead. DMH4 treatment does not appear to alter 
pax2a expression but eliminates tln1 expression from the OF. Broken white lines outline the retinal lobes. 





Figure 3-5 Hyaloid vasculature is a source of mmp2 during optic fissure fusion. 
A) Fluorescent whole mount in situ hybridization comparing mmp2, mmp14a and mmp14b expression in 
WT vs pax2a-/- and DMSO vs DMH4 treated embryos at 32hpf. Broken white lines outline the OF retinal 
lobes. mmp2, 14a and 14b expression within the OF is reduced in pax2a-/- and DMH4 treated embryos. 
Scale bar = 50m. B) qPCR analysis confirms a decrease in expression of mmp2, 14a and 14b in both 
pax2a-/- and DMH4 treated embryos. C) Two color whole mount in situ hybridization simultaneously 
examining mmp2 and kdrl, or mmp2 and rorB expression at 32hpf. DNA was stained with DAPI. Scale bar 





Figure 3-6 Proper timing of mmp2 activity is required for optic fissure fusion. 
A) Whole mount Immunohistochemistry was used to visualize laminin (green) and DAPI (blue) in ARP101 
treated Tg[rx3:GFP] embryos at 32, 36 and 48hpf. Stacks of central-proximal regions of the OF are 
displayed. Scale bar = 50m. B) Quantification of 48hpf ARP101 treated embryos for fissure fusion 
(absence of laminin signal), partial fusion (partial retention of laminin) or failure to fuse (retention of 
laminin throughout the fissure). n= 41 (10M), 38 (15M), 42 (20M) ANOVA p<0.0001. C) 3D 
reconstructions of whole mount Tg[kdrl:mCherry] (red) embryos treated with 20 M ARP101 from 24-32, 
36 or 38hpf. DNA was stained with DAPI (blue). Scale bar = 50m.  D) Quantification of the number of 
mCherry positive cells from 3D confocal stacks within the region of the OF after DMSO or 20 M 
ARP101 treatment. Individual embryo results are depicted. E) Quantification of 48hpf ARP101 treated 
embryos for fissure fusion, partial fusion or failure to fuse after various treatment initiation times from 24-







 TRANSCRIPTOMIC PROFILING OF ZEBRAFISH OPTIC FISSURE CLOSURE IN 




 Prevalent throughout embryogenesis, the fusion of epithelial tissue to seal 
naturally occurring gaps is critical for proper organogenesis. One such event occurs 
during vertebrate eye development and involves fusion of the optic fissure. The optic 
fissure forms as a consequence of optic cup morphogenesis and serves as a conduit for 
the migration of endothelial vasculature during hyaloid angiogenesis. Failure of optic 
fissure fusion results in a congenital blinding disorder known as coloboma. Recent 
studies have linked hyaloid vasculature precursor cells to be potential triggers for 
initiating optic fissure fusion. In order to examine this link, we analyzed the 
transcriptional and molecular events associated with optic fissure fusion and hyaloid 
angiogenesis in the zebrafish pax2anoi mutant coloboma model. To examine how the 
fusion process is disrupted in the absence of pax2a function, we compared transcriptomic 
profiles between pax2a-/- and wildtype (WT) whole retinas. We sought to validate and 
investigate those targets which were thought to be of importance to the molecular 
machinery involved in fusion, particularly those involving the actin cytoskeleton and 
angiogenesis. This analysis uncovered a novel connection between regulation of 
angiogenesis and fusion. Loss of pax2a resulted in increased expression of an anti-




Tg[kdrl:mCherry] embryos, attempting to mimic the pax2a increase in expression, 
resulted in decreased hyaloid vasculature which phenocopies the pax2a-/- phenotype. 
Based on the ability of migrating endothelial cells to activate integrin signaling we also 
began looking for the possibility of reduced actin associated transcripts in our RNA 
sequencing data. We uncovered preliminary evidence that certain actin associated 
proteins are also differentially regulated, particularly rho-associated protein kinase 
(ROCK). Taken together, we propose that Pax2a negatively regulates ADAMTS1 
expression. This enables timely hyaloid vascularization of the retina which in turn 
directly signals to initiate fissure fusion via cytoskeletal rearrangements and subsequent 
basement membrane remodeling. 
4.2 Introduction 
 Epithelial fusion is the process by which two distinct populations of epithelial 
cells become apposed and eventually fuse to create a single continuous sheet. This 
process can be observed at several stages during development, including the closure of 
the neural tube, the palatal shelf, presumptive genitalia, eyelids, and the optic fissure of 
the developing retina [27, 200-202] Formation of a fully functioning human eye requires 
precise and coordinated cellular mechanisms during very early development. One such 
mechanism is responsible for the formation of the eye, which forms a 3D structure from a 
flat sheet of cells. This leads to the creation of a gap (fissure), at the ventral region of the 
eye. This fissure, the optic fissure, remains open during morphogenesis of the eye to 
allow the establishment of the hyaloid vasculature. The hyaloid vasculature is a 
temporary circulatory system developed during eye morphogenesis [122]. As soon as the 




optic fissure will undergo fusion to seal the optic stalk which houses the retinal ganglion 
cell axons. Failure of optic fissure fusion leads to a congenital blinding disorder known as 
coloboma [30, 130]. Coloboma is a leading cause of pediatric blindness, accounting for 
approximately 10% of cases worldwide [152, 154]. Coloboma is a spectrum disorder 
presenting unilaterally or bilaterally and ranging in severity from minor visual 
impairment, to complete blindness in the affected eye [155]. This spectrum of severity is 
associated with the location and degree to which the optic fissure was able to fuse and the 
severity of subsequent loss of ganglion cell axons [153]. Epithelial fusion has been 
studied for over a century, and is known to involve transcriptional regulation, cell 
signaling pathways, and morphogen gradients [160, 161]. However, in regard to the optic 
fissure we are still lacking a basic understanding of how these molecular mechanisms 
coordinate and directly facilitate fusion. Recent work has begun to implicate some of the 
cellular processes involved in optic fissure fusion. For example, the actin cytoskeleton is 
known to be a crucial component of the machinery driving fusion of the optic fissure as 
well as other tissues [162]. The actin cytoskeleton is thought to be involved in fusion by 
the formation of lamellipodia and filopodia projections between the apposing epithelia. It 
is thought that these projections help to “zipper” the cells together [164-166]. It has been 
observed that fusion often fails when lamellipodial and filopodial projections are 
precluded [163]. However, while it has been observed that actin protrusions likely play a 
functional role during optic fissure fusion, it still remains to be determined what actin 
cytoskeletal components are required during optic fissure fusion. Another cellular 
mechanism known to be directly involved in epithelial fusion is the breakdown of the 




which must be removed in order for fusion to complete. Recent work, including our own, 
across several species has characterized progressive removal of the BM during choroid 
fissure fusion [88, 119, 167, 168]. However, the molecular mechanisms facilitating this 
process, in particular BM breakdown, remain largely unknown. James et al. 2016, 
showed that zebrafish cloche mutants, which lack all early hyaloid vasculature, have 
delayed basement membrane breakdown in the region of the choroid fissure [119]. James 
et al. 2016 also reported that talin1 mutants, an actin scaffolding protein required for 
migration, fail to breakdown the basement membrane resulting in coloboma [119]. This 
finding was the basis of our investigation into vasculature in our pax2a coloboma model. 
Our previous work has shown a direct requirement for migrating endothelial cells. In the 
absence of all vasculature through the use of drug inhibition results in a retention of the 
basement membrane [203]. There is therefore a clear link between optic fissure fusion 
initiation and hyaloid vasculature migration through the fissure. There are two proposed 
mechanisms that hyaloid vasculature regulates optic fissure fusion, the secretion of 
proteins involved in the fusion process, as observed in our previous work showing 
vasculature supplied mmp2 [203]. Another role that the vasculature could be playing is 
through angiocrine signaling. Angiocrine signaling is known to provide growth factors 
and other proteins capable of stimulating epithelial cells to modify themselves, including 
the stimulation of actin cytoskeletal rearrangements [136, 138]. Finally, the sheer 
presence of the endothelial cells themselves could initiate fusion by exerting force on the 
rim cells of the optic fissure while passing through [135]. This could lead to 
mechanosensation by the basement membrane of the rim cells which would induce 




has been studied for many decades in many different species. This has led to a general 
outline of the signaling and morphogenetic pathways required for proper optic fissure 
formation and fusion (recently reviewed in [156]). This study aims to further analyze 
zebrafish optic fissure fusion comparing WT and the pax2a-/- coloboma model to expand 
upon our previous findings [203]. Using transcriptomic analysis to compare WT and 
pax2a-/- eyes we discovered misregulation in angiogenic signaling, resulting in decreased 
vascularization of the early retina and optic fissure fusion failure. In particular we found 
that pax2a-/- embryos exhibit an increase in A disintegrin and metalloproteinase with 
thrombospondin motifs 1 (ADAMTS1) expression, an anti- angiogenic protease [204, 
205]. Overexpression of ADAMTS1 both phenocopied the pax2a-/- hyaloid vasculature 
and coloboma phenotypes. Once we knew how crucial migrating endothelial cells were to 
the fusion process and how this process could possibly be disrupted in a coloboma model, 
via ADAMTS1, we next sought to understand potential mechanisms that these 
endothelial cells act through. We decided to specifically look at actin cytoskeleton and its 
accessory proteins since the actin cytoskeleton is essential for cell signaling and several 
studies have shown how endothelial cells contribute angiocrine signaling to the actin 
cytoskeleton [135, 136, 138]. Looking at the transcriptomic data again several actin 
associated transcripts which were differentially expressed between WT and pax2a-/- 
embryos, in particular (ROCK). This led us to propose a novel pathway for the regulation 
of optic fissure fusion where pax2a mediates proper regulation of anti-angiogenic factors 






4.3.1 Pax2a retinal transcriptomic profile during optic fissure fusion. 
Although pax2 has been studied in many systems, there are currently no obvious 
transcriptional targets of pax2 that would directly point to the mechanistic regulation of 
optic fissure fusion. In an effort to understand the absence of vasculature and F-actin (as 
discussed in previous published work [203]) observed in pax2a-/- embryos we compared 
retinal transcriptomic profiles between WT and pax2a-/- embryos. Eyes from 48hpf WT 
and pax2a-/- embryos were isolated and total RNA was subsequently purified and 
sequenced using Illumina sequencing. 48hpf was chosen for our experimental time point 
as pax2a-/- embryos are easily phenotyped at this age thanks to observable heart 
malformations. When comparing three replicates for WT and pax2a-/- embryos using 
RSEM software, we detected 1215 transcripts significantly upregulated (>95% 
confidence interval) and 1202 transcripts significantly downregulated (Figure 4.1A, D). 
Gene ontology analysis indicated a wide spread of biological function being affected, 
including cytoskeletal signaling, adhesion and developmental processes (Figure 4.1B, E). 
In support of our previous publication we found that tln1, an actin scaffolding protein 
known to be required for cell migration, was significantly down regulated in pax2 
mutants. The distribution of biological function between up- and down-regulated genes 
was highly similar (Figure 4.1B, D). When comparing gene ontology between up- and 
down-regulated genes in pax2, they shared a similar pattern and trend. Among the most 
commonly represented biological function from both lists were cellular processes, which 
included signal transduction, actin-based processes, cell communication, and cellular 




favor, the angiogenesis pathway which was more heavily represented in the genes down-
regulated in pax2 mutants. This further confirms results in our previous work that pax2 
mutants have reduced vasculature. The other biological pathway heavily favored genes 
up-regulated in pax2 mutants, the Wnt signaling pathway. One gene of interest that came 
out of this data was a gene labelled as a metalloprotease called ADAMTS1 which was 
up-regulated in pax2 mutants, however, it was also associated with the angiogenesis 
pathway through its antiangiogenic capacity [204, 205]. Actin cytoskeletal proteins were 
evenly represented amongst the two groups, perhaps representing the loss of vasculature 
associated actin related proteins. However, two different genes which perform similar 
functions as down-stream effectors of the Rho signaling pathway were down-regulated in 
pax2 mutants, ROCK1 and ROCK2b [206]. A list of top 20 up and down regulated genes 
is outlined in Figure 4.1C and F. Results of all the statistically significant up and 
downregulated genes identified in our assay are presented as supplementary data 
(Appendix Tables 1.1 and 1.2).  
 
4.3.2 Anti-angiogenic protease adamts1 is upregulated in optic fissure of pax2a mutant 
embryos. 
Having previously established a connection between pax2a function and 
recruitment of hyaloid vasculature cells into the optic fissure [203], we next sought to 
examine the mechanism. To do so, we examined our transcriptomic comparison of WT 
and pax2a-/- eyes, with a focus on angiogenic regulation. This examination revealed 
misexpression of a disintegrin and metalloproteinase with thrombospondin motifs 1 




Being a member of the ADAMTS family, adamts1 contains three thrombospondin motifs 
enabling it to directly bind and sequester VEGF [205]. Furthermore, the protease activity 
of adamts1 has bene shown to target thrombospondin 1 and 2 for cleavage, ultimately 
liberating their active forms which bind to and block VEGF from binding the VEGF 
receptor [204]. Our RNA sequencing data indicated that adamts1 expression was 
upregulated almost two-fold in pax2a-/- eyes. This would suggest that the expression of 
adamts1, and therefore its anti-angiogenic activity, is normally somehow kept in check 
by pax2a. Pax2a has not been reported to harbor transcriptionally repressive function, so 
this may involve an indirect mechanism. To confirm our RNA sequencing results we 
performed WISH, examining adamts1 expression at 28 and 36hpf. In agreement with our 
transcriptomic analysis, we observed an upregulation in adamts1 in the ventral region of 
pax2a-/- eyes, specifically surrounding the optic fissure (Figure 4.2A). This was further 
confirmed using qPCR (Figure 4.2B). To test whether upregulation of adamts1 
expression would have direct effects on hyaloid vascularization and optic fissure fusion 
we injected Tg[kdrl:mCherry] embryos with adamts1 mRNA. We subsequently 
examined hyaloid vasculature using 3D confocal imaging between 24-48hpf. Injection of 
adamts1 mRNA resulted in a significant decrease in the number of kdrl:mCherry cells 
found within the optic fissure (Figure 4.2B, C). The observed decrease mirrored the 
results from pax2a-/- embryos (Figure 4.2C). Our findings therefore suggest that adamts1 
expression needs to be tightly regulated in order to ensure proper vascularization of the 
retina, including the optic fissure. Furthermore, the observed up-regulation of adamts1 






4.3.3 Overexpression of adamts1 inhibits optic fissure fusion mechanics. 
Having mimicked the vasculature phenotype of pax2a mutants by over expressing 
adamts1, we next examined whether it had any effects on optic fissure fusion. To do so, 
we performed whole mount laminin and F-actin staining in adamts1 mRNA injected 
embryos at 24, 32, 36, and 48hpf (Figure 4.3A). Confocal imaging of the fissure 
indicated that adamts1 mRNA injection also phenocopied pax2a-/- associated persistence 
of laminin and therefore failure of optic fissure fusion. Quantified levels of laminin 
persisting at 48hpf was similar to pax2a-/- embryos (Figure 4.3B). Similar to pax2a-/- 
embryos, we again noted a lack F-actin accumulation between 24-32hpf in adamts1 
overexpressing embryos (Figure 4.3C). As was observed with pax2a-/-, timing for 
apposition of the lobes was not affected in adamts1 overexpressing embryos (Appendix 
2.2). Taken together, our data suggest that maintaining proper levels of adamts1 
expression is necessary to enable VEGF signaling and subsequent recruitment of hyaloid 
vasculature required for initiation of optic fissure BM remodeling.  
 
4.3.4 Rho-associated protein kinase (ROCK) is down-regulated in pax2 mutants 
 Having established a definitive link between the hyaloid vasculature cells and 
optic fissure fusion, we next sought to understand how migrating endothelial cells operate 
during optic fissure fusion. I felt there was a high probability that these migrating 
endothelial cells were eliciting cytoskeletal responses in and around the fissure, as these 




cytoskeleton, including mechanosensation and angiocrine signaling [135, 136, 138]. 
Angiocrine signaling has also been shown to contribute to integrin signaling, which 
activates the Rho family of GTPases and subsequently mediates cytoskeletal responses 
[138]. To investigate whether the actin cytoskeleton and/or its accessory proteins were 
impacted in pax2 mutants, we turned once again to the RNA sequencing data. When 
comparing WT and pax2a-/- whole retina RNA sequencing data two particular transcripts 
were of interest, Rock1 and Rock2b. Rho-associated Protein Kinase (ROCK) is a down-
stream target of RhoA, B, and C. ROCK’s have a diverse range of function, of interest for 
this work was their involvement in actin cytoskeleton organization, cell adhesion, and 
extracellular matrix remodeling [116]. ROCK1 had over a 25 fold change, showing a 
dramatic reduction of ROCK1 expression in pax2 mutants. ROCK2b was also down-
regulated in pax2 mutants with an approximately 6 fold reduction. To validate these 
results, we performed qPCR on cDNA of dissected eyes from WT and pax2 mutants for 
all known ROCK’s in zebrafish, ROCK1, ROCK2a, and ROCK2b. qPCR results 
validated down-regulation of ROCK’s in pax2a mutant eyes (Figure 4.4A). We next 
performed whole-mount in situ hybridizations for Rock1 and Rock2b using embryos 
from an in-cross of pax2a+/noi heterozygous fish. The results show that in approximately 
25% of embryos, expected mendelian ratio, the expression appeared reduced compared to 
the other 75% of embryos, indicating that these 25% were likely homozygous pax2 
mutants (Figure 4.4B). To examine the functional consequence of Rock down regulation, 
I attempted ROCK inhibition using a drug called Y-27632 which is a selective ROCK 
inhibitor, previously having been successfully used in zebrafish [208]. Y-27632 inhibits 




treatment using Y-27632 at various concentrations starting at 24 to 48 hpf, and from 32 to 
48 hpf. This experiment, however, has so far been unsuccessful, with almost zero 
phenotypic abnormalities across the entire embryo even at concentrations of up to 100 
𝜇M. ROCK is expressed ubiquitously throughout the entire zebrafish embryo and the 
odds ROCK inhibition having no effect on the embryo seems unlikely. I have therefore 
concluded it is possibly an ineffective batch of the drug and warrants further study using 
fresh inhibitor or trying other ROCK inhibitors. In the future, if drug inhibition is still 
unsuccessful the most effective way to understand ROCK’s function during optic fissure 
fusion would be to create a transgenic line of zebrafish which would express a dominant 
negative form of ROCK, lacking a kinase domain, under the control of a heat shock 
promoter [209]. It is likely a ROCK CRISPR mutant would not survive the earlier stages 
of development and would thus be unsuitable for studying optic fissure fusion.  
4.4 Discussion 
 While optic fissure fusion has been studied extensively, spanning decades and 
across many different species, we still lack the functional knowledge of the mechanics 
driving this process. We have previously characterized some aspects of optic fissure 
fusion in zebrafish and found a definitive link between the hyaloid vasculature and fusion 
of the optic fissure, where without vasculature fusion fails to occur. It is becoming widely 
accepted now that vasculature (or the POM cells which contribute to the hyaloid 
vasculature) is involved in this process, however, it still remained unknown as to why 
vasculature would be affected in coloboma, specifically in pax2 mutants. It became the 
focus of this study to investigate how a transcription factor could control angiogenesis 




proper vascularization of the optic fissure by restricting anti-angiogenic activity of 
adamts1 to enable hyaloid vasculature invasion of the optic fissure. Proper 
vascularization of the eye is crucial to optic fissure fusion. We have shown here and 
previous work that a reduction in vasculature leads to fusion failure, however, it has also 
been reported that hypertrophic hyaloid vasculature also results in fusion failure likely 
due to the increased distance between the lobes of the fissure [210]. 
 In our transcriptomic comparison of WT and pax2a mutants we discovered a 
connection between fissure fusion and angiogenesis. In the absence of pax2a function we 
observed an upregulation of adamts1, an anti-angiogenic regulator. Examining adamts1 
expression in the eye further confirmed an upregulation of expression in the ventral 
regions of pax2a-/- retinas. Encoding 3 thrombospondin (thsb) motifs able to directly bind 
and sequester VEGF, in addition to targeting thsb1 and 2 for cleavage into their active 
VEGF inhibiting form, adamts1 is well known for its anti-angiogenic function in cancer, 
aortic and renal biology [211]. In our study, we show that upregulating adamts1 
expression reduces the number of hyaloid vasculature cells in the OF. Up regulation of 
adamts1 also prevents the accumulation of F-actin and subsequent BM remodeling. 
Taken together we propose that the reduction in hyaloid vasculature observed in pax2a-/- 
embryos likely stems from an upregulation of adamts1 leading to suppressed VEGF 
signaling and therefore limited vascularization of the optic fissure.  
 In our transcriptomic comparison we also uncovered a potential connection 
between optic fissure fusion and the actin cytoskeleton. In the absence of pax2 there was 
a marked decrease in the expression of two up-stream activators of actin based focal 




So far this is one of the few correlations to have been made between an actin cytoskeleton 
regulator and a coloboma model. I speculate that ROCK is required in the epithelium of 
the fissure, previously a study revealed its requirement during fusion of the eyelid and 
ventral body wall in mice [116]. When ROCK is knocked out in mice, the contractile ring 
surrounding the eyelid epithelium fails to contract resulting in an inability to close the 
gap [116]. ROCK1 is a negative regulator of VEGF endothelial cell activation, it has 
been previously reported that ROCK inhibition stimulates the migratory behavior of 
various cell types including endothelial cells [212]. Since ROCK inhibition has a 
stimulatory effect on endothelial cell migration it seems unlikely that hyaloid vasculature 
cells are the contributors of ROCK expression in the optic fissure. During palatal fusion 
in mice it has also been observed that when inhibiting ROCK the epithelia still appose, 
however, cell intercalation and neighbor exchange fail to occur resulting in cleft palate 
[213]. It is therefore plausible that ROCK activity is required to begin the actual 
combining of the two epithelial sheets in the optic fissure and that the activation of 
ROCK could be triggered by the migrating endothelial cells. This preliminary data will 
hopefully provide the groundwork for future studies involving ROCK activity during 
optic fissure fusion.  
 Taken together, these findings further validate the knowledge that hyaloid 
vasculature is an active component of the machinery driving optic fissure fusion in 
zebrafish. We present a new piece of data to add to our model for the mechanism of optic 
fissure fusion, where pax2a restricts expression of adamts1 in the ventral retina to enable 
hyaloid vasculature invasion of the optic fissure. Once in the fissure, vasculature cells 




becomes restricted from the fissure and ultimately the two retinal lobes fuse. For future 
studies it will be important to understand how pax2a regulates adamts1 expression and to 
examine whether mutations in adamts1 resulting in mis-expression of this transcript are 
potential markers for coloboma. It will be equally important to further investigate the 
mechanisms behind actin cytoskeletal rearrangements with an emphasis on ROCK. I 
believe ROCK is vital to the actual combining of the two sheets of epithelium, to test 
whether ROCK acts in this manner it would be most effective to create a transgenic line 
of zebrafish to express a dominant negative version of ROCK under the control of a heat 
shock promoter. This would then allow us to assess the effects of ROCK inhibition on the 
removal of the basement membrane and whether or not the hyaloid vasculature is 
affected. If the vasculature is not affected by the knock down of ROCK but still results 
fusion failure it would support this hypothesis. If this connection were to be made, it 







Figure 4-1 Retinal transcriptomic comparison between WT and pax2anoi/noi. 
A) Heat map representing transcripts found to be significantly down regulated in pax2a-/- embryos. B) Gene 
ontology for pax2a-/- downregulated transcripts. C) Top 20 downregulated transcripts are outlined in order 
of fold change. D) Heat map representing transcripts found to be significantly upregulated in pax2a-/- 
embryos. E) Gene ontology for pax2a-/- upregulated transcripts. F) Top 20 upregulated transcripts are 







Figure 4-2 ADAMTS1 inhibits retinal vascularization. 
A) Wholemount in situ hybridization comparing ADAMTS1 expression between WT and pax2a-/- embryos 
at 28 and 32hpf. ADAMTS1 signal within the optic fissure (yellow arrowhead) is clearly increased in 
Pax2a-/- embryos. B) qPCR results for ADAMTS1 expression from heads of pax2a+/+ and pax2a-/- embryos 
at 32hpf. C) Comparison of WT and ADAMTS1 mRNA injected embryo vascularization during optic 
fissure fusion, 24-48hpf. 3D reconstructions of whole mount Tg[kdrl:mCherry] (red) WT or ADAMTS1 
mRNA injected embryos with DNA stained by DAPI (blue). Scale bar = 50um. D) Quantification of 
mCherry positive cells from 3D confocal stacks within the region of the optic fissure. Individual embryo 








Figure 4-3 ADAMTS1 misregulation leads to failure of optic fissure fusion. 
A) Whole mount Immunohistochemistry was used to simultaneously visualize F-actin (red) and laminin 
(green) during optic fissure fusion, 24-72hpf in ADAMTS1 mRNA injected embryos. Central-proximal 
sections obtained using confocal imaging were collected and quantified. Scale bar = 50um. B) 
Quantification of laminin signal intensity within the optic fissure, normalized to regions of laminin staining 
juxtaposed to the lens. Relative pixel intensities are displayed. A green dotted line depicts the trend in 
laminin intensity over time, blue line depicts WT trends. ANOVA p<0.0001. C) Quantification of F-actin 
signal intensity (phalloidin staining) within the optic fissure, normalized to regions of F-actin signal within 
the lobe of the retina. Relative pixel intensities are displayed. A red dotted line represents the trend in F-










Figure 4-4 Down-Regulation of ROCK1, ROCK2a, and ROCK2b in pax2 mutants. 
A) Wholemount in situ hybridization comparing ROCK1 and ROCK2b expression between WT and pax2a-
/- embryos at 32hpf. ROCK1 and ROCK2b signal within the eye is clearly decreased in the suspected 
Pax2a-/- embryos. B) qPCR results for ROCK1, ROCK2a, and ROCK2b expression from heads of pax2a+/+ 






 On the surface, epithelial fusion seems like a simple process: push sheets of cells 
close together and glue them. The actual process is anything but simple, requiring precise 
coordinated cell movements, specific spatially and temporally controlled expression of 
many genetic factors, detailed cell-cell communication and so much more. Many tissues 
throughout morphogenesis require epithelial fusion, including the heart, neural tube, eye, 
and more [27, 200-202]. For almost every epithelial fusion event there is an associated 
congenital birth defect: malformed hearts, spina bifida and coloboma to name a few [27, 
200-202]. Often times these congenital defects present themselves as part of syndromes, 
as is the case in CHARGE syndrome where many epithelial fusion events have failed to 
occur [31]. Based on the presence of these syndromes where multiple fusion events fail to 
occur properly it is highly reasonable to assume that these events share some core 
common mechanisms. Therefore studying one fusion event could potentially be 
advantageous for understanding the mechanisms governing other fusion events as well. 
 Optic fissure fusion presents a unique system to be able to understand the 
mechanisms governing epithelial fusion. In zebrafish fusion of the optic fissure occurs 
rapidly, retinal morphogenesis is completed by 72 hours post fertilization. Eye 
development is easily accessible to study as it develops peripheral to the organism, 
allowing for detailed analysis of the mechanisms that occur during fusion. Like with most 
fusion events, failure of optic fissure fusion results in a congenital disorder, in this case 
coloboma [57]. Coloboma is a prevalent cause of pediatric blindness, accounting for 
approximately 10% of all pediatric blindness cases worldwide [58]. This blindness is due 




environment resulting in neuronal death preventing the transduction of signals from the 
eye to the brain. While some colobomas can be traced back to environmental causes, such 
as in the case of vitamin A deficiency resulting in a failure to activate the RA pathway 
[78]. Most causes of coloboma, however, are the result of genetic aberrations. 
Unfortunately, only approximately 30% of non-syndromic coloboma cases have a 
definitive genetic link, and of those 30% many do not reveal a functional explanation as 
to their requirement in fusion [140]. Pax2 is one of the 30% of known genetic 
abnormalities which lacks a functional explanation to its requirement in optic fissure 
fusion [174]. Nevertheless, pax2 is a cause of coloboma across many species, including 
humans [173]. Approximately 50% of renal coloboma cases in humans can be traced 
back to a mutation in pax2, of which 92 mutations have been found and one particular 
mutation has been reported 57 times [61]. This makes pax2 mutants an effective model to 
study coloboma and the mechanisms which go awry during the process of optic fissure 
fusion.  
 Much of the decades of previous work on optic fissure fusion has focused on the 
genes and genetic pathways required for this process to occur. Most of these mutations 
result in a morphological coloboma, where failure of the proper patterning and 
morphogenetic movements of the eye fail to occur resulting in a large morphological gap 
between the lobes of the fissure and not due to any defects in the actual epithelial fusion 
process. This morphological based coloboma also presents difficulty when trying to 
understand the direct mechanisms involved in the actual joining of the two tissues. It has 
been reported in some species, such as mouse and chick, that mechanisms such as 




their involvement in optic fissure formation and growth it is nearly impossible to say 
whether these mechanisms are directly involved in the fusion process or are the result of 
morphogenesis [88]. The direct cellular machinery is still the most poorly understood 
aspect of optic fissure fusion. What is known about the cellular machinery driving this 
process can be summed up in three broad mechanisms. Two mechanisms have long been 
accepted to be involved in epithelial fusion in general, basement membrane removal and 
actin cytoskeletal rearrangements. The basement membrane that surrounds epithelial 
tissue performs important tasks, one of which is to provide a barrier that distinguishes the 
boundaries of tissues [90]. This important role for the basement membrane becomes 
problematic when epithelial fusion needs to occur as it keeps the tissues separate and 
within separate boundaries. It also hinders the actin cytoskeleton from being able to form 
necessary structures to contact and communicate between the fusing sheets [90]. The 
requirement of basement membrane removal has been the consensus and commonality 
amongst all vertebrate species studied to date [140].  
 The actin cytoskeleton has been observed during epithelial fusion across many 
different fusion events such as Drosophila dorsal closure and mouse neural tube 
development, to name a few [162]. It is generally accepted that the actin cytoskeleton 
forms critical structures to aid in fusion by forming lamellipodia and filopodia [163]. 
These structures help to connect and communicate to the apposing tissue and acts as a 
zippering-type mechanism, seaming the tissues together along the length. In a recent 
study, RNA sequencing was performed comparing human and murine laser captured 
microdissections of the optic fissure and found that there was high conservation in their 




epithelial to mesenchymal transition were enriched in the human optic fissure during the 
fusion process [215]. Patel, et al. further showed that cells at the fissure margins 
delaminate and create cellular protrusions which then go on to rearrange to create a 
continuous sheet [215]. It was also noted that apoptosis was not observed in the human 
optic fissure during fusion [215].  
 The third mechanism, specifically in optic fissure fusion, has only recently been 
elucidated and is still in its infancy, the hyaloid vasculature. For many decades it was 
believed that the hyaloid vasculature was only a passive process, merely taking advantage 
of the open fissure to establish the vasculature network at the back of the lens. However, 
it is now understood that migrating POM-derived endothelial cells forming the hyaloid 
vasculature are critical to the fusion process [139]. With these cells’ ability to produce 
secreted factors which could affect fissure fusion they are quickly becoming a key area of 
study. James et al. showed that in zebrafish talin1 mutants, an actin scaffolding protein 
known to be required for cell migration, the hyaloid vasculature was greatly reduced and 
optic fissure fusion failed to occur [119]. In this same work James et al. also showed that 
in cloche mutants, which lack all early vasculature, basement membrane degradation was 
delayed compared to normal optic fissure fusion [119]. Basement membrane degradation, 
actin cytoskeletal rearrangements, and the establishment of the hyaloid vasculature 
painted the backdrop to our understanding of the cellular machinery involved in optic 
fissure fusion. This, however, was merely a beginning, so much was still left unanswered. 
Which cellular mechanism is the initiating factor? How is the basement membrane 




vasculature cells required during optic fissure fusion? These questions were the basis of 
this dissertation.  
 Our broad hypothesis was that basement membrane removal, actin cytoskeletal 
rearrangements, and migrating vasculature cells were intimately connected to one 
another, without one, the others fail to occur. The beginning of this research was 
performing a detailed analysis of the three known mechanisms involved in optic fissure 
fusion. We needed to pinpoint the precise timing and behaviors of each of these 
mechanisms before we could even begin to understand and test how they interact with 
one another. Through whole mount immunohistochemistry using wild-type embryos and 
staining for laminin, a marker for the basement membrane, we discovered that 
degradation of the basement membrane begins at approximately 32 hours post 
fertilization (hpf). This degradation begins medially and the epithelial sheets fuse along 
the ventral axis proximally and distally from this median. The degradation continues until 
around 48 hpf around the time which laminin can longer be detected within the vast 
majority of the optic fissure. We also characterized the actin cytoskeleton through 
phalloidin staining. We discovered that an increase in f-actin staining immediately 
preceded (between 24 to 32 hpf) basement membrane degradation in the lobes of the 
optic fissure. This suggests that actin remodeling plays some part in initiating basement 
membrane degradation. The final mechanism we extensively characterized was the 
establishment of the hyaloid vasculature and its relationship to the other mechanisms. 
Using a transgenic line of zebrafish which fluorescently tags the VEGF receptor kdrl, we 
determined that endothelial cells begin migrating into the optic cup before 24 hpf, as 




hpf individual cells are no longer distinguishable. One of the major challenges in this 
characterization was examining the actin cytoskeleton. This was due to the presence of 
these migratory cells, it became nearly impossible to distinguish the behavior of the actin 
cytoskeleton associated to the epithelial cells surrounding the optic fissure and the actin 
cytoskeleton associated to the migrating endothelial cells. Regardless of our inability to 
distinguish the individual behaviors of the actin cytoskeleton we knew that migrating 
endothelial cells were the first to appear in the optic fissure, ever before increases in f-
actin and basement membrane degradation occur. We now felt we had a clear 
understanding of the behavior of these three cellular mechanisms during optic fissure 
fusion, but it told us little in the way of their function. We next wanted to see if in fact 
these three cellular mechanisms were involved in optic fissure fusion by doing the same 
analysis in a coloboma model, pax2a. We hypothesized that since we feel the three 
cellular mechanisms are intimately linked, that in coloboma all three mechanisms would 
be aberrant. By performing the same analyses on pax2a mutants that were performed on 
wild-type embryos we confirmed our hypothesis that in coloboma these cellular 
mechanisms show great irregularities. In pax2a mutants we observed a retention of the 
basement membrane up to and including 72 hpf, well beyond the time when the basement 
membrane has been completely degraded in wild-type. The actin cytoskeleton, also, fails 
to undergo the required rearrangements, as an increase in f-actin staining could not be 
detected in the optic fissure when it was detected in wild-type. Finally, in pax2a mutants 
the hyaloid vasculature is malformed compared to wild-type and through cell counting 
we were able to confirm that there is a significant reduction in the number of endothelial 




qPCR analysis which showed that several transcripts specifically associated to the 
hyaloid vasculature were down-regulated in pax2a mutants, including the actin 
scaffolding protein talin1. Due to the findings from pax2a mutants, and the fact that 
endothelial cells are the first to arrive on scene, we hypothesized that these endothelial 
cells were crucial and were possibly the catalyst that initiates the subsequent mechanisms 
involved in optic fissure fusion. One of the most well-known mechanisms for the growth 
of vasculature is VEGF signaling (vascular endothelial growth factor), interestingly it 
was discovered that several VEGF ligands are down-regulated in pax2 mutants when 
compared to their wild-type counterpart. This allowed us to test our hypothesis of 
vasculature being required for optic fissure fusion by inhibiting VEGF signaling. To do 
so we used DMH-4 which blocks VEGF signaling and we then were able to assess the 
consequences to optic fissure fusion. We found that when vasculature is precluded from 
the optic cup the basement membrane fails to degrade and an increase in f-actin is unable 
to occur and ultimately resulting in coloboma. By performing a drug inhibition time 
course for the spatial requirement of these vasculature cells we also found that these cells 
are required early in optic cup morphogenesis to complete optic fissure fusion, when 
treated from 12 hpf to 48 hpf this resulted in a 100% inhibition of optic fissure closure. 
However, when treatment began at 24 hpf almost 25% of fissures were able to fuse, 
beginning at 28 hpf approximately 50% were able to fuse, and beginning at 32 hpf 
approximately 90% were still able to fuse. By this point we had been able to provide a 
considerable amount of evidence to show that these migrating endothelial cells are 
undoubtedly required for proper optic fissure fusion. Although we knew that vasculature 




mechanism, we still didn’t know why these vasculature cells were involved. Previous 
literature searches had revealed that endothelial cells participate in angiocrine signaling, a 
process in which endothelial cells can deposit proteins which aid in development and 
repair, including extracellular matrix components (ref). We wanted to test the possibility 
of endothelial cells providing extracellular matrix remodelers like metalloproteases, 
which would contribute to basement membrane degradation in the optic fissure. To test 
this we first had to determine which metalloproteases had expression in the fissure. To do 
so we performed whole mount in situ hybridizations (WISH) and further performed 
whole mount fluorescent in situ hybridizations (FWISH)  on the potential targets. From 
these experiments we were able to uncover three promising metalloproteases which show 
expression at the appropriate time during optic fissure fusion, mmp2, mmp14a and 
mmp14b. Interestingly, mmp14 is an activator of mmp2 so it seemed promising that these 
metalloproteases showed strong expression in the optic fissure together. We wanted to 
ascertain which cells were providing this metalloprotease, the epithelial or endothelial 
cells. We performed two-color FWISH probing for mmp2 and an eye specific promoter 
(rorB), and mmp2 and kdrl. From this we saw an overlapping expression between mmp2 
and kdrl, providing evidence to our presumption that endothelial cells could participate in 
angiocrine signaling while passing through the optic fissure by depositing mmp2 to 
degrade the basement membrane. However, this didn’t reveal if mmp2 is actually 
involved in fusion, it could simply be a metalloprotease which the migratory cells use to 
help them detach from their temporary connections to basement membranes along their 
migration path. To test whether mmp2 activity is required for optic fissure fusion, we 




from 24 to 48hpf approximately 90% of embryos had either partial or complete retention 
of the basement membrane, suggesting that 90% of embryos treated with the mmp2 
inhibitor developed coloboma. This showed the first direct evidence of possible 
endothelial cell contribution to optic fissure fusion, showing for the first time a functional 
component of these cells.  
 After these findings, where we showed direct functional evidence to the 
requirement of endothelial cells in optic fissure fusion, we wanted to understand how it 
was possible for vasculature to be impacted by pax2 function or lack thereof. To do so we 
undertook the painstaking task of collecting zebrafish eye tissue at 48 hpf and extracting 
RNA for sequencing. Once the bioinformatic analyses were complete we began 
separating our results into separate groups based on their gene ontology looking at the 
pathways and biological processes these genes could be separated into. Based on this we 
made a novel discovery of a possible mechanism through which pax2 can modulate 
hyaloid vasculature establishment. What we initially thought was a metalloprotease 
actually had ability to function as an anti-angiogenic protein called ADAMTS1. 
ADAMTS1 was up-regulated in pax2a mutants by about 2-fold, suggesting that pax2a 
directly or indirectly inhibits the expression of this anti-angiogenic protein. ADAMTS1 
has been implicated in cancer metastasis when there is a loss of its function, showing that 
there is indeed a role for ADAMTS1 in the regulation of angiogenesis. One we had 
validated this finding through qPCR, we wanted to see if we could mimic the effect by 
performing overexpression experiments. Upon analysis of ADAMTS1 injected embryos 
we were amazed to see almost a direct imitation of the pax2a mutant phenotype. 




entering through the optic fissure, and when comparing cell counts there was not a 
significant difference to that in pax2a mutant. We also performed immunohistochemistry 
on these injected embryos and discovered that just as in pax2 mutants there is a failure to 
degrade the basement membrane as well as the failure to dramatically increase f-actin 
accumulation in the optic fissure. So now we felt we knew, at least in part, how the 
endothelial cells were being modulated during optic fissure fusion. At this point we also 
felt we had a firm grasp on the impact the endothelial cells have on the basement 
membrane of the optic fissure. One area that we felt we still lacked any concrete evidence 
for was the potential effects the migrating endothelial cells have on the actin 
cytoskeleton. After searching the RNA sequencing data again and separating out actin 
associated proteins, we became interested in two genes that were down-regulated in 
pax2a mutants, ROCK1 and ROCK2b. These two genes caught our attention for their 
involvement in many epithelial fusion events, when mutated across different species and 
under different circumstances it has resulted in open eyelids, open ventral body wall, and 
has a diverse range of functions from cell adhesion to extracellular matrix remodeling. 
Through qPCR and WISH staining of a clutch of pax2a mutant in-cross embryos I was 
able to validate our RNA sequencing data. This showed promising results leading toward 
a link between coloboma and the actin cytoskeleton, but further work needs to be done to 
further this work.  
 This dissertation made a novel discovery in the field of coloboma, one of the first 
direct links to the cellular mechanisms used during fusion (Figure 5.1). We found that 
slightly before 24 hpf in zebrafish embryos the endothelial cells begin migrating through 




precluded fusion fails to occur. In the pax2a coloboma model we also discovered a novel 
technique in which pax2a modulates the migration of these cells. These endothelial cells 
contribute both directly and indirectly to the fusion process by providing a source of the 
metalloprotease mmp2 which is one of the components required for basement membrane 
degradation in the optic fissure beginning at 32 hpf. These endothelial cells might also 
possibly contribute to the actin cytoskeletal dynamics in the epithelial cells via integrin 
signaling, activating Rho signaling to ROCK, though further work needs to be done. At 
48 hpf we see a complete lack of the basement membrane in the fissure region, a 
continuous sheet of epithelial cells, and a formed vasculature network at the back of the 
lens, and thus completing eye morphogenesis. This work begins to uncover the cellular 
machinery involved in fusion. This provides advantages in the fight against coloboma as 
it specifies cellular markers that could potentially contribute to genetic screening for this 
disease and others. In the past, we’ve relied on single gene studies which contribute only 
a single gene to screening efforts. By finding the cellular mechanisms used during this 
process a large scale screening can be done for genes associated with all the cellular 
machinery involved.  
 Future work in the field of optic fissure fusion should focus on endothelial cells 
and their mechanisms for regulating this process. It is my belief these cells are the crux of 
optic fissure fusion and more work needs to be done to investigate how they do what they 
do. Firstly, I believe it would be beneficial to perform single cell RNA sequencing on 
FACS sorted eye cells, separating endothelial cells (kdrl transgenic line) from epithelial 
cells (rx3 transgenic line). The biggest challenge here are the technical aspects, to once 




time to examine them would be at 32 hpf when fusion is just beginning, this puts timing 
to the early evening when accessing the required materials is difficult. This is also 
challenging at 32 hpf as pax2a mutants do not have a visible phenotype until 48 hpf so a 
wide scale genotyping on live embryos would have to be undertaken. Further work also 
needs to focus on differentiating hyaloid endothelial cells’ actin cytoskeleton from the 
fissure epithelial cells’ actin cytoskeleton. Talin1 is thought to be associated to the 
endothelial cells and is required for their migration, and I hypothesized that ROCK is 
associated to epithelial cells and is required for cytoskeletal dynamics involved in fusion 
of the tissue. However, these cannot be fully resolved without the ability to distinguish 
the actin cytoskeleton of endothelial cells from the actin cytoskeleton of epithelial cells. It 
is highly probable that integrin signaling is involved in fusion through angiocrine 
signaling from endothelial cells. By examining integrin mutants we could begin to 
uncover the potential mechanisms through which endothelial cells contribute to 
cytoskeletal dynamics in optic fissure fusion. Additional validation also needs to be 
performed on this dissertation’s findings by examining mmp2 and ADAMTS1 mutants. I 
have generated CRISPR mutants for both of these genes that are currently maturing. The 
mmp2 line needs to be examined to ensure that knock-out of mmp2 results in coloboma 
as was observed in the inhibitor study. It will be interesting to see if ADAMTS1 mutants 
also develop coloboma. It has been observed that pax2 levels need to be precisely 
controlled, we’ve shown that lack of pax2a function results in coloboma, however, 
overexpression of pax2 also results in coloboma [216]. It has also been reported that over 
production of vasculature in the retina also results in coloboma [210]. By observing 




vascularization of the retina resulting in coloboma, requiring a precise concentration of 
expression much like pax2. Along these same lines it would also be beneficial to 
investigate if overexpression of pax2a will result in a down-regulation of ADAMTS1.  
 Not only is this dissertation an advancement for our understanding of optic fissure 
fusion, but also could be the advancement for other epithelial fusion events as well. Our 
finding of endothelial cell requirement in optic fissure fusion is not unique to optic fissure 
epithelial fusion. In mouse neural tube closure endothelial cells were shown to be 
required, when endothelial cells were not properly modulated and directed this resulted in 
severe phenotypes one being neural tube defects [217]. Angiogenesis has also been 
shown to be required during wound healing, and is thought to be due to angiocrine 
signaling leading to proliferation and differentiation of progenitor cells [136]. This 
dissertation further confirms and expounds upon the idea of endothelial cell requirements 
during epithelial fusion. It would be very beneficial to our understanding of epithelial 











Figure 5-1Detailed Model of Optic Fissure Fusion. 














APPENDIX 1: DIFFERENTIAL TRANSCRIPT EXPRESSION PROFILE BETWEEN 
PAX2 MUTANTS AND WT. 
Table A1.1: Down-regulated genes in pax2 mutants. 
Gene ID PPDE PostFC 
aifm1 1 1223.99707 
si:ch211-57b15.1 1 175.669227 
si:rp71-36a1.5 1 140.545568 
krt96 1 159.577655 
si:dkey-9c18.3 1 135.672416 
arf5 1 116.803923 
dock1 1 111.340616 
sumo3a 1 699.778621 
lim2.1 1 694.142353 
zgc:152951 1 97.6461015 
pcbp3 1 93.498624 
ddx43 1 47.0232655 
abracl 1 78.7184492 
tfb2m 1 283.563781 
znf1034 1 38.8839082 
nsun5 1 17.3779661 
tln1 1 249.437187 
ptprna 1 173.271619 
crygs1 1 65.1862175 
mgst2 1 194.272308 
si:ch73-7i4.2 1 27.2410028 




Table A1.1: Continued 
Gene ID PPDE PostFC 
hn1l 1 12.4968928 
zdhhc16a 1 18.0239348 
sept9a 1 142.868951 
pyroxd2 1 76.7017298 
gpsm1b 1 81.5093272 
cryl1 1 73.8133177 
atp8b1 1 69.0944517 
slc16a8 1 11.9456451 
zgc:195170 1 8.53785003 
si:ch211-180n24.3 1 7.97368407 
emc4 1 4.84517879 
zgc:158803 1 5.1361905 
ccdc15 1 5.36868841 
cyp1b1 1 4.84809106 
ftr36 1 3.92235 
nedd1 1 3.71353033 
si:dkeyp-53d3.5 1 3.43253567 
gsta.1 1 3.42834504 
gsta.1 1 3.42834504 
crybb1l3 1 3.31490641 
nags 1 2.99342656 
trpm2 1 2.61882 
yif1b 1 2.56620613 
zgc:171242 1 2.50632681 





Table A1.1: Continued 
Gene ID PPDE PostFC 
wdr11 1 2.26390257 
capn3a 1 2.2636352 
nif3l1 1 2.26196314 
si:ch73-111m19.2 1 2.19476442 
cyp17a1 1 2.13605558 
si:ch73-111m19.2 1 2.14361341 
si:ch211-210c8.7 1 2.12701659 
gja8b 1 2.06529674 
crygmxl1 1 2.06431522 
lim2.5 1 1.90946226 
abhd17aa 1 1.88126807 
dnajb6b 1 1.85337252 
pabpc4 1 1.82916711 
pld3 1 1.82056501 
spg20a 1 1.79453331 
crygmx 1 1.77666289 
si:ch211-152c2.3 1 1.78464777 
usp45 1 1.77463243 
ccdc85cb 1 1.77711578 
cx23 1 1.74621358 
slc25a22 1 1.72877889 
cryba4 1 1.6950759 
tdh2 1 1.70536566 
arsj 1 1.65984403 





Table A1.1: Continued 
Gene ID PPDE PostFC 
lctlb 1 1.63883046 
otc 1 1.63219085 
gja8a 1 1.59332984 
mipa 1 1.59090101 
oxa1l 1 1.58340918 
sptbn5 1 1.58041002 
rps25 1 1.56500706 
exoc3 1 1.56852543 
scp2a 1 1.55977927 
dpp3 1 1.53549039 
lim2.1 1 1.52576615 
eif4ba 1 1.48108286 
daam1b 1 1.48283158 
ank3b 1 1.47309668 
mipb 1 1.47151262 
pitrm1 1 1.44887687 
wdr48b 1 1.44611811 
si:ch211-214j24.14 1 1.94211311 
CU570881.1 1 6.78543573 
zgc:92275 1 4.23766612 
crybb1 1 1.71609167 
slc25a15b 1 3.23368643 
rac1b 1 1.60544192 
cps1 1 1.60689024 





Table A1.1: Continued 
Gene ID PPDE PostFC 
si:dkey-221j11.3 1 2.11172447 
dennd2db 1 2.43279657 
zgc:153929 1 1.98064232 
rgs12b 1 62.8409305 
srsf2b 1 1.47707825 
si:dkey-183c16.7 1 13.0146393 
dusp22b 1 2.27505567 
asna1 1 56.2488278 
cap2 1 1.51908495 
fuca1.2 1 1.56651662 
map7d1b 1 2.50556695 
vamp8 1 1.4582063 
p3h3 1 1.71118286 
#N/A 1 2.08389311 
myo3b 1 2.14868484 
rabif 1 2.13834441 
si:dkey-105i14.1 1 3.62992484 
pebp1 1 1.73882751 
rock1 1 25.3621951 
agt 1 58.8429679 
alg12 1 1.80945907 
lman1 1 1.5279362 
si:dkey-147f3.4 1 2.09715543 
cryba1b 1 1.53629026 





Table A1.1: Continued 
Gene ID PPDE PostFC 
CR847505.1 1 2.00613265 
gpr22a 1 58.9490895 
si:ch211-161h7.8 1 1.83852528 
nom1 1 1.47612084 
ascc2 1 1.48866247 
aifm5 1 1.77670654 
tubb6 1 1.81145175 
lim2.3 1 1.58248375 
cast 1 1.52337612 
acad8 1 1.65017367 
atp5j 1 58.1667188 
si:ch211-271b14.1 1 4.61968968 
phkg2 1 1.75324828 
ascc1 1 1.79211659 
lctla 1 1.66701741 
mfsd2b 1 1.86878124 
rock2b 1 6.79767627 
crybb1l2 1 1.53754283 
si:rp71-36a1.5 1 16.6577328 
sncga 1 1.74153709 
tp53inp2 1 1.45399487 
hmbsb 1 55.9932726 
fbxl4 1 1.5696002 
zgc:193541 1 1.57657677 





Table A1.1: Continued 
Gene ID PPDE PostFC 
si:dkeyp-80d11.4 1 20.6510718 
dap3 1 1.45876876 
ncam3 1 2.69695494 
rnf146 1 5.81313939 
rmdn1 1 3.32221771 
cx23 1 1.76681385 
sub1a 1 1.85500891 
dmrt1 1 51.2481844 
itprip 1 2.10199487 
UBA6 1 1.62157642 
tpi1b 1 1.64792889 
cmtm7 1 1.66102804 
adgre9 1 18.9178814 
bmpr1ba 1 1.48208161 
itga2.3 1 9.48822663 
coq2 1 1.58976076 
snrnp35 1 5.78146624 
ppp1r7 1 53.7696831 
crygn2 1 1.58095118 
engase 0.99999999 1.61017979 
crybb1l1 0.99999999 1.48527984 
hsf4 0.99999999 1.56782213 
cryba2a 0.99999999 1.52431995 
ggctb 0.99999999 1.67449333 





Table A1.1: Continued 
Gene ID PPDE PostFC 
tbc1d7 0.99999999 2.80969394 
coro7 0.99999999 6.18818573 
cfl2 0.99999999 1.49370552 
CU570881.3 0.99999998 2.11755421 
lim2.5 0.99999998 1.91023961 
pax2a 0.99999998 6.78650436 
kpna4 0.99999998 15.6249193 
cbx2 0.99999997 3.99260728 
hbbe1.1 0.99999997 105.902985 
chfr 0.99999996 2.64468057 
srrm1 0.99999996 1.73461837 
map2k2a 0.99999996 1.54454791 
rab1ab 0.99999995 1.57140359 
dnajb11 0.99999994 160.269319 
cryba1l1 0.99999994 1.57377739 
cars2 0.99999994 2.1521133 
alpl 0.99999994 1.87004743 
oat 0.99999993 2.05824632 
si:dkeyp-73d8.9 0.99999993 15.0767668 
alkbh6 0.99999993 1.49683117 
gle1 0.99999992 3.14754418 
paqr3b 0.99999992 2.48499927 
dennd3b 0.99999992 26.293977 
npc2 0.99999991 9.37448709 





Table A1.1: Continued 
Gene ID PPDE PostFC 
grifin 0.99999988 2.02773908 
zgc:123295 0.99999987 4.1125871 
cyp2k8 0.99999986 1.8099226 
psmb7 0.99999986 1.75487666 
nrl 0.99999985 1.8069002 
TDRD7 (1 of many) 0.99999984 1.73659262 
zgc:198419 0.99999983 4.5448607 
alkbh1 0.99999983 1.6768179 
crybb2 0.99999983 5.18024141 
ddx43 0.99999983 17.1825958 
mustn1a 0.99999983 8.93863489 
polh 0.99999982 4.76200218 
krt222 0.99999981 2.05228912 
krt5 0.99999979 1.71033081 
DNAH10 0.99999978 3.73671831 
stk24b 0.99999975 50.6381636 
apaf1 0.99999972 45.7857349 
nadk2 0.99999969 1.94148452 
npm1a 0.99999964 1.8523304 
rnf44 0.9999996 2.10459288 
cox6b1 0.99999954 1.82301315 
ms4a17a.8 0.99999948 3.38703217 
plcxd1 0.99999941 1.83893967 
gsto2 0.99999939 1.45118731 





Table A1.1: Continued 
Gene ID PPDE PostFC 
si:ch211-198g14.4 0.99999929 4.64968836 
plcb3 0.99999922 1.89038588 
kpnb3 0.99999921 70.5079153 
ncs1a 0.99999913 4.77662414 
ppp1r13l 0.99999909 1.63056225 
gbgt1l3 0.99999895 5.16494507 
upb1 0.99999894 1.83222994 
fah 0.99999888 2.10977636 
crygm2d10 0.99999873 1.6257291 
aatf 0.99999871 1.81229155 
lim2.4 0.99999866 1.55456654 
b3gat3 0.99999856 1.56667896 
rnf213a 0.99999855 1.75125497 
CU929052.1 0.99999851 1.59986814 
krt222 0.99999806 2.08429438 
si:dkey-66a8.7 0.99999801 3.37314446 
cryba2b 0.9999977 1.62916318 
tssc4 0.99999762 2.28817405 
dhx40 0.99999758 2.69060175 
dnase1l4.2 0.99999747 1.65174174 
fli1b 0.99999746 2.13903918 
vetz 0.99999737 6.9774706 
slc25a15b 0.99999733 1.63327092 
gtf2f2a 0.99999733 1.48762735 





Table A1.1: Continued 
Gene ID PPDE PostFC 
yif1b 0.99999719 1.87811913 
elovl8b 0.9999971 3.08625651 
arl16 0.99999632 4.30365674 
rpl30 0.99999572 3.73752824 
si:ch211-110e21.4 0.99999494 1.9678438 
tsen54 0.99999443 1.56210688 
grtp1a 0.99999429 3.93572394 
fbxl3b 0.99999413 6.77888696 
CABZ01084225.1 0.99999385 47.2480885 
si:dkeyp-73d8.6 0.99999299 45.9496467 
si:dkey-13n23.3 0.99999296 2.5385895 
zgc:100832 0.99999245 1.47224445 
si:ch211-255g12.6 0.99999203 3.81044639 
ugt5b2 0.99999102 2.0851078 
nnt2 0.99998971 2.6948858 
ern1 0.99998941 2.64396353 
gmds 0.99998914 4.40703883 
mrc1a 0.99998882 1.52029426 
pdcd5 0.99998776 1.45326914 
si:ch73-204p21.2 0.99998744 2.09409472 
si:ch211-157b11.12 0.99998632 3.00711252 
tango6 0.99998497 73.7546973 
si:ch73-281f12.4 0.99998414 1.81719242 
tomm40 0.99998315 10.579481 





Table A1.1: Continued 
Gene ID PPDE PostFC 
cct8 0.9999793 2.31810813 
vdac1 0.99997762 9.86898347 
fam161b 0.99997658 4.0967888 
ablim3 0.99997505 1.47215069 
aifm4 0.99997496 2.66574247 
vps26b 0.99997492 2.26824301 
cryba2b 0.99997371 1.44821852 
vwa1 0.99997347 1.4909354 
si:dkey-262k9.4 0.9999716 2.53036937 
fam117aa 0.99996981 1.49639138 
psip1b 0.99996929 2.99620151 
pnp5a 0.99996577 1.67919183 
ndufa1 0.99996108 1.92982224 
ascc3 0.99996065 1.50769842 
foxi2 0.99995996 1.51486128 
NAPSA 0.99995937 1.55556349 
mylka 0.99995809 1.84965425 
chrne 0.99995726 2.12600375 
CABZ01094849.1 0.99995647 1.46047706 
tmem107 0.99995594 49.6969667 
rwdd 0.99995341 1.65893455 
plpp1a 0.9999515 1.72251411 
sprn2 0.99995112 1.77495768 
mettl26 0.99995054 1.69643824 





Table A1.1: Continued 
Gene ID PPDE PostFC 
ruvbl1 0.9999492 2.93279286 
sash1a 0.99994471 1.60057577 
cldn12 0.99994412 60.0968843 
zgc:101716 0.99994364 1.94767793 
CU459012.1 0.9999394 1.48985218 
pigr 0.99993628 2.26705729 
si:ch211-219a15.3 0.99993415 4.55017415 
rbm39a 0.99993037 1.66007852 
ints10 0.99992692 11.0237361 
pde4cb 0.99992688 5.12396905 
si:dkey-79f11.7 0.99992283 5.05453674 
si:ch73-111m19.2 0.99992196 1.45434574 
prpsap1 0.99991189 1.53003315 
mibp 0.99991124 1.69516215 
tma16 0.99990892 1.4521418 
wdr55 0.99990199 3.56272814 
si:ch211-66k16.27 0.99990112 2.84187921 
si:dkey-12j5.1 0.99989726 1.66907093 
tmem17 0.99988971 1.60818914 
ppa1b 0.99988901 4.81460436 
slc16a8 0.99988704 43.9083338 
pax2a 0.99988662 4.06164295 
casp7 0.99987887 1.81812348 
atp6v0a1a 0.99986267 1.50149016 





Table A1.1: Continued 
Gene ID PPDE PostFC 
si:dkeyp-2e4.3 0.9998582 2.44070041 
scaf4a 0.99985144 6.3933154 
si:dkey-26m3.3 0.99984702 1.74852389 
crygm2d8 0.99984678 1.53097877 
prpf8 0.99983712 4.9201693 
brf2 0.99983243 2.25170028 
cx23 0.99982901 1.60869914 
rbpms2b 0.99980491 1.73186733 
rab4a 0.99979591 1.6847137 
zgc:158846 0.99979367 31.5286328 
commd1 0.99979017 1.55930685 
itga2.3 0.99978443 4.2771078 
cica 0.99976018 41.1959819 
malt1 0.999759 3.34750251 
bod1l1 0.99975731 9.09496507 
si:dkey-261j11.3 0.9997531 1.77944191 
42993 0.99973487 1.51714524 
rbm39a 0.99973356 1.47439292 
rnf34a 0.99973336 1.75915986 
dtwd2 0.99972077 1.72006039 
mpped2a 0.99972016 32.5580078 
CR933791.2 0.99971927 3.27982281 
trpv4 0.99971765 2.17703217 
ggt1a 0.99970297 1.58616604 





Table A1.1: Continued 
Gene ID PPDE PostFC 
apooa 0.99965681 2.88784954 
si:ch211-264e16.1 0.99963493 2.39559255 
tubgcp5 0.99961663 5.32353255 
apaf1 0.99958797 2.86180472 
CABZ01085177.1 0.99958356 2.58997286 
gfap 0.9995812 1.50124367 
brf1a 0.99957332 3.57032962 
snu13a 0.99956005 1.70802978 
col28a1a 0.99952056 1.45732635 
ccdc127b 0.99949035 3.11935788 
sptlc3 0.99948548 1.73405455 
si:ch211-245n8.4 0.9994782 1.57060769 
ndufa4 0.99940293 1.83210307 
cep97 0.99939637 43.8091499 
thyn1 0.99934831 1.70517312 
zgc:194125 0.99931666 5.76729451 
wnt5b 0.99931648 1.68119178 
ehmt1a 0.9993046 1.87654878 
cars 0.99929838 1.84299387 
dnase1l4.2 0.99929022 5.90812952 
gss 0.99926297 1.68269843 
tagapb 0.99925649 4.19828835 
znf1156 0.99925388 2.7711738 
rad51b 0.99924574 1.91152316 





Table A1.1: Continued 
Gene ID PPDE PostFC 
zgc:171435 0.99923297 2.96143816 
borcs7 0.99920318 1.57831473 
APBA3 0.99919107 1.58086061 
trim2a 0.99913752 1.74917993 
gja8a 0.99910053 1.91053323 
ppm1bb 0.99909997 6.54259548 
mllt3 0.99909297 1.59082337 
gemin8 0.99908491 1.72856285 
si:dkeyp-41f9.3 0.99902658 2.27342844 
pttg1 0.99901023 1.4547877 
CABZ01017733.2 0.99898879 2.52185913 
si:dkey-250l23.4 0.99897471 1.49278173 
bag5 0.99889185 1.45172344 
tg 0.99888699 4.16034917 
adprh 0.9988756 2.6621234 
si:dkey-93n13.1 0.99878054 2.54997607 
zgc:101783 0.99873615 2.09015323 
crygm2d2 0.99872877 1.7872225 
crygm2d18 0.99872235 1.56372307 
necab1 0.99871626 6.89174956 
crygm2d13 0.9986437 32.172129 
flad1 0.9985978 2.81680295 
arglu1b 0.99856812 1.54702655 
nrp2b 0.99855951 9.23551662 





Table A1.1: Continued 
Gene ID PPDE PostFC 
CABZ01056516.1 0.99848177 1.88996358 
abcb6b 0.99847751 1.63195204 
ghrb 0.99841373 2.1246351 
gba 0.99840894 1.5459978 
CR388055.1 0.99835951 8.38118796 
CABZ01104045.1 0.99822521 3.09104858 
cyp1b1 0.99821377 4.23301803 
dgcr14 0.99819288 1.4540346 
naa15b 0.99816171 2.14548158 
zgc:153901 0.99813824 2.37028815 
stk25a 0.99811129 1.6808346 
hps1 0.99808501 5.20504829 
crygm2d10 0.99803451 1.54346497 
acox3 0.99798949 1.64901789 
sfxn1 0.9979626 3.67337931 
dph6 0.99794754 1.66754809 
orc3 0.99786918 4.11144521 
ftr34 0.99778972 7.12927033 
hspa5 0.99776347 1.45900932 
CR388166.2 0.99774393 4.80751572 
CR847505.1 0.99767147 1.56087377 
creb3l3l 0.99763926 28.9280217 
klhdc3 0.99754477 1.49959371 
plxnb2b 0.99739686 2.8708384 





Table A1.1: Continued 
Gene ID PPDE PostFC 
lace1a 0.99738843 2.55480026 
CABZ01076758.1 0.99738747 2.03221845 
b4galt4 0.99734815 1.61207282 
hmga1a 0.99733818 27.2336772 
GRB14 0.99722118 4.25034902 
opa1 0.99720239 7.04487531 
hsf1 0.99711966 2.4653613 
hagh 0.99711242 42.0700683 
aldh1a3 0.99697862 1.73063958 
havcr2 0.99691498 2.24716526 
adam8b 0.99683177 2.3934117 
hao2 0.99667813 1.45767521 
anxa11b 0.99665607 1.85238107 
pvrl1b 0.9966317 1.50586087 
si:ch211-105c13.3 0.99659112 1.58270309 
krt1-19d 0.99656907 1.49066487 
nudt22 0.99653157 1.54375413 
CAPN2 (1 of many) 0.9964168 3.76333227 
aifm5 0.99637373 1.5049305 
kera 0.99634127 1.46945741 
hao2 0.99620531 1.53216224 
grhl2a 0.99615744 1.47061948 
dctn4 0.99605291 1.93311304 
dusp8b 0.9959429 1.70674605 





Table A1.1: Continued 
Gene ID PPDE PostFC 
slc8a2b 0.99590537 3.00473688 
zgc:110249 0.99585384 1.56521469 
srsf1a 0.9957298 2.31580174 
zgc:162613 0.99568074 2.42296574 
plcd4a 0.99543533 1.88003062 
CR759830.1 0.99535448 1.72946897 
erbb2ip 0.99515345 7.54838897 
hmg20b 0.99512041 1.59115006 
gmnn 0.99500198 1.87787088 
znf1149 0.99485221 2.27037118 
glmp 0.99455088 1.45732006 
rhobtb2a 0.99451278 1.7608224 
trpc6b 0.99445783 4.48237794 
eno1a 0.99440949 46.4447679 
MFAP4 (1 of many) 0.99437498 5.34202918 
dhrs13a.1 0.99434608 1.52869638 
cryba1a 0.99426025 1.81056152 
CASKIN2 0.99414096 2.2137431 
irf6 0.99390149 1.44744897 
selm 0.99383238 1.70120157 
crybb1l3 0.99371216 2.97624852 
NPNT (1 of many) 0.99362616 1.95726061 
zer1 0.99360223 2.80517208 
si:dkey-31f5.11 0.99353156 11.1294797 





Table A1.1: Continued 
Gene ID PPDE PostFC 
ddx3b 0.99333702 1.75648871 
hnrpkl 0.99332646 2.45360045 
fam198a 0.99303582 2.13154654 
si:ch211-284e13.4 0.99283436 8.43875312 
crygm2d4 0.99275242 1.46073229 
uxt 0.99233654 1.60243282 
zgc:101858 0.99209436 1.45613599 
taf9 0.99204649 1.97353727 
si:ch211-173d10.1 0.99199547 1.68915066 
slc5a8 0.99166367 2.12299005 
ngfb 0.99166004 1.44577767 
arhgef37 0.99164547 1.562217 
rpl22 0.99163915 3.13135745 
ppp1r13bb 0.99156071 1.56393958 
ago4 0.99116545 2.19502113 
erf 0.99114441 1.65065804 
mecp2 0.99111311 38.6749009 
zdhhc15b 0.99090374 4.27276771 
map1sb 0.99082125 5.04991096 
abi2b 0.99072228 1.69961379 
xirp1 0.99059602 1.75159236 
akap1b 0.9900875 1.44567166 
cryba1a 0.98994725 1.54555777 
crygm2d20 0.98980548 1.50404838 





Table A1.1: Continued 
Gene ID PPDE PostFC 
BX548028.1 0.98945111 3.49002902 
kaznb 0.98896385 2.9465309 
rpp25l 0.98893984 1.48102682 
MFAP4 (1 of many) 0.99437498 5.34202918 
dhrs13a.1 0.99434608 1.52869638 
cryba1a 0.99426025 1.81056152 
CASKIN2 0.99414096 2.2137431 
irf6 0.99390149 1.44744897 
selm 0.99383238 1.70120157 
crybb1l3 0.99371216 2.97624852 
NPNT (1 of many) 0.99362616 1.95726061 
zer1 0.99360223 2.80517208 
si:dkey-31f5.11 0.99353156 11.1294797 
trap1 0.99346372 1.77854316 
ddx3b 0.99333702 1.75648871 
hnrpkl 0.99332646 2.45360045 
fam198a 0.99303582 2.13154654 
si:ch211-284e13.4 0.99283436 8.43875312 
crygm2d4 0.99275242 1.46073229 
uxt 0.99233654 1.60243282 
zgc:101858 0.99209436 1.45613599 
taf9 0.99204649 1.97353727 
si:ch211-173d10.1 0.99199547 1.68915066 
slc5a8 0.99166367 2.12299005 





Table A1.1: Continued 
Gene ID PPDE PostFC 
arhgef37 0.99164547 1.562217 
rpl22 0.99163915 3.13135745 
ppp1r13bb 0.99156071 1.56393958 
ago4 0.99116545 2.19502113 
erf 0.99114441 1.65065804 
mecp2 0.99111311 38.6749009 
zdhhc15b 0.99090374 4.27276771 
map1sb 0.99082125 5.04991096 
abi2b 0.99072228 1.69961379 
xirp1 0.99059602 1.75159236 
akap1b 0.9900875 1.44567166 
cryba1a 0.98994725 1.54555777 
crygm2d20 0.98980548 1.50404838 
si:ch73-134f24.1 0.98963798 3.79514899 
BX548028.1 0.98945111 3.49002902 
kaznb 0.98896385 2.9465309 
rpp25l 0.98893984 1.48102682 
grem2b 0.98840721 1.6401085 
stat5b 0.98818129 2.2384188 
trmt2b 0.98799964 1.62792379 
asb8 0.98763456 6.32303274 
hsc70 0.98739015 1.49960826 
cyp26a1 0.98733145 1.64335689 
rpl37 0.98725961 2.92008536 





Table A1.1: Continued 
Gene ID PPDE PostFC 
zgc:136439 0.98694594 9.58528702 
dnaaf2 0.98686954 4.10438419 
iqcb1 0.98647642 14.8057006 
crygm2d10 0.98626777 1.92092397 
btr22 0.98577043 8.44109199 
rcn3 0.98499508 1.56897787 
ca14 0.9848079 1.7047417 
si:ch73-281n10.2 0.98456979 2.76853798 
si:dkeyp-89c11.3 0.98431684 1.92360526 
agla 0.98413602 1.98005925 
zgc:153116 0.98400883 1.70434076 
ctbp2a 0.98383447 1.53984914 
micu2 0.98366744 1.7372849 
clec19a 0.98189703 1.45307978 
emc9 0.98158258 1.74015908 
nrp1b 0.98123275 1.55739945 
gulp1b 0.98112447 1.62498013 
ccni 0.98083135 1.5056777 
bmp7b 0.98074939 2.11860707 
cyb5a 0.98040352 13.7938711 
eef2a.1 0.98013775 1.4510759 
zgc:172121 0.98000405 1.82363909 
tfg 0.9798687 1.58011965 
fblim1 0.97979129 1.77328086 





Table A1.1: Continued 
Gene ID PPDE PostFC 
cep19 0.97874227 2.4618082 
doc2d 0.97848231 3.49920863 
znf1073 0.97838562 2.16310443 
CABZ01085201.1 0.97830492 2.96636405 
tfeb 0.97829145 1.46413418 
acp6 0.97792259 1.5256828 
znf1118 0.97774921 3.39687326 
ilf3a 0.97707425 1.84330217 
ptrh2 0.97704389 1.5029118 
tgm1 0.97657977 1.5338101 
pdlim2 0.9759612 1.59719201 
secisbp2 0.97592857 25.5378271 
RCCD1 (1 of many) 0.97539801 1.68445582 
vac14 0.97488809 5.93408401 
zgc:66474 0.97372109 3.39204342 
olfml2bb 0.97371175 2.82580675 
CABZ01075923.1 0.97274973 2.26923045 
tfdp1b 0.97245876 1.55551519 
abca4a 0.97225083 4.7715995 
CR589875.3 0.97170361 2.75512657 
atrn 0.97145862 4.66187743 
CABZ01055168.2 0.9714083 1.63583948 
cmc2 0.97050977 1.70432897 
arv1 0.96991978 1.48332418 





Table A1.1: Continued 
Gene ID PPDE PostFC 
hipk1a 0.96877742 1.8625903 
si:ch211-223a10.1 0.96857825 5.35573704 
znf1152 0.9676443 3.63460721 
ggps1 0.96751221 3.70570249 
fam173a 0.96744173 3.86747503 
crygm2d3 0.96695004 1.60396175 
dnmt3bb.3 0.96686231 2.6999396 
CU693379.1 0.96668328 1.52661285 
tagapb 0.9654193 1.83986801 
glb1l 0.96497259 1.85660888 
twistnb 0.96435182 1.77734076 
ndnl2 0.96381045 2.85173594 
si:dkey-82i20.1 0.96380499 2.62985496 
kaznb 0.96334556 2.02298041 
anapc4 0.9631407 1.56027347 
cln8 0.96289215 13.4774094 
zgc:112052 0.96139714 1.44930654 
zgc:171727 0.96086624 1.70111235 
fam49ba 0.95946633 1.855808 
tpcn1 0.95910115 1.48385356 
wdr48a 0.9589923 1.62285736 
cluap1 0.95827713 2.61477459 
zdhhc7 0.95786733 1.50000559 
flnca 0.95758306 3.23763588 





Table A1.1: Continued 
Gene ID PPDE PostFC 
slc2a3a 0.95601753 3.34083472 
znf1166 0.95598227 4.55499374 
frs2a 0.95597591 2.09852415 
derl3 0.95435887 1.62321733 
ctnna2 0.95395215 2.04026997 
csnk2b 0.95359456 2.18662568 
cdk4 0.95316458 2.45041839 
stat6 0.9526223 2.48125567 
map7d1a 0.95201836 2.85615694 
dclk2a 0.95168893 3.23282027 
txn2 0.95167271 1.95248048 
spag9a 0.95122725 1.46292078 
zgc:113314 0.95026817 4.54549698 
gcnt4a 0.94979986 1.48342598 
hccsa.1 0.9496067 1.4601552 
si:dkey-245p14.7 0.9489146 1.45676336 
sowahab 0.94813264 2.1742691 
tshr 0.94716513 2.05431466 
gpr31 0.94647795 13.2846251 





Table A1.2: Up-regulated genes in pax2 mutants 
Gene ID PPDE PostFC 
gsta.1 1 0.00605684 
gmnn 1 0.00236076 
col11a1a 1 0.00254868 
fubp3 1 0.0031324 
ublcp1 1 0.00443801 
smarcal1 1 0.00462374 
pde6g 1 0.02375396 
tbc1d7 1 0.0062857 
aldh2.2 1 0.03090445 
scg5 1 0.00674314 
ggact.3 1 0.00719755 
srek1 1 0.00643062 
nppa 1 0.01164394 
kat5b 1 0.04170289 
ahsa1a 1 0.00758063 
eed 1 0.0080722 
zer1 1 0.02303175 
dpf3 1 0.00797029 
tdrd3 1 0.00932432 
pcbp3 1 0.01034905 
mhc1ula 1 0.01467228 
nefmb 1 0.01010116 
si:ch211-24o10.6 1 0.01057941 
acox3 1 0.01163691 




Table A1.2: Continued 
Gene ID PPDE PostFC 
polh 1 0.03515468 
lin37 1 0.01228555 
si:dkey-71b5.3 1 0.01294887 
brf2 1 0.05558196 
dclk2a 1 0.01219264 
rnf17 1 0.01389209 
sema3gb 1 0.015136 
si:ch211-125e6.8 1 0.03272142 
zgc:172253 1 0.01342178 
rfx1a 1 0.01294848 
anxa11b 1 0.04866037 
si:dkey-147f3.4 1 0.02478841 
actr2b 1 0.03317023 
anxa3a 1 0.00550592 
si:dkey-271j15.3 1 0.04660447 
si:dkey-26g8.4 1 0.00829112 
slc16a3 1 0.00965152 
CR550302.3 1 0.01057006 
trrap 1 0.21584799 
irf6 1 0.01398657 
si:dkey-207l24.2 1 0.05698701 
nedd1 1 0.07552394 
si:dkey-121n8.8 1 0.10626453 
zfr 1 0.01319333 




Table A1.2: Continued 
Gene ID PPDE PostFC 
mhc1uma 1 0.06937348 
igfbp6b 1 0.07147004 
prkcq 1 0.07391903 
tnnt2a 1 0.08817417 
emc4 1 0.0895896 
adh8b 1 0.11792317 
si:ch211-181d7.3 1 0.12295161 
prl 1 0.12017863 
zgc:195023 1 0.12569586 
DNAH10 1 0.16942855 
znf1105 1 0.13822185 
aldh2.2 1 0.15241552 
fancl 1 0.1444089 
znf1048 1 0.16402274 
plin2 1 0.16403027 
znf1034 1 0.18687438 
gsta.2 1 0.18085137 
si:dkey-5i16.5 1 0.18748923 
zgc:173714 1 0.20999774 
si:ch211-160d14.15 1 0.22822963 
eef1db 1 0.22287253 
ntrk3a 1 0.27797563 
zgc:174703 1 0.29096933 
tert 1 0.28974784 




Table A1.2: Continued 
Gene ID PPDE PostFC 
si:ch1073-190k2.1 1 0.30376193 
il1rapl1a 1 0.3123487 
si:ch1073-340i21.3 1 0.31130225 
si:ch211-108d22.2 1 0.31005669 
CR792418.2 1 0.33536041 
srsf2b 1 0.32807851 
tbc1d7 1 0.32250552 
zgc:158803 1 0.33672707 
scg2a 1 0.35062128 
KRTCAP2 (1 of many) 1 0.35836328 
tenm1 1 0.37730235 
rcvrn2 1 0.39002411 
nucb1 1 0.39293702 
atp1b1b 1 0.43567966 
RNPS1 (1 of many) 1 0.44174727 
myl9b 1 0.45103869 
adamts1 1 0.44705479 
slc43a2a 1 0.46419371 
agtr2 1 0.46218335 
zgc:194627 1 0.48479429 
BX936382.1 1 0.48711738 
BX324003.1 1 0.4915192 
abat 1 0.49261779 
adh8b 1 0.50732741 




Table A1.2: Continued 
Gene ID PPDE PostFC 
znf979 1 0.18126761 
nkx2.4a 1 0.2021106 
GUCY2C (1 of many) 1 0.3443919 
nub1 1 0.14429663 
uts1 1 0.06183254 
nup43 1 0.11502627 
eno1b 1 0.07687637 
si:dkeyp-4c4.1 1 0.36378464 
phka2 1 0.50035147 
slc16a9b 1 0.17178494 
htr2aa 1 0.01643461 
si:dkey-45h7.1 1 0.47751149 
slc43a2a 1 0.30613397 
capn12 1 0.3479607 
hsbp1b 1 0.05548599 
mt2 1 0.26694464 
f8 1 0.16074891 
BX324179.3 1 0.33614006 
BX901907.6 1 0.26215142 
slc1a4 1 0.15797326 
znf995 1 0.32190552 
fgfr1bl 1 0.3510277 
ccdc177 1 0.44522542 
slc2a3a 1 0.4137739 




Table A1.2: Continued 
Gene ID PPDE PostFC 
lgals1l1 1 0.37934349 
znf1147 1 0.08193842 
si:dkey-242h9.3 1 0.2540002 
si:ch211-223a21.4 1 0.36493309 
CR749167.2 1 0.10761652 
disc1 1 0.01686798 
CABZ01074309.1 1 0.31134412 
CABZ01059415.2 1 0.09291659 
si:dkeyp-94g1.1 1 0.01445691 
grid2ipb 1 0.38371713 
add2 1 0.50906471 
rps25 1 0.17436522 
serpinb1l2 1 0.17340022 
CR792418.1 1 0.34514169 
flnca 1 0.01318045 
BX663613.2 1 0.31368995 
znf1121 1 0.10248789 
znf395b 1 0.51509725 
si:ch211-223a21.6 1 0.01746367 
CDHR1 (1 of many) 1 0.22887757 
theg 1 0.01879636 
zgc:174224 1 0.42871578 
srsf2a 1 0.06525884 
si:dkey-6f10.5 1 0.29589366 




Table A1.2: Continued 
Gene ID PPDE PostFC 
aptx 1 0.19691078 
ch25hl1.1 1 0.33840597 
clcn2c 1 0.26789997 
gcdhb 1 0.24512506 
znf1062 1 0.20305682 
si:ch1073-296i8.2 1 0.52581858 
tpi1b 1 0.01904369 
epb41l3a 1 0.46450579 
atp1a1a.2 1 0.36962255 
kctd7 1 0.40297206 
gpr19 1 0.26318709 
nrxn3a 1 0.13405496 
acot11b 1 0.18663379 
CABZ01088933.1 1 0.45514622 
cldn7b 1 0.16934132 
si:ch211-111e20.1 1 0.19462454 
nup205 1 0.39737498 
opn1lw2 1 0.23384836 
cgnb 1 0.21116152 
mybpc3 1 0.12868531 
CR792418.3 1 0.31223861 
si:ch211-198c19.3 1 0.22238102 
si:ch211-207i1.2 1 0.25235196 
BX000534.1 1 0.00372337 




Table A1.2: Continued 
Gene ID PPDE PostFC 
si:dkey-122c11.8 1 0.31334123 
BX649341.2 1 0.35945158 
nppb 0.99999999 0.01627465 
BX323994.1 0.99999999 0.1114317 
otpb 0.99999999 0.45651345 
si:ch211-256e16.11 0.99999999 0.1622364 
anxa1b 0.99999999 0.5166512 
tpm4a 0.99999999 0.1624046 
map1lc3b 0.99999999 0.53569482 
tnni1b 0.99999999 0.09825563 
si:dkey-112g5.13 0.99999999 0.18950452 
si:dkey-16p6.1 0.99999999 0.18928537 
lingo2a 0.99999998 0.36833509 
zgc:174855 0.99999998 0.00604256 
FKBP15 (1 of many) 0.99999998 0.12550064 
rock2b 0.99999998 0.13597191 
si:dkey-84j12.1 0.99999998 0.41554627 
hspb11 0.99999997 0.05682637 
hydin 0.99999997 0.01887102 
slc8a1a 0.99999997 0.29133813 
si:dkey-269i1.4 0.99999997 0.00595867 
gnb2l1 0.99999997 0.47063333 
aspg 0.99999997 0.44627924 
astn1 0.99999997 0.27853299 




Table A1.2: Continued 
Gene ID PPDE PostFC 
kiaa0907 0.99999996 0.07222343 
irbp 0.99999996 0.39165389 
znf1106 0.99999996 0.44388768 
BX957278.1 0.99999996 0.49481015 
impg2b 0.99999995 0.19513826 
npdc1a 0.99999995 0.49223924 
nsmfb 0.99999995 0.49570044 
cx43 0.99999995 0.02002255 
he1b 0.99999994 0.00536729 
si:dkey-26g8.4 0.99999993 0.00742039 
vmhcl 0.99999992 0.16366526 
si:ch211-197e7.3 0.99999991 0.52009958 
f2r 0.99999991 0.48535001 
rps6kl1 0.99999989 0.20512967 
nrxn2b 0.99999987 0.33225849 
si:dkeyp-82a1.1 0.99999987 0.01904509 
cmlc1 0.99999987 0.11093626 
si:dkey-92j16.2 0.99999987 0.27043652 
znf1157 0.99999986 0.24069362 
tor4aa 0.99999986 0.18322423 
CT027772.3 0.99999985 0.29867134 
pcloa 0.99999984 0.43372962 
fam184a 0.99999983 0.26126644 
42796 0.99999982 0.53660844 




Table A1.2: Continued 
Gene ID PPDE PostFC 
BX571711.1 0.99999976 0.32284419 
pcdh1g18 0.99999976 0.42250717 
zgc:174154 0.99999976 0.00804295 
thbs4b 0.99999975 0.23118379 
znf977 0.99999974 0.34438838 
fhl2a 0.99999973 0.45685578 
scn4ba 0.99999972 0.07022859 
he1a 0.99999969 0.00819939 
dnph1 0.99999968 0.35437231 
si:dkey-26g8.5 0.99999961 0.01032659 
si:dkey-7j14.5 0.99999954 0.18644607 
si:dkey-239j18.3 0.9999995 0.0075251 
junbb 0.99999943 0.43790282 
ctslb 0.99999942 0.00889435 
znfl1 0.99999941 0.20701605 
cfap36 0.99999935 0.01958596 
gngt2a 0.9999993 0.4050215 
znf1119 0.99999925 0.46128681 
prpf3 0.99999923 0.50640869 
micu3b 0.99999908 0.46813479 
syt1a 0.99999904 0.52186761 
si:dkey-26g8.4 0.99999904 0.00925787 
gpr22a 0.99999888 0.24416183 
si:dkey-81e3.2 0.99999882 0.52677003 




Table A1.2: Continued 
Gene ID PPDE PostFC 
cstf2 0.99999877 0.45558629 
pdcb 0.9999986 0.26736076 
tspan2b 0.99999858 0.51315374 
nek7 0.99999857 0.32629349 
he1a 0.9999983 0.00762769 
npc1 0.99999825 0.01955754 
ahdc1 0.99999821 0.5379481 
si:ch211-214b16.3 0.99999815 0.29170238 
si:ch73-14h1.2 0.99999801 0.18166907 
cnksr2b 0.99999781 0.46450493 
acin1a 0.99999777 0.02079049 
zgc:174855 0.9999976 0.01367869 
CR388363.1 0.99999758 0.51692887 
c1qtnf4 0.99999741 0.38287378 
syngr3a 0.99999728 0.45035044 
eif3c 0.99999686 0.48468976 
lrfn2b 0.99999684 0.44072086 
gsta.1 0.99999647 0.16304539 
zgc:172075 0.99999637 0.24973437 
CT956057.1 0.99999628 0.17513741 
fxyd6l 0.99999607 0.14701245 
ndfip1l 0.99999595 0.36873527 
si:ch211-223a21.6 0.99999568 0.37847979 
CABZ01032454.1 0.99999513 0.21525651 




Table A1.2: Continued 
Gene ID PPDE PostFC 
ptprna 0.99999404 0.23099451 
sez6l 0.99999386 0.14239586 
CR847893.3 0.99999384 0.1665221 
fam20a 0.99999377 0.12860207 
adar 0.99999348 0.44769287 
gle1 0.99999335 0.00801162 
sall1a 0.99999331 0.51108119 
nadl1.2 0.99999309 0.41834251 
rfng 0.99999263 0.14409881 
slco5a2 0.99999146 0.53376039 
ggact.2 0.99999062 0.19809603 
opn1sw1 0.99999056 0.13566756 
myl7 0.99999004 0.09274435 
bmp7b 0.9999898 0.30189624 
nr4a2a 0.99998928 0.17682409 
c1galt1a 0.99998925 0.33147259 
si:ch211-194h1.2 0.99998909 0.29492706 
zgc:174153 0.99998908 0.01571141 
mybpc3 0.99998905 0.11037837 
BX548044.7 0.99998835 0.05211966 
p2ry11 0.99998699 0.15300167 
BX511155.1 0.99998606 0.53358307 
si:ch211-113d22.2 0.999986 0.37050545 
gnb3b 0.99998556 0.02068565 




Table A1.2: Continued 
Gene ID PPDE PostFC 
si:ch1073-155h21.2 0.99998443 0.3588151 
sh2b1 0.99998437 0.3860128 
fn1b 0.99998428 0.14378086 
apobb.1 0.99998229 0.09242128 
si:dkey-16b10.2 0.99998093 0.25532652 
TTC9 0.9999809 0.52745814 
slc43a3a 0.99998036 0.4935222 
setd8b 0.99997993 0.28637834 
abcb4 0.99997919 0.47901977 
lca5 0.99997904 0.02063078 
si:dkey-269i1.4 0.99997904 0.01903747 
RAC1 (1 of many) 0.99997904 0.32246713 
BX324179.1 0.99997888 0.40549971 
gria3a 0.99997813 0.34424777 
cdkl5 0.99997803 0.420323 
plgrkt 0.9999778 0.38095655 
col17a1b 0.99997729 0.01314006 
si:dkey-286j17.4 0.9999772 0.32145018 
atp6v0a1b 0.99997637 0.44181414 
oxr1b 0.99997633 0.19362888 
zp2l2 0.9999743 0.02199306 
si:ch211-256e16.11 0.99997352 0.13986696 
he1b 0.99997258 0.02282588 
luzp2 0.99997139 0.35329778 




Table A1.2: Continued 
Gene ID PPDE PostFC 
si:ch1073-127d16.1 0.99997043 0.32632915 
pnp5b 0.99997025 0.29533656 
nrxn2a 0.99996873 0.4250459 
si:ch1073-366l7.1 0.99996727 0.37106907 
prickle2b 0.99996598 0.21852975 
aatkb 0.99996537 0.23448957 
CR847850.1 0.99996514 0.17674901 
bc2 0.99996495 0.05986953 
si:ch211-93f2.1 0.99996077 0.50500491 
myom1b 0.99995932 0.39651079 
fn1b 0.99995762 0.11232947 
u2af2b 0.99995593 0.31532612 
BX914205.3 0.99995509 0.10837343 
adgrb3 0.99995467 0.18501697 
BX640584.2 0.99995417 0.53284409 
BX322541.1 0.99995356 0.31353973 
si:ch211-165i18.2 0.99995176 0.18903043 
CR931788.1 0.99995172 0.24675288 
atp5o 0.99995136 0.20038995 
mpp3a 0.99995021 0.52516293 
CABZ01002768.1 0.99994937 0.22169614 
arrdc3a 0.99994648 0.51975915 
mtmr1a 0.99994502 0.28070692 
pou3f3a 0.99994433 0.44230918 




Table A1.2: Continued 
Gene ID PPDE PostFC 
BX000703.1 0.99993805 0.34392657 
srsf7a 0.99993709 0.01527172 
vipas39 0.99993582 0.36641068 
gsta.2 0.99993502 0.23226863 
atp1a1a.3 0.99993282 0.40810091 
git2b 0.99993176 0.16288131 
mapta 0.99992941 0.51561394 
si:dkeyp-9d4.3 0.99992788 0.41909251 
AL928808.1 0.99992644 0.14391856 
arr3b 0.99992288 0.25712168 
si:ch211-282j17.13 0.99991595 0.04561393 
si:ch211-235m3.10 0.9999129 0.51852354 
dnase1l4.2 0.99991105 0.05647451 
mfap4 0.99991046 0.35300431 
eef1db 0.99991019 0.46422003 
fli1b 0.99990926 0.01652762 
trpm1a 0.99990064 0.4800735 
CR388165.2 0.99990014 0.24042398 
gnaq 0.99989913 0.33903861 
si:dkey-14k9.2 0.99989605 0.42620912 
RASSF5 0.9998929 0.02427608 
commd1 0.99988542 0.1763567 
LHX3 0.99988166 0.51142684 
snrnp35 0.99987969 0.43557735 




Table A1.2: Continued 
Gene ID PPDE PostFC 
nrgna 0.99986854 0.36166558 
CR361561.1 0.99986302 0.53207609 
apof 0.99986096 0.14434438 
#N/A 0.99985941 0.32650324 
ppp3r1a 0.99985049 0.07054015 
si:dkey-103d23.5 0.99984223 0.06579386 
cbx5 0.99983682 0.23748332 
ppfia3 0.99982417 0.48046714 
chd 0.9998145 0.50444185 
ilf3a 0.99979959 0.35162936 
camta1b 0.9997943 0.50547858 
trip10a 0.99979284 0.08712916 
fgfr1bl 0.999784 0.07293974 
MREG 0.99978366 0.32333976 
tmem151a 0.99978327 0.45913585 
ctslb 0.9997776 0.01053025 
si:dkey-16p19.1 0.9997757 0.11990754 
galnt13 0.99977564 0.49255122 
gnb5b 0.99976854 0.40939435 
ogfrl2 0.99976392 0.30383139 
BX005448.1 0.99976207 0.51731988 
kcnn3 0.99975601 0.43523744 
pde9a 0.99975099 0.40524452 
slc16a9a 0.99975002 0.45470445 




Table A1.2: Continued 
Gene ID PPDE PostFC 
si:dkey-63j12.4 0.99974299 0.27294906 
BX548067.2 0.99972938 0.41980011 
BX571760.1 0.99972549 0.35638927 
si:dkey-265c15.6 0.99972421 0.2317945 
kbtbd7 0.99972157 0.02098151 
zfpm2a 0.99971423 0.12914748 
adcy8 0.99971032 0.44743017 
cyp2p7 0.9996982 0.14511267 
tbkbp1 0.9996973 0.32085361 
znf995 0.99969253 0.33400782 
si:dkey-207m2.4 0.99969194 0.10649332 
pde6c 0.99967916 0.43102165 
pik3ip1 0.99965659 0.40449202 
CABZ01055017.1 0.99965531 0.16724577 
CR450780.5 0.99964515 0.15697399 
STX3 (1 of many) 0.99964283 0.54176976 
CABZ01076666.1 0.99962856 0.03607037 
zgc:56585 0.99962397 0.42477835 
capgb 0.99962323 0.17859531 
pik3ap1 0.99962049 0.2788905 
pcnxl2 0.99961905 0.40958864 
si:ch211-111e20.1 0.99960794 0.21902183 
smtla 0.99959106 0.13179384 
meis3 0.99958584 0.40726959 




Table A1.2: Continued 
Gene ID PPDE PostFC 
si:rp71-36a1.3 0.99957462 0.12413078 
foxp2 0.99957183 0.17788992 
si:ch211-233h19.2 0.9995265 0.29795032 
gata5 0.9995221 0.22390887 
nrg2b 0.99952022 0.49071232 
mamdc2b 0.99951438 0.20066243 
palmda 0.99949614 0.53539551 
zgc:174650 0.99949605 0.46882009 
aatka 0.99948406 0.33106956 
robo3 0.99947399 0.52580485 
arpp21 0.99946131 0.17905093 
ubald1a 0.99943311 0.14558743 
plch2b 0.99941744 0.29725076 
zgc:174862 0.99941116 0.03098591 
ska3 0.99940779 0.33853889 
TULP2 0.99940681 0.46356169 
sypb 0.99940662 0.45209877 
si:ch211-160f23.7 0.99940474 0.32220536 
BX569782.1 0.99938975 0.11218363 
si:dkey-242h9.3 0.9993791 0.24226441 
pimr140 0.99937648 0.34795996 
actn2b 0.99936892 0.52684436 
si:dkey-17o15.2 0.99935655 0.34166514 
tlx1 0.99935163 0.32815912 




Table A1.2: Continued 
Gene ID PPDE PostFC 
glrbb 0.99933051 0.39962525 
snap25b 0.99932995 0.52458432 
si:dkey-17m8.2 0.99931364 0.16763477 
and1 0.99929729 0.44088156 
si:ch211-137i24.12 0.99922915 0.30406675 
CR361561.2 0.99916814 0.51668512 
si:ch211-237i5.4 0.99916601 0.46815971 
si:dkey-15j16.6 0.99913094 0.05887786 
clstn2 0.99910238 0.40919186 
fmr1 0.99908162 0.05598639 
rock2b 0.99906025 0.25128439 
lcat 0.99905384 0.41946461 
pgap2 0.99902124 0.18219928 
rtn1b 0.99901482 0.14984629 
BX548067.4 0.99900623 0.37333621 
zgc:172051 0.99896586 0.29981927 
upf3a 0.99891803 0.27721657 
cyp3c4 0.99891437 0.28911372 
gngt1 0.99886624 0.39153483 
slc25a23a 0.99885307 0.19903103 
zbtb12.1 0.99880117 0.05108555 
#N/A 0.99879076 0.29417649 
tph1a 0.99876626 0.28592932 
gria2a 0.99875441 0.36911053 




Table A1.2: Continued 
Gene ID PPDE PostFC 
STK19 (1 of many) 0.99874336 0.42211276 
gria2a 0.99868907 0.41654551 
lin7b 0.99868348 0.42339228 
smc1a 0.99865029 0.21612456 
si:dkey-33c12.11 0.99860824 0.24289676 
CR361547.1 0.99858121 0.54184368 
cpeb1b 0.99856564 0.35662865 
vmhc 0.99854042 0.3707909 
hadhaa 0.99853789 0.02408856 
fam118b 0.99849721 0.2936514 
si:ch211-198c19.3 0.9984391 0.17071168 
sorbs2a 0.99839987 0.07941511 
unc5da 0.99834257 0.46699416 
nrsn1 0.99833169 0.4815366 
tssc4 0.99829327 0.32854313 
cep170ab 0.99824139 0.20235369 
BX548173.2 0.99822428 0.48671549 
BX088603.1 0.99822417 0.37982781 
atp2a2a 0.99821767 0.19310722 
pofut1 0.99821104 0.39122323 
tmem30c 0.99821082 0.49440203 
svopl 0.99803434 0.14001985 
si:dkey-199m13.5 0.99796626 0.5338679 
usp28 0.99796 0.39340668 




Table A1.2: Continued 
Gene ID PPDE PostFC 
prss59.1 0.99789646 0.06478723 
cnp 0.99788786 0.29033878 
clstn1 0.9977331 0.45891161 
olfm1b 0.99770209 0.26797938 
si:dkey-16p19.1 0.99769172 0.44490378 
grtp1a 0.99765923 0.28861649 
anos1a 0.9975957 0.48956643 
ankrd6b 0.99757064 0.47614088 
necab1 0.99756925 0.1677846 
fam210aa 0.99756863 0.33668483 
EML5 0.9975263 0.28571868 
h6pd 0.99747697 0.08355315 
si:dkey-72l14.3 0.9974624 0.32762292 
si:dkey-247i3.5 0.99745893 0.23279795 
si:dkey-106c17.2 0.9973468 0.06308066 
tnni1b 0.99722671 0.14537484 
foxi1 0.99721862 0.46869515 
smc1a 0.99865029 0.21612456 
si:dkey-33c12.11 0.99860824 0.24289676 
CR361547.1 0.99858121 0.54184368 
cpeb1b 0.99856564 0.35662865 
vmhc 0.99854042 0.3707909 
hadhaa 0.99853789 0.02408856 
fam118b 0.99849721 0.2936514 




Table A1.2: Continued 
Gene ID PPDE PostFC 
sorbs2a 0.99839987 0.07941511 
unc5da 0.99834257 0.46699416 
nrsn1 0.99833169 0.4815366 
tssc4 0.99829327 0.32854313 
cep170ab 0.99824139 0.20235369 
BX548173.2 0.99822428 0.48671549 
BX088603.1 0.99822417 0.37982781 
atp2a2a 0.99821767 0.19310722 
pofut1 0.99821104 0.39122323 
tmem30c 0.99821082 0.49440203 
svopl 0.99803434 0.14001985 
si:dkey-199m13.5 0.99796626 0.5338679 
usp28 0.99796 0.39340668 
sorbs2b 0.99792967 0.49360822 
prss59.1 0.99789646 0.06478723 
cnp 0.99788786 0.29033878 
clstn1 0.9977331 0.45891161 
olfm1b 0.99770209 0.26797938 
si:dkey-16p19.1 0.99769172 0.44490378 
grtp1a 0.99765923 0.28861649 
anos1a 0.9975957 0.48956643 
ankrd6b 0.99757064 0.47614088 
necab1 0.99756925 0.1677846 
fam210aa 0.99756863 0.33668483 




Table A1.2: Continued 
Gene ID PPDE PostFC 
h6pd 0.99747697 0.08355315 
si:dkey-72l14.3 0.9974624 0.32762292 
si:dkey-247i3.5 0.99745893 0.23279795 
si:dkey-106c17.2 0.9973468 0.06308066 
tnni1b 0.99722671 0.14537484 
foxi1 0.99721862 0.46869515 
ppp1r10 0.9971817 0.31566413 
eif3ja 0.99716268 0.10759212 
arsh 0.99714327 0.51084012 
socs2 0.99707086 0.33862715 
zgc:113333 0.99701473 0.48806542 
syn2b 0.99697139 0.16181821 
CR788231.1 0.99694096 0.46205745 
penka 0.99686597 0.24151652 
arr3a 0.99674751 0.33671613 
rcan3 0.99653441 0.42763208 
mdkb 0.99652328 0.4792949 
tulp4b 0.99640019 0.3400266 
plch2a 0.9963892 0.43414676 
si:ch73-366i20.1 0.99626497 0.18688615 
pou2f1b 0.9962637 0.02252641 
CU570691.1 0.99623741 0.31135079 
dnajb4 0.99620725 0.50764527 
ildr2 0.99618784 0.429353 




Table A1.2: Continued 
Gene ID PPDE PostFC 
sept9a 0.9961613 0.27769595 
hspb7 0.99615524 0.41688574 
cdh18a 0.99609341 0.43477686 
BX663505.2 0.99605135 0.29371093 
rdh5 0.99604646 0.43069853 
CR392001.1 0.99598014 0.45047628 
nlgn3a 0.99596324 0.50170763 
ckba 0.99595455 0.29232671 
celsr3 0.99584857 0.53324135 
rcvrn3 0.99578257 0.4186381 
slc30a8 0.9957401 0.50888327 
si:dkey-238i5.3 0.99562058 0.45159519 
eef1da 0.99548107 0.42087634 
pkd1b 0.99547678 0.17922092 
si:ch73-233f7.1 0.99541097 0.27060703 
arpc4l 0.99540159 0.33397983 
si:ch211-219a15.3 0.99538616 0.02617741 
ypel2a 0.99536953 0.47145165 
rtkn2a 0.99533576 0.36806433 
akap6 0.99516938 0.47976634 
cd3eap 0.99499816 0.1297364 
ACTC1 (1 of many) 0.99497978 0.12838549 
irs2a 0.99496498 0.32848364 
snx19a 0.99494703 0.22426436 




Table A1.2: Continued 
Gene ID PPDE PostFC 
si:ch211-117l17.4 0.99485799 0.53449259 
si:ch1073-416d2.4 0.99481988 0.27280906 
CABZ01054391.1 0.99476265 0.54061221 
CR450780.3 0.99471676 0.45661858 
si:dkey-61n16.5 0.99470348 0.4480572 
tanc1a 0.99467751 0.22942662 
polh 0.99456912 0.32963852 
atp2b3b 0.99453908 0.39885767 
si:dkey-15j16.3 0.99451645 0.12377964 
mcf2la 0.99446661 0.35998886 
impg1b 0.99408334 0.5276069 
guk1b 0.99399637 0.3992008 
casq2 0.99391508 0.25234985 
CR293532.2 0.99382183 0.30193611 
MPP4 (1 of many) 0.99368021 0.17820716 
zgc:113162 0.99365896 0.54493411 
si:ch211-260e23.9 0.99363777 0.38735105 
spegb 0.99363588 0.49379843 
si:ch211-93f2.1 0.99359625 0.540328 
gna15.1 0.99356414 0.41281225 
ftr19 0.9934938 0.39801259 
dpp6b 0.99332427 0.33522735 
znf1051 0.99325023 0.3657999 
st8sia5 0.99317221 0.11021142 




Table A1.2: Continued 
Gene ID PPDE PostFC 
serp2 0.99303 0.34916793 
fli1b 0.99301507 0.07298589 
cep55l 0.99292065 0.25585232 
acta1b 0.99281556 0.20926185 
rgs8 0.99274697 0.4378912 
si:dkey-253d23.3 0.99267489 0.42125889 
opn1lw2 0.99261065 0.15683271 
fam161b 0.99257004 0.42795112 
grm8a 0.99253304 0.44719067 
fgfbp2b 0.99242545 0.2897598 
rab11bb 0.99220361 0.53381992 
twf2b 0.99201412 0.23613863 
si:dkey-21e13.3 0.99184247 0.53498727 
pou4f3 0.99182861 0.49661927 
ccdc25 0.99163652 0.29962577 
zgc:162509 0.99146588 0.3126065 
tpm4a 0.99145388 0.09958568 
42796 0.9912496 0.04546687 
si:dkey-222b8.4 0.99113274 0.39885113 
hand2 0.9910868 0.47909457 
rs1a 0.99088979 0.13095277 
chchd6a 0.99060067 0.36740341 
tfg 0.9905928 0.26433446 
slc38a5a 0.99055222 0.36036061 




Table A1.2: Continued 
Gene ID PPDE PostFC 
zgc:123105 0.98986653 0.24153466 
znrf3 0.98983536 0.04391429 
zgc:113531 0.98979116 0.51391876 
calb1 0.98975339 0.16767843 
c3b.2 0.98957542 0.17765725 
si:dkey-66l17.4 0.9893992 0.51583976 
sult4a1 0.98928161 0.43535851 
hdc 0.98896129 0.06750581 
si:ch211-79g12.2 0.98892337 0.26166782 
cnih3 0.98881535 0.3110016 
noto 0.98863457 0.2052465 
drgx 0.98843264 0.30796203 
alg12 0.98820982 0.29418768 
ppp2r2cb 0.98819323 0.51668074 
impg2b 0.98818767 0.34561901 
oxct1a 0.98811745 0.54101178 
vmhcl 0.98809193 0.20945583 
si:dkey-33i11.4 0.98763609 0.35345677 
s100u 0.98761248 0.37089481 
slc25a15a 0.98755591 0.1897895 
fn1b 0.98697321 0.1878315 
si:dkeyp-72g9.4 0.98672307 0.21862989 
nupr1 0.98652818 0.51315228 
si:dkey-147f3.8 0.9864812 0.25121241 




Table A1.2: Continued 
Gene ID PPDE PostFC 
nlgn2b 0.98631225 0.49507378 
hn1a 0.98610062 0.44222616 
ndufb2 0.98587561 0.49353525 
trim46a 0.98561541 0.44012316 
lztfl1 0.98558362 0.31935219 
znf1031 0.98552297 0.27992984 
kcnj13 0.98523455 0.54101153 
znf1057 0.98521796 0.25606035 
fads2 0.98498678 0.49090429 
zgc:113142 0.98476021 0.40221139 
wdr48a 0.98473442 0.1353603 
nlgn3b 0.98464672 0.28900974 
plxna4 0.98455123 0.47478424 
arl16 0.98427536 0.54250124 
ncapg2 0.9842736 0.38835764 
FAM184A (1 of many) 0.98426004 0.53075272 
abcg2a 0.9837326 0.02346977 
ppifb 0.98334978 0.13571935 
si:ch211-157b11.12 0.98296842 0.42474795 
pde6h 0.98256823 0.16049071 
si:dkey-105e17.1 0.98225519 0.24679011 
taf8 0.98192987 0.19510277 
CABZ01064771.1 0.98176596 0.37632913 
c6 0.98164716 0.42118817 




Table A1.2: Continued 
Gene ID PPDE PostFC 
CR936465.1 0.98135577 0.08774286 
zgc:153395 0.98086674 0.23058634 
cadm4 0.98058407 0.06138467 
camk2n1a 0.98034432 0.41572865 
cyp2x7 0.97998169 0.51793515 
znf1131 0.97979638 0.4735899 
myh7ba 0.97969455 0.22438734 
si:dkey-16b10.1 0.97929879 0.44544289 
si:ch73-389b16.1 0.97875434 0.23958235 
gria4a 0.97861614 0.26259505 
itm2ca 0.97753555 0.43704432 
cry1ba 0.97666774 0.33856193 
znf994 0.97663852 0.46073918 
BEGAIN 0.97592993 0.10225209 
timp2b 0.97590496 0.52736743 
tnk1 0.97588672 0.05899409 
si:ch211-129p6.2 0.97586531 0.31341198 
ptprea 0.97559587 0.42453101 
si:ch211-214b16.4 0.97484417 0.29770599 
bub1ba 0.97484319 0.39636886 
dhx40 0.97294287 0.30948921 
cntn5 0.97287777 0.38254809 
iqgap2 0.97247808 0.1843422 
rp1l1a 0.97100286 0.40675409 




Table A1.2: Continued 
Gene ID PPDE PostFC 
KDELR3 (1 of many) 0.97085599 0.49625291 
terf1 0.97057376 0.37724518 
zgc:73340 0.96932261 0.31925491 
si:dkey-263j23.1 0.96878114 0.32598928 
CABZ01075274.1 0.9685992 0.37816227 
si:dkey-7i4.1 0.96805313 0.43934928 
scg2b 0.96610063 0.41028188 
neflb 0.96601728 0.3631633 
arrdc3b 0.96542687 0.41347113 
gnat2 0.96537125 0.41841261 
si:ch73-190f9.4 0.96520906 0.48903437 
dusp3a 0.96520644 0.50400501 
si:dkey-121n8.7 0.9649275 0.26397169 
znf1037 0.9644884 0.49286282 
wu:fb15h11 0.96443468 0.51443917 
dcxr 0.96400181 0.23025058 
best2 0.96360649 0.17632091 
HAPLN1 (1 of many) 0.96300039 0.53719484 
dpf1 0.96269164 0.48531478 
txnipb 0.96253993 0.40760013 
si:dkey-71l4.4 0.96251744 0.16573605 
si:dkey-19b23.7 0.96242286 0.08607903 
CU019657.1 0.96148095 0.0815658 
tfa 0.96097901 0.05897177 




Table A1.2: Continued 
Gene ID PPDE PostFC 
s100s 0.96023075 0.52694675 
stat5b 0.9598209 0.23982466 
marveld2a 0.95959336 0.34466221 
lactbl1a 0.95938868 0.34126686 
zgc:112285 0.95909538 0.48311105 
gria3a 0.95878225 0.48271079 
znf1045 0.9587422 0.28303742 
CABZ01007222.1 0.95873271 0.37222436 
wdcp 0.95868921 0.30433753 
aldoaa 0.95812396 0.13957413 
fam19a5a 0.95732088 0.23665981 
flnb 0.95683468 0.48648732 
atoh1a 0.95633242 0.46995944 
nudt4a 0.95556182 0.05090048 
slc25a36a 0.95552038 0.31423411 
si:dkey-84j12.1 0.95546887 0.3112841 
syncripl 0.95540168 0.53187346 
ext1c 0.95491243 0.32431173 
stmn4l 0.95463368 0.43816975 
si:dkey-92i17.2 0.95445004 0.4047597 
slc4a4a 0.9540154 0.49042554 
rwdd 0.9535332 0.45741438 
lbr 0.95348921 0.07580637 
nsfa 0.95291503 0.31128612 




Table A1.2: Continued 
Gene ID PPDE PostFC 
bmf2 0.95256271 0.34001067 
tbk1 0.95190409 0.45565895 
si:dkey-179k24.5 0.95178885 0.25049258 
sfxn2 0.95168976 0.20745988 
tlx2 0.95150031 0.46849491 
rptor 0.95087934 0.52624772 
spire1a 0.95035563 0.47267528 
si:dkey-14o6.8 0.94906939 0.36394209 
acp5a 0.94900787 0.398649 
ezra 0.94876884 0.29818762 
NR4A2 (1 of many) 0.94826882 0.44024088 
nlgn4a 0.94822785 0.14391656 
nub1 0.94786208 0.53860431 
si:ch73-359m17.2 0.94777675 0.20374278 
prdm2a 0.94759204 0.41787615 
si:dkeyp-35e5.9 0.94744637 0.53169761 
serpini1 0.94722541 0.38752968 
rac3b 0.94641459 0.10355966 
CR450842.5 0.94549936 0.41332942 
si:dkey-20i20.10 0.94533106 0.51265615 
bves 0.94513289 0.1359183 
camkk1b 0.94483436 0.35851054 






APPENDIX 2: SUPPLEMENTARY FIGURES 
 
 
Appendix 2.1: Optic Fissure quantification 
A) Graphical representation of the region of OF analyzed using confocal microscopy. B) 
Sample image depicting regions of the OF (1), laminin normalization (2) and F-actin 
normalization (3) used for signal intensity quantification. C) Quantification of laminin 
and F-actin signal intensity in wild type embryos within the distal, medial and proximal 
regions of the OF, normalized to regions of laminin staining juxtaposed to the lens and F-
actin signal within the lobe of the retina. Relative pixel intensities are displayed. ANOVA 
p<0.0001. D) Quantification of laminin and F- actin signal intensity in pax2a-/- embryos 
within the distal, medial and proximal regions of the OF, normalized to regions of 
laminin staining juxtaposed to the lens and F-actin signal within the lobe of the retina. 





Appendix 2.2: Optic Fissure apposition measurements. 
Measurements of the distance between retinal lobes (apposition) in WT, pax2a-/- or 
DMH4 treated or embryos at 48hpf. Measurements were made using laminin staining as 







Appendix 2.3: pax2a and tln1 expression during development 
A) Whole mount in situ hybridization of pax2a probe at 24, 48, 54 and 72hpf. Lateral 
(top) and ventral (bottom) images depicting OF expression are shown. Pax2a expression 
persists in the fissure up to 54hpf. B) Whole mount in situ hybridization of tln1 probe at 
24, 48, 54 and 72hpf. Lateral (top) and ventral (bottom) images depicting OF expression 







Appendix 2.4: DMH4 dose response 
A) 3D reconstructions of 48hpf whole mount Tg[kdrl:mCherry] (red) embryos treated 
with 1, 5, 50 or 100uM DMH4. DNA stained with DAPI (blue). Increasing concentration 
of DMH4 eliminates mCherry expressing cells from the OF and retina. Scale bar = 50μm. 
B) Brightfield images of DMSO or DMH4 treated embryos at 24, 48 and 72hpf. C) 3D 
reconstructions of whole mount Tg[kdrl:mCherry] (red) embryos treated with DMSO or 
100μM DMH4 from 12-24, 32, 36, 48 or 56hpf. DNA was stained with DAPI (blue). 
Scale bar = 50μm. D) Whole mount Immunohistochemistry was used to simultaneously 
visualize F-actin (red) and laminin (green) in DMSO treated embryos from 24-72hpf. 
Central-proximal regions of the OF are displayed. Scale bar = 50μm. E) Whole mount 
Immunohistochemistry was used to visualize laminin (green) and DNA (blue) 25 or 
50μM DMH4 12-72hpf treatment. Central-proximal regions of the OF are displayed. 





Appendix 2.5: Time course of mmp2, mmp14a and mmp14b ocular expression 
A) Whole mount in situ hybridization of mmp2, mmp14a, mmp14b probes at 24, 26, 30 
32, 34, 36 and 38hpf. Mmp2 expression is present in the OF from 26-34hpf (yellow 
arrowheads). Mmp14a expression is present in the OF from 32-36hpf (yellow 
arrowheads). Mmp14b expression is present in the OF from 32-36hpf (yellow 
arrowheads). B) Whole mount in situ hybridization comparing mmp2, mmp14a and 
mmp14b expression in WT vs pax2a-/- and DMSO vs DMH4 treated embryos at 32hpf. 
Mmp2, 14a and 14b signal within the OF (yellow arrowhead) appears decreased in pax2a-






Appendix 2.6: ARP101 treatment dose response 
A) Brightfield images of DMSO and ARP treated embryos at 48hpf. Concentrations of 
ARP101 exceeding 20uM result in toxic effects. B) Whole mount Immunohistochemistry 
was used to visualize laminin (red) in ARP101 treated Tg[rx3:GFP] embryos at 48hpf. 
Central-proximal and distal regions of the OF are displayed. Scale bar = 50μm. C) 
Fluorescent whole mount in situ hybridization of pax2a probe at 32hpf in DMSO or 
20μM ARP101 treated embryos. OF expression is indicated with a yellow arrowhead. 
ARP101 treatment does not appear to alter pax2a expression in the OF. Broken white 






Appendix 2.7: mmp2 Alt-R crRNA injection results in OF fusion failure phenotypes. 
Brightfield images of A) uninjected, B) mmp2 crRNA or C) pax2a-/- embryos at 72hpf. 
OF fusion failure is observed as a notch in the ventral retina in both mmp2 crRNA 
injected embryos as well as in pax2-/-. Confocal stacks of laminin stained embryos at 
72hpf from D) uninjected, E) mmp2 crRNA and F) pax2a-/- embryos. Pax2a-/- embryos 
display a clear fissure at 72hpf, while mmp2 crRNA injected embryos achieve only 
partial fusion when compared to uninjected controls. G) mmp2 crRNA efficacy was 
assayed using PCR flanking the region targeted. Lanes 1-8 represent gDNA assays from 
individual embryos assayed at 72hpf. Control is found in well 9. ** indicate changes in 






Appendix 2.8: mmp2 expression in cloche mutants 
Whole mount in situ hybridization of mmp2 expression at 32hpf in clo+/+ and clom39/m39 
embryos. Individual dissected eyes were imaged at 20X using DIC optics. Yellow 
arrowheads indicate OF expression in wholemount samples. Magenta arrowheads 






APPENDIX 3: TEMPORAL CHARACTERIZATION OF OPTIC FISSURE 
BASEMENT MEMBRANE COMPOSITION SUGGESTS NIDOGEN MAY BE AN 
INITIAL TARGET OF REMODELING. 


















































APPENDIX 4: SPATIOTEMPORAL CHARACTERIZATION OF ANTERIOR 
SEGMENT MESENCHYME HETEROGENEITY DURING ZEBRAFISH OCULAR 
ANTERIOR SEGMENT DEVELOPMENT 
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